| 10-Deacetyltaxol | nan |
| 11C Topotecan | nan |
| 11D10 AluGel Anti-Idiotype Monoclonal Antibody | nan |
| 12-Allyldeoxoartemisinin | nan |
| 13-Deoxydoxorubicin | nan |
| 14C BMS-275183 | nan |
| 17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521 | nan |
| 2-Deoxy-D-glucose | nan |
| 2-Ethylhydrazide | nan |
| 2-Fluoroadenine | nan |
| 2-Fluorofucose-containing SGN-2FF | nan |
| 2-Hydroxyestradiol | nan |
| 2-Hydroxyestrone | nan |
| 2-Hydroxyflutamide Depot | nan |
| 2-Hydroxyoleic Acid | nan |
| 2-Methoxyestradiol | nan |
| 2-Methoxyestradiol Nanocrystal Colloidal Dispersion | nan |
| 2-Methoxyestrone | nan |
| 2-O; 3-O Desulfated Heparin | nan |
| 2;6-Diaminopurine | nan |
| 2;6-Dimethoxyquinone | nan |
| 2'-F-ara-deoxyuridine | nan |
| 3'-C-ethynylcytidine | nan |
| 3'-dA Phosphoramidate NUC-7738 | nan |
| 4-Nitroestrone 3-Methyl Ether | nan |
| 4-Thio-2-deoxycytidine | nan |
| 4'-Iodo-4'-Deoxydoxorubicin | nan |
| 5-Aza-4'-thio-2'-deoxycytidine | nan |
| 5-Fluoro-2-Deoxycytidine | nan |
| 6-Phosphofructo-2-kinase/fructose-2;6-bisphosphatases Isoform 3 Inhibitor ACT-PFK-158 | nan |
| 7-Cyanoquinocarcinol | nan |
| 7-Ethyl-10-Hydroxycamptothecin | nan |
| 7-Hydroxystaurosporine | nan |
| 8-Azaguanine | nan |
| 9-Ethyl 6-Mercaptopurine | nan |
| 9H-Purine-6Thio-98D | nan |
| A2A Receptor Antagonist EOS100850 | nan |
| Abagovomab | nan |
| Abarelix | nan |
| Abemaciclib | nan |
| Abemaciclib Mesylate | nan |
| Abexinostat | nan |
| Abexinostat Tosylate | nan |
| Abiraterone | nan |
| Abiraterone Acetate | nan |
| Abituzumab | nan |
| Acai Berry Juice | nan |
| Acalabrutinib | nan |
| Acalisib | nan |
| Aceglatone | nan |
| Acetylcysteine | nan |
| Acitretin | nan |
| Acivicin | nan |
| Aclacinomycin B | nan |
| Aclarubicin | nan |
| Acodazole | nan |
| Acodazole Hydrochloride | nan |
| Acolbifene Hydrochloride | nan |
| Acridine | nan |
| Acridine Carboxamide | nan |
| Acronine | nan |
| Actinium Ac 225 Lintuzumab | nan |
| Actinium Ac 225-FPI-1434 | nan |
| Actinium Ac-225 Anti-PSMA Monoclonal Antibody J591 | nan |
| Actinomycin C2 | nan |
| Actinomycin C3 | nan |
| Actinomycin F1 | nan |
| Activin Type 2B Receptor Fc Fusion Protein STM 434 | nan |
| Acyclic Nucleoside Phosphonate Prodrug ABI-1968 | nan |
| Ad-RTS-hIL-12 | nan |
| Adagloxad Simolenin | nan |
| Adavosertib | nan |
| Adecatumumab | nan |
| Adenosine A2A Receptor Antagonist AZD4635 | nan |
| Adenosine A2A Receptor Antagonist CS3005 | nan |
| Adenosine A2A Receptor Antagonist NIR178 | nan |
| Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999 | nan |
| Adenosine A2A/A2B Receptor Antagonist AB928 | nan |
| Adenosine A2B Receptor Antagonist PBF-1129 | nan |
| Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201 | nan |
| Adenoviral Brachyury Vaccine ETBX-051 | nan |
| Adenoviral Cancer Vaccine PF-06936308 | nan |
| Adenoviral MUC1 Vaccine ETBX-061 | nan |
| Adenoviral PSA Vaccine ETBX-071 | nan |
| Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001 | nan |
| Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP | nan |
| Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901 | nan |
| Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE | nan |
| Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918 | nan |
| Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931 | nan |
| Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3 | nan |
| Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001 | nan |
| Aderbasib | nan |
| ADH-1 | nan |
| AE37 Peptide/GM-CSF Vaccine | nan |
| AEE788 | nan |
| Aerosol Gemcitabine | nan |
| Aerosolized Aldesleukin | nan |
| Aerosolized Liposomal Rubitecan | nan |
| Afatinib | nan |
| Afatinib Dimaleate | nan |
| Afimoxifene | nan |
| Afuresertib | nan |
| Agatolimod Sodium | nan |
| Agerafenib | nan |
| Aglatimagene Besadenovec | nan |
| Agonistic Anti-CD40 Monoclonal Antibody ADC-1013 | nan |
| Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949 | nan |
| Agonistic Anti-OX40 Monoclonal Antibody MEDI6469 | nan |
| AKR1C3-activated Prodrug OBI-3424 | nan |
| AKT 1/2 Inhibitor BAY1125976 | nan |
| AKT Inhibitor ARQ 092 | nan |
| Akt Inhibitor LY2780301 | nan |
| Akt Inhibitor MK2206 | nan |
| Akt Inhibitor SR13668 | nan |
| Akt/ERK Inhibitor ONC201 | nan |
| Alacizumab Pegol | nan |
| Alanosine | nan |
| Albumin-binding Cisplatin Prodrug BTP-114 | nan |
| Aldesleukin | nan |
| Aldoxorubicin | nan |
| Alectinib | nan |
| Alefacept | nan |
| Alemtuzumab | nan |
| Alestramustine | nan |
| Alflutinib Mesylate | nan |
| Algenpantucel-L | nan |
| Alisertib | nan |
| Alitretinoin | nan |
| ALK Inhibitor | nan |
| ALK Inhibitor ASP3026 | nan |
| ALK Inhibitor PLB 1003 | nan |
| ALK Inhibitor RO5424802 | nan |
| ALK Inhibitor TAE684 | nan |
| ALK Inhibitor WX-0593 | nan |
| ALK-2 Inhibitor TP-0184 | nan |
| ALK-FAK Inhibitor CEP-37440 | nan |
| ALK/c-Met Inhibitor TQ-B3139 | nan |
| ALK/FAK/Pyk2 Inhibitor CT-707 | nan |
| ALK/ROS1/Met Inhibitor TQ-B3101 | nan |
| ALK/TRK Inhibitor TSR-011 | nan |
| Alkotinib | nan |
| Allodepleted T Cell Immunotherapeutic ATIR101 | nan |
| Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715 | nan |
| Allogeneic Anti-BCMA-CAR T-cells PBCAR269A | nan |
| Allogeneic Anti-BCMA/CS1 Bispecific CAR-T Cells | nan |
| Allogeneic Anti-CD19 CAR T-cells ALLO-501A | nan |
| Allogeneic Anti-CD19 Universal CAR-T Cells CTA101 | nan |
| Allogeneic Anti-CD19-CAR T-cells PBCAR0191 | nan |
| Allogeneic Anti-CD20 CAR T-cells LUCAR-20S | nan |
| Allogeneic Anti-CD20-CAR T-cells PBCAR20A | nan |
| Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22 | nan |
| Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100 | nan |
| Allogeneic CD56-positive CD3-negative Natural Killer Cells CYNK-001 | nan |
| Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001 | nan |
| Allogeneic Cellular Vaccine 1650-G | nan |
| Allogeneic CRISPR-Cas9 Engineered Anti-BCMA T Cells CTX120 | nan |
| Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130 | nan |
| Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A | nan |
| Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM | nan |
| Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine | nan |
| Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine | nan |
| Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo | nan |
| Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo | nan |
| Allogeneic IL13-Zetakine/HyTK-Expressing-Glucocorticoid Resistant Cytotoxic T Lymphocytes GRm13Z40-2 | nan |
| Allogeneic Irradiated Melanoma Cell Vaccine CSF470 | nan |
| Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307 | nan |
| Allogeneic Melanoma Vaccine AGI-101H | nan |
| Allogeneic Natural Killer Cell Line MG4101 | nan |
| Allogeneic Natural Killer Cell Line NK-92 | nan |
| Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01 | nan |
| Allogeneic Renal Cell Carcinoma Vaccine MGN1601 | nan |
| Allogeneic Third-party Suicide Gene-transduced Anti-HLA-DPB1*0401 CD4+ T-cells CTL 19 | nan |
| Allosteric ErbB Inhibitor BDTX-189 | nan |
| Allovectin-7 | nan |
| Almurtide | nan |
| Alobresib | nan |
| Alofanib | nan |
| Alpelisib | nan |
| Alpha Galactosylceramide | nan |
| Alpha V Beta 1 Inhibitor ATN-161 | nan |
| Alpha V Beta 8 Antagonist PF-06940434 | nan |
| alpha-Folate Receptor-targeting Thymidylate Synthase Inhibitor ONX-0801 | nan |
| Alpha-Gal AGI-134 | nan |
| Alpha-lactalbumin-derived Synthetic Peptide-lipid Complex Alpha1H | nan |
| Alpha-Thioguanine Deoxyriboside | nan |
| Alpha-tocopheryloxyacetic Acid | nan |
| Alsevalimab | nan |
| Altiratinib | nan |
| Altretamine | nan |
| Alvespimycin | nan |
| Alvespimycin Hydrochloride | nan |
| Alvocidib | nan |
| Alvocidib Hydrochloride | nan |
| Alvocidib Prodrug TP-1287 | nan |
| Amatuximab | nan |
| Ambamustine | nan |
| Ambazone | nan |
| Amblyomin-X | nan |
| Amcasertib | nan |
| Ametantrone | nan |
| Amifostine | nan |
| Amino Acid Injection | nan |
| Aminocamptothecin | nan |
| Aminocamptothecin Colloidal Dispersion | nan |
| Aminoflavone Prodrug AFP464 | nan |
| Aminopterin | nan |
| Aminopterin Sodium | nan |
| Amivantamab | nan |
| Amolimogene Bepiplasmid | nan |
| Amonafide L-Malate | nan |
| Amrubicin | nan |
| Amrubicin Hydrochloride | nan |
| Amsacrine | nan |
| Amsacrine Lactate | nan |
| Amsilarotene | nan |
| Amustaline | nan |
| Amustaline Dihydrochloride | nan |
| Amuvatinib | nan |
| Amuvatinib Hydrochloride | nan |
| Anakinra | nan |
| Anastrozole | nan |
| Anaxirone | nan |
| Ancitabine | nan |
| Ancitabine Hydrochloride | nan |
| Andecaliximab | nan |
| Androgen Antagonist APC-100 | nan |
| Androgen Receptor Antagonist BAY 1161116 | nan |
| Androgen Receptor Antagonist SHR3680 | nan |
| Androgen Receptor Antagonist TAS3681 | nan |
| Androgen Receptor Antagonist TRC253 | nan |
| Androgen Receptor Antisense Oligonucleotide AZD5312 | nan |
| Androgen Receptor Antisense Oligonucleotide EZN-4176 | nan |
| Androgen Receptor Degrader ARV-110 | nan |
| Androgen Receptor Degrader CC-94676 | nan |
| Androgen Receptor Downregulator AZD3514 | nan |
| Androgen Receptor Inhibitor EPI-7386 | nan |
| Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118 | nan |
| Androgen Receptor/Glucocorticoid Receptor Antagonist CB-03-10 | nan |
| Andrographolide | nan |
| Androstane Steroid HE3235 | nan |
| Anetumab Ravtansine | nan |
| Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241 | nan |
| Angiogenesis Inhibitor GT-111 | nan |
| Angiogenesis Inhibitor JI-101 | nan |
| Angiogenesis/Heparanase Inhibitor PG545 | nan |
| Angiopoietin-2-specific Fusion Protein PF-04856884 | nan |
| Anhydrous Enol-oxaloacetate | nan |
| Anhydrovinblastine | nan |
| Aniline Mustard | nan |
| Anlotinib Hydrochloride | nan |
| Annamycin | nan |
| Annamycin Liposomal | nan |
| Annonaceous Acetogenins | nan |
| Ansamitomicin P-3 | nan |
| Anthramycin | nan |
| Anthrapyrazole | nan |
| Anti c-KIT Antibody-drug Conjugate LOP628 | nan |
| Anti-5T4 Antibody-drug Conjugate ASN004 | nan |
| Anti-5T4 Antibody-Drug Conjugate PF-06263507 | nan |
| Anti-5T4 Antibody-drug Conjugate SYD1875 | nan |
| Anti-A33 Monoclonal Antibody KRN330 | nan |
| Anti-A5B1 Integrin Monoclonal Antibody PF-04605412 | nan |
| Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087 | nan |
| Anti-AG7 Antibody Drug Conjugate AbGn-107 | nan |
| Anti-AGS-16 Monoclonal Antibody AGS-16M18 | nan |
| Anti-AGS-5 Antibody-Drug Conjugate ASG-5ME | nan |
| Anti-AGS-8 Monoclonal Antibody AGS-8M4 | nan |
| Anti-alpha BCMA/Anti-alpha CD3 T-cell Engaging Bispecific Antibody TNB-383B | nan |
| Anti-alpha5beta1 Integrin Antibody MINT1526A | nan |
| Anti-ANG2 Monoclonal Antibody MEDI-3617 | nan |
| Anti-angiopoietin Monoclonal Antibody AMG 780 | nan |
| Anti-APRIL Monoclonal Antibody BION-1301 | nan |
| Anti-AXL Fusion Protein AVB-S6-500 | nan |
| Anti-AXL/PBD Antibody-drug Conjugate ADCT-601 | nan |
| Anti-B7-H3 Antibody DS-5573a | nan |
| Anti-B7-H3/DXd Antibody-drug Conjugate DS-7300a | nan |
| Anti-B7-H4 Monoclonal Antibody FPA150 | nan |
| Anti-B7H3 Antibody-drug Conjugate MGC018 | nan |
| Anti-BCMA Antibody SEA-BCMA | nan |
| Anti-BCMA Antibody-drug Conjugate AMG 224 | nan |
| Anti-BCMA Antibody-drug Conjugate CC-99712 | nan |
| Anti-BCMA Antibody-drug Conjugate GSK2857916 | nan |
| Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA | nan |
| Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459 | nan |
| Anti-BCMA/CD3 BiTE Antibody AMG 420 | nan |
| Anti-BCMA/CD3 BiTE Antibody AMG 701 | nan |
| Anti-BCMA/CD3 BiTE Antibody REGN5458 | nan |
| Anti-BCMA/PBD ADC MEDI2228 | nan |
| Anti-BTLA Monoclonal Antibody TAB004 | nan |
| Anti-BTN3A Agonistic Monoclonal Antibody ICT01 | nan |
| Anti-c-fms Monoclonal Antibody AMG 820 | nan |
| Anti-c-KIT Monoclonal Antibody CDX 0158 | nan |
| Anti-c-Met Antibody-drug Conjugate HTI-1066 | nan |
| Anti-c-Met Antibody-drug Conjugate TR1801 | nan |
| Anti-c-Met Monoclonal Antibody ABT-700 | nan |
| Anti-c-Met Monoclonal Antibody ARGX-111 | nan |
| Anti-c-Met Monoclonal Antibody HLX55 | nan |
| Anti-c-MET Monoclonal Antibody LY2875358 | nan |
| Anti-C-met Monoclonal Antibody SAIT301 | nan |
| Anti-C4.4a Antibody-Drug Conjugate BAY1129980 | nan |
| Anti-C5aR Monoclonal Antibody IPH5401 | nan |
| Anti-CA19-9 Monoclonal Antibody 5B1 | nan |
| Anti-CA6-DM4 Immunoconjugate SAR566658 | nan |
| Anti-CCR7 Antibody-drug Conjugate JBH492 | nan |
| Anti-CD117 Monoclonal Antibody JSP191 | nan |
| Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1 | nan |
| Anti-CD123 ADC IMGN632 | nan |
| Anti-CD123 Monoclonal Antibody CSL360 | nan |
| Anti-CD123 Monoclonal Antibody KHK2823 | nan |
| Anti-CD123 x Anti-CD3 Bispecific Antibody XmAb1404 | nan |
| Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A | nan |
| Anti-CD123/CD3 Bispecific Antibody APVO436 | nan |
| Anti-CD123/CD3 Bispecific Antibody JNJ-63709178 | nan |
| Anti-CD123/CD3 BiTE Antibody SAR440234 | nan |
| Anti-CD137 Agonistic Monoclonal Antibody ADG106 | nan |
| Anti-CD137 Agonistic Monoclonal Antibody AGEN2373 | nan |
| Anti-CD137 Agonistic Monoclonal Antibody ATOR-1017 | nan |
| Anti-CD137 Agonistic Monoclonal Antibody CTX-471 | nan |
| Anti-CD137 Agonistic Monoclonal Antibody LVGN6051 | nan |
| Anti-CD157 Monoclonal Antibody MEN1112 | nan |
| Anti-CD166 Probody-drug Conjugate CX-2009 | nan |
| Anti-CD19 Antibody-drug Conjugate SGN-CD19B | nan |
| Anti-CD19 Antibody-T-cell Receptor-expressing T-cells ET019003 | nan |
| Anti-CD19 iCAR NK Cells | nan |
| Anti-CD19 Monoclonal Antibody DI-B4 | nan |
| Anti-CD19 Monoclonal Antibody MDX-1342 | nan |
| Anti-CD19 Monoclonal Antibody MEDI-551 | nan |
| Anti-CD19 Monoclonal Antibody XmAb5574 | nan |
| Anti-CD19-DM4 Immunoconjugate SAR3419 | nan |
| Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL | nan |
| Anti-CD19/CD22 CAR NK Cells | nan |
| Anti-CD19/CD3 BiTE Antibody AMG 562 | nan |
| Anti-CD19/CD3 Tetravalent Antibody AFM11 | nan |
| Anti-CD20 Monoclonal Antibody B001 | nan |
| Anti-CD20 Monoclonal Antibody BAT4306F | nan |
| Anti-CD20 Monoclonal Antibody MIL62 | nan |
| Anti-CD20 Monoclonal Antibody PRO131921 | nan |
| Anti-CD20 Monoclonal Antibody SCT400 | nan |
| Anti-CD20 Monoclonal Antibody TL011 | nan |
| Anti-CD20 Monoclonal Antibody-Interferon-alpha Fusion Protein IGN002 | nan |
| Anti-CD20-engineered Toxin Body MT-3724 | nan |
| Anti-CD20/Anti-CD3 Bispecific IgM Antibody IGM2323 | nan |
| Anti-CD20/CD3 Monoclonal Antibody REGN1979 | nan |
| Anti-CD20/CD3 Monoclonal Antibody XmAb13676 | nan |
| Anti-CD205 Antibody-drug Conjugate OBT076 | nan |
| Anti-CD22 ADC TRPH-222 | nan |
| Anti-CD22 Monoclonal Antibody-MMAE Conjugate DCDT2980S | nan |
| Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A | nan |
| Anti-CD25 Monoclonal Antibody RO7296682 | nan |
| Anti-CD25-PBD Antibody-drug Conjugate ADCT-301 | nan |
| Anti-CD26 Monoclonal Antibody YS110 | nan |
| Anti-CD27 Agonistic Monoclonal Antibody MK-5890 | nan |
| Anti-CD27L Antibody-Drug Conjugate AMG 172 | nan |
| Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1) | nan |
| Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044 | nan |
| Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody JNJ-64007957 | nan |
| Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody PF-06863135 | nan |
| Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05 | nan |
| Anti-CD3/Anti-GPRC5D Bispecific Monoclonal Antibody JNJ-64407564 | nan |
| Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119 | nan |
| Anti-CD3/CD20 Bispecific Antibody GEN3013 | nan |
| Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424 | nan |
| Anti-CD3/CD7-Ricin Toxin A Immunotoxin | nan |
| Anti-CD30 Monoclonal Antibody MDX-1401 | nan |
| Anti-CD30 Monoclonal Antibody XmAb2513 | nan |
| Anti-CD30/CD16A Monoclonal Antibody AFM13 | nan |
| Anti-CD30/DM1 Antibody-drug Conjugate F0002 | nan |
| Anti-CD32B Monoclonal Antibody BI-1206 | nan |
| Anti-CD33 Antibody-drug Conjugate IMGN779 | nan |
| Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564 | nan |
| Anti-CD33 Monoclonal Antibody BI 836858 | nan |
| Anti-CD33 Monoclonal Antibody-DM4 Conjugate AVE9633 | nan |
| Anti-CD33/CD3 Bispecific Antibody GEM 333 | nan |
| Anti-CD33/CD3 Bispecific Antibody JNJ-67571244 | nan |
| Anti-CD33/CD3 BiTE Antibody AMG 330 | nan |
| Anti-CD33/CD3 BiTE Antibody AMG 673 | nan |
| Anti-CD352 Antibody-drug Conjugate SGN-CD352A | nan |
| Anti-CD37 Antibody-Drug Conjugate IMGN529 | nan |
| Anti-CD37 Bispecific Monoclonal Antibody GEN3009 | nan |
| Anti-CD37 MMAE Antibody-drug Conjugate AGS67E | nan |
| Anti-CD37 Monoclonal Antibody BI 836826 | nan |
| Anti-CD38 Antibody-drug Conjugate STI-6129 | nan |
| Anti-CD38 Monoclonal Antibody MOR03087 | nan |
| Anti-CD38 Monoclonal Antibody SAR442085 | nan |
| Anti-CD38 Monoclonal Antibody TAK-079 | nan |
| Anti-CD38-targeted IgG4-attenuated IFNa TAK-573 | nan |
| Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257 | nan |
| Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342 | nan |
| Anti-CD39 Monoclonal Antibody SRF617 | nan |
| Anti-CD39 Monoclonal Antibody TTX-030 | nan |
| Anti-CD40 Agonist Monoclonal Antibody ABBV-927 | nan |
| Anti-CD40 Agonist Monoclonal Antibody CDX-1140 | nan |
| Anti-CD40 Monoclonal Antibody Chi Lob 7/4 | nan |
| Anti-CD40 Monoclonal Antibody SEA-CD40 | nan |
| Anti-CD40/Anti-4-1BB Bispecific Agonist Monoclonal Antibody GEN1042 | nan |
| Anti-CD40/Anti-TAA Bispecific Monoclonal Antibody ABBV-428 | nan |
| Anti-CD40L Fc-Fusion Protein BMS-986004 | nan |
| Anti-CD44 Monoclonal Antibody RO5429083 | nan |
| Anti-CD45 Monoclonal Antibody AHN-12 | nan |
| Anti-CD46 Antibody-drug Conjugate FOR46 | nan |
| Anti-CD47 ADC SGN-CD47M | nan |
| Anti-CD47 Monoclonal Antibody AO-176 | nan |
| Anti-CD47 Monoclonal Antibody CC-90002 | nan |
| Anti-CD47 Monoclonal Antibody Hu5F9-G4 | nan |
| Anti-CD47 Monoclonal Antibody IBI188 | nan |
| Anti-CD47 Monoclonal Antibody IMC-002 | nan |
| Anti-CD47 Monoclonal Antibody SHR-1603 | nan |
| Anti-CD47 Monoclonal Antibody SRF231 | nan |
| Anti-CD47 Monoclonal Antibody TJC4 | nan |
| Anti-CD47/CD19 Bispecific Monoclonal Antibody TG-1801 | nan |
| Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A | nan |
| Anti-CD52 Monoclonal Antibody ALLO-647 | nan |
| Anti-CD70 Antibody-Drug Conjugate MDX-1203 | nan |
| Anti-CD70 Antibody-drug Conjugate SGN-CD70A | nan |
| Anti-CD70 CAR-expressing T Lymphocytes | nan |
| Anti-CD70 Monoclonal Antibody MDX-1411 | nan |
| Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029 | nan |
| Anti-CD73 Monoclonal Antibody BMS-986179 | nan |
| Anti-CD73 Monoclonal Antibody CPI-006 | nan |
| Anti-CD73 Monoclonal Antibody NZV930 | nan |
| Anti-CD73 Monoclonal Antibody TJ4309 | nan |
| Anti-CD74 Antibody-drug Conjugate STRO-001 | nan |
| Anti-CD98 Monoclonal Antibody IGN523 | nan |
| Anti-CDH6 Antibody-drug Conjugate HKT288 | nan |
| Anti-CEA BiTE Monoclonal Antibody AMG211 | nan |
| Anti-CEA/Anti-DTPA-In (F6-734) Bispecific Antibody | nan |
| Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2 | nan |
| Anti-CEACAM1 Monoclonal Antibody CM-24 | nan |
| Anti-CEACAM5 Antibody-Drug Conjugate SAR408701 | nan |
| Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47 | nan |
| Anti-CEACAM6 Antibody BAY1834942 | nan |
| Anti-claudin18.2 Monoclonal Antibody AB011 | nan |
| Anti-Claudin18.2 Monoclonal Antibody TST001 | nan |
| Anti-CLDN6 Monoclonal Antibody ASP1650 | nan |
| Anti-CLEC12A/CD3 Bispecific Antibody MCLA117 | nan |
| Anti-CLEVER-1 Monoclonal Antibody FP-1305 | nan |
| Anti-CSF1 Monoclonal Antibody PD-0360324 | nan |
| Anti-CSF1R Monoclonal Antibody IMC-CS4 | nan |
| Anti-CSF1R Monoclonal Antibody SNDX-6352 | nan |
| Anti-CTGF Monoclonal Antibody FG-3019 | nan |
| Anti-CTLA-4 Monoclonal Antibody ADG116 | nan |
| Anti-CTLA-4 Monoclonal Antibody ADU-1604 | nan |
| Anti-CTLA-4 Monoclonal Antibody AGEN1181 | nan |
| Anti-CTLA-4 Monoclonal Antibody BCD-145 | nan |
| Anti-CTLA-4 Monoclonal Antibody HBM4003 | nan |
| Anti-CTLA-4 Monoclonal Antibody MK-1308 | nan |
| Anti-CTLA-4 Monoclonal Antibody ONC-392 | nan |
| Anti-CTLA-4 Monoclonal Antibody REGN4659 | nan |
| Anti-CTLA-4 Probody BMS-986288 | nan |
| Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217 | nan |
| Anti-CTLA-4/LAG-3 Bispecific Antibody XmAb22841 | nan |
| Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015 | nan |
| Anti-CTLA4 Antibody Fc Fusion Protein KN044 | nan |
| Anti-CTLA4 Monoclonal Antibody BMS-986218 | nan |
| Anti-CXCR4 Monoclonal Antibody PF-06747143 | nan |
| Anti-Denatured Collagen Monoclonal Antibody TRC093 | nan |
| Anti-DKK-1 Monoclonal Antibody LY2812176 | nan |
| Anti-DKK1 Monoclonal Antibody BHQ880 | nan |
| Anti-DLL3/CD3 BiTE Antibody AMG 757 | nan |
| Anti-DLL4 Monoclonal Antibody MEDI0639 | nan |
| Anti-DLL4/VEGF Bispecific Monoclonal Antibody OMP-305B83 | nan |
| Anti-DR5 Agonist Monoclonal Antibody TRA-8 | nan |
| Anti-DR5 Agonistic Antibody DS-8273a | nan |
| Anti-DR5 Agonistic Monoclonal Antibody INBRX-109 | nan |
| Anti-EGFR Monoclonal Antibody CPGJ 602 | nan |
| Anti-EGFR Monoclonal Antibody EMD 55900 | nan |
| Anti-EGFR Monoclonal Antibody GC1118 | nan |
| Anti-EGFR Monoclonal Antibody GT-MAB 5.2-GEX | nan |
| Anti-EGFR Monoclonal Antibody HLX-07 | nan |
| Anti-EGFR Monoclonal Antibody Mixture MM-151 | nan |
| Anti-EGFR Monoclonal Antibody RO5083945 | nan |
| Anti-EGFR Monoclonal Antibody SCT200 | nan |
| Anti-EGFR Monoclonal Antibody SYN004 | nan |
| Anti-EGFR TAP Antibody-drug Conjugate IMGN289 | nan |
| Anti-EGFR/c-Met Bispecific Antibody EMB-01 | nan |
| Anti-EGFR/c-Met Bispecific Antibody JNJ-61186372 | nan |
| Anti-EGFR/CD16A Bispecific Antibody AFM24 | nan |
| Anti-EGFR/DM1 Antibody-drug Conjugate AVID100 | nan |
| Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013 | nan |
| Anti-EGFR/PBD Antibody-drug Conjugate ABBV-321 | nan |
| Anti-EGFRvIII Antibody Drug Conjugate AMG 595 | nan |
| Anti-EGFRvIII Immunotoxin MR1-1 | nan |
| Anti-EGFRvIII/CD3 BiTE Antibody AMG 596 | nan |
| Anti-EGP-2 Immunotoxin MOC31-PE | nan |
| Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F | nan |
| Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F | nan |
| Anti-Ep-CAM Monoclonal Antibody ING-1 | nan |
| Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310 | nan |
| Anti-EphA2 Monoclonal Antibody DS-8895a | nan |
| Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547 | nan |
| Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111 | nan |
| Anti-ErbB3 Antibody ISU104 | nan |
| Anti-ErbB3 Monoclonal Antibody AV-203 | nan |
| Anti-ErbB3 Monoclonal Antibody CDX-3379 | nan |
| Anti-ErbB3 Monoclonal Antibody REGN1400 | nan |
| Anti-ErbB3/Anti-IGF-1R Bispecific Monoclonal Antibody MM-141 | nan |
| Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A | nan |
| Anti-FAP/Interleukin-2 Fusion Protein RO6874281 | nan |
| Anti-FCRH5/CD3 BiTE Antibody BFCR4350A | nan |
| Anti-FGFR2 Antibody BAY1179470 | nan |
| Anti-FGFR3 Antibody-drug Conjugate LY3076226 | nan |
| Anti-FGFR4 Monoclonal Antibody U3-1784 | nan |
| Anti-FLT3 Antibody-drug Conjugate AGS62P1 | nan |
| Anti-FLT3 Monoclonal Antibody 4G8-SDIEM | nan |
| Anti-FLT3 Monoclonal Antibody IMC-EB10 | nan |
| Anti-FLT3/CD3 BiTE Antibody AMG 427 | nan |
| Anti-Folate Receptor-alpha Antibody Drug Conjugate STRO-002 | nan |
| Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202 | nan |
| Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012 | nan |
| Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962 | nan |
| Anti-GARP Monoclonal Antibody ABBV-151 | nan |
| Anti-GCC Antibody-Drug Conjugate MLN0264 | nan |
| Anti-GCC Antibody-Drug Conjugate TAK-164 | nan |
| Anti-GD2 hu3F8/Anti-CD3 huOKT3 Bispecific Antibody | nan |
| Anti-GD2 Monoclonal Antibody hu14.18K322A | nan |
| Anti-GD2 Monoclonal Antibody MORAb-028 | nan |
| Anti-GD3 Antibody-drug Conjugate PF-06688992 | nan |
| Anti-GITR Agonistic Monoclonal Antibody ASP1951 | nan |
| Anti-GITR Agonistic Monoclonal Antibody BMS-986156 | nan |
| Anti-GITR Agonistic Monoclonal Antibody INCAGN01876 | nan |
| Anti-GITR Monoclonal Antibody GWN 323 | nan |
| Anti-GITR Monoclonal Antibody MK-4166 | nan |
| Anti-Globo H Monoclonal Antibody OBI-888 | nan |
| Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999 | nan |
| Anti-Glypican 3/CD3 Bispecific Antibody ERY974 | nan |
| Anti-GnRH Vaccine PEP223 | nan |
| Anti-gpA33/CD3 Monoclonal Antibody MGD007 | nan |
| Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a | nan |
| Anti-gremlin-1 Monoclonal Antibody UCB6114 | nan |
| Anti-GRP78 Monoclonal Antibody PAT-SM6 | nan |
| Anti-HA Epitope Monoclonal Antibody MEDI8852 | nan |
| Anti-HB-EGF Monoclonal Antibody KHK2866 | nan |
| Anti-HBEGF Monoclonal Antibody U3-1565 | nan |
| Anti-hepcidin Monoclonal Antibody LY2787106 | nan |
| Anti-HER-2 Bispecific Antibody KN026 | nan |
| Anti-HER2 ADC DS-8201a | nan |
| Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702 | nan |
| Anti-HER2 Antibody-drug Conjugate A166 | nan |
| Anti-HER2 Antibody-drug Conjugate ARX788 | nan |
| Anti-HER2 Antibody-drug Conjugate BAT8001 | nan |
| Anti-HER2 Antibody-drug Conjugate DP303c | nan |
| Anti-HER2 Antibody-drug Conjugate MEDI4276 | nan |
| Anti-HER2 Antibody-drug Conjugate RC48 | nan |
| Anti-HER2 Bi-specific Monoclonal Antibody ZW25 | nan |
| Anti-HER2 Bispecific Antibody-drug Conjugate ZW49 | nan |
| Anti-HER2 Immune Stimulator-antibody Conjugate NJH395 | nan |
| Anti-HER2 Monoclonal Antibody B002 | nan |
| Anti-HER2 Monoclonal Antibody CT-P6 | nan |
| Anti-HER2 Monoclonal Antibody HLX22 | nan |
| Anti-HER2 Monoclonal Antibody/Anti-CD137Anticalin Bispecific Fusion Protein PRS-343 | nan |
| Anti-HER2-DM1 ADC B003 | nan |
| Anti-HER2-DM1 Antibody-drug Conjugate GQ1001 | nan |
| Anti-HER2-vc0101 ADC PF-06804103 | nan |
| Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody BTRC 4017A | nan |
| Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302 | nan |
| Anti-HER2/Anti-HER3 Bispecific Monoclonal Antibody MCLA-128 | nan |
| Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522 | nan |
| Anti-HER2/MMAE Antibody-drug Conjugate MRG002 | nan |
| Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A | nan |
| Anti-HER3 Antibody-drug Conjugate U3 1402 | nan |
| Anti-HER3 Monoclonal Antibody GSK2849330 | nan |
| Anti-HGF Monoclonal Antibody TAK-701 | nan |
| Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968 | nan |
| Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1 | nan |
| Anti-HLA-DR Monoclonal Antibody IMMU-114 | nan |
| Anti-HLA-G Antibody TTX-080 | nan |
| Anti-human GITR Monoclonal Antibody AMG 228 | nan |
| Anti-human GITR Monoclonal Antibody TRX518 | nan |
| Anti-ICAM-1 Monoclonal Antibody BI-505 | nan |
| Anti-ICOS Agonist Antibody GSK3359609 | nan |
| Anti-ICOS Agonist Monoclonal Antibody BMS-986226 | nan |
| Anti-ICOS Monoclonal Antibody KY1044 | nan |
| Anti-ICOS Monoclonal Antibody MEDI-570 | nan |
| Anti-IGF-1R Monoclonal Antibody AVE1642 | nan |
| Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022 | nan |
| Anti-IL-1 alpha Monoclonal Antibody MABp1 | nan |
| Anti-IL-13 Humanized Monoclonal Antibody TNX-650 | nan |
| Anti-IL-15 Monoclonal Antibody AMG 714 | nan |
| Anti-IL-8 Monoclonal Antibody BMS-986253 | nan |
| Anti-IL-8 Monoclonal Antibody HuMax-IL8 | nan |
| Anti-ILDR2 Monoclonal Antibody BAY 1905254 | nan |
| Anti-ILT4 Monoclonal Antibody MK-4830 | nan |
| Anti-integrin Beta-6/MMAE Antibody-drug Conjugate SGN-B6A | nan |
| Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388 | nan |
| Anti-IRF4 Antisense Oligonucleotide ION251 | nan |
| Anti-KIR Monoclonal Antibody IPH 2101 | nan |
| Anti-KSP/Anti-VEGF siRNAs ALN-VSP02 | nan |
| Anti-LAG-3 Monoclonal Antibody IBI-110 | nan |
| Anti-LAG-3 Monoclonal Antibody INCAGN02385 | nan |
| Anti-LAG-3 Monoclonal Antibody LAG525 | nan |
| Anti-LAG-3 Monoclonal Antibody REGN3767 | nan |
| Anti-LAG-3/PD-L1 Bispecific Antibody FS118 | nan |
| Anti-LAG3 Monoclonal Antibody BI 754111 | nan |
| Anti-LAG3 Monoclonal Antibody MK-4280 | nan |
| Anti-LAG3 Monoclonal Antibody TSR-033 | nan |
| Anti-LAMP1 Antibody-drug Conjugate SAR428926 | nan |
| Anti-latent TGF-beta 1 Monoclonal Antibody SRK-181 | nan |
| Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102 | nan |
| Anti-LGR5 Monoclonal Antibody BNC101 | nan |
| Anti-LIF Monoclonal Antibody MSC-1 | nan |
| Anti-LILRB4 Monoclonal Antibody IO-202 | nan |
| Anti-LIV-1 Monoclonal Antibody-MMAE Conjugate SGN-LIV1A | nan |
| Anti-Ly6E Antibody-Drug Conjugate RG 7841 | nan |
| Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C | nan |
| Anti-Melanin Monoclonal Antibody PTI-6D2 | nan |
| Anti-mesothelin Antibody-drug Conjugate BMS-986148 | nan |
| Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100 | nan |
| Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A | nan |
| Anti-mesothelin/MMAE Antibody-drug Conjugate RC88 | nan |
| Anti-Met Monoclonal Antibody Mixture Sym015 | nan |
| Anti-Met/EGFR Monoclonal Antibody LY3164530 | nan |
| Anti-MMP-9 Monoclonal Antibody GS-5745 | nan |
| Anti-MUC1 Monoclonal Antibody BTH1704 | nan |
| Anti-MUC16/CD3 Bispecific Antibody REGN4018 | nan |
| Anti-MUC16/CD3 BiTE Antibody REGN4018 | nan |
| Anti-MUC16/MMAE Antibody-Drug Conjugate DMUC4064A | nan |
| Anti-MUC17/CD3 BiTE Antibody AMG 199 | nan |
| Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062 | nan |
| Anti-myostatin Monoclonal Antibody LY2495655 | nan |
| Anti-NaPi2b Antibody-drug Conjugate XMT-1592 | nan |
| Anti-NaPi2b Monoclonal Antibody XMT-1535 | nan |
| Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E | nan |
| Anti-Neuropilin-1 Monoclonal Antibody MNRP1685A | nan |
| Anti-nf-P2X7 Antibody Ointment BIL-010t | nan |
| Anti-NRP1 Antibody ASP1948 | nan |
| Anti-Nucleolin Aptamer AS1411 | nan |
| Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A | nan |
| Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso | nan |
| Anti-OFA Immunotherapeutic BB-MPI-03 | nan |
| Anti-OX40 Agonist Monoclonal Antibody ABBV-368 | nan |
| Anti-OX40 Agonist Monoclonal Antibody BGB-A445 | nan |
| Anti-OX40 Agonist Monoclonal Antibody PF-04518600 | nan |
| Anti-OX40 Antibody BMS 986178 | nan |
| Anti-OX40 Hexavalent Agonist Antibody INBRX-106 | nan |
| Anti-OX40 Monoclonal Antibody GSK3174998 | nan |
| Anti-OX40 Monoclonal Antibody IBI101 | nan |
| Anti-PD-1 Antibody-interleukin-21 Mutein Fusion Protein AMG 256 | nan |
| Anti-PD-1 Checkpoint Inhibitor PF-06801591 | nan |
| Anti-PD-1 Fusion Protein AMP-224 | nan |
| Anti-PD-1 Monoclonal Antibody 609A | nan |
| Anti-PD-1 Monoclonal Antibody AK105 | nan |
| Anti-PD-1 Monoclonal Antibody AMG 404 | nan |
| Anti-PD-1 Monoclonal Antibody BAT1306 | nan |
| Anti-PD-1 Monoclonal Antibody BCD-100 | nan |
| Anti-PD-1 Monoclonal Antibody BI 754091 | nan |
| Anti-PD-1 Monoclonal Antibody CS1003 | nan |
| Anti-PD-1 Monoclonal Antibody F520 | nan |
| Anti-PD-1 Monoclonal Antibody GLS-010 | nan |
| Anti-PD-1 Monoclonal Antibody HLX10 | nan |
| Anti-PD-1 Monoclonal Antibody HX008 | nan |
| Anti-PD-1 Monoclonal Antibody JTX-4014 | nan |
| Anti-PD-1 Monoclonal Antibody LZM009 | nan |
| Anti-PD-1 Monoclonal Antibody MEDI0680 | nan |
| Anti-PD-1 Monoclonal Antibody MGA012 | nan |
| Anti-PD-1 Monoclonal Antibody SCT-I10A | nan |
| Anti-PD-1 Monoclonal Antibody Sym021 | nan |
| Anti-PD-1 Monoclonal Antibody TSR-042 | nan |
| Anti-PD-1/Anti-CTLA4 DART Protein MGD019 | nan |
| Anti-PD-1/Anti-HER2 Bispecific Antibody IBI315 | nan |
| Anti-PD-1/Anti-LAG-3 Bispecific Antibody RO7247669 | nan |
| Anti-PD-1/Anti-LAG-3 DART Protein MGD013 | nan |
| Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318 | nan |
| Anti-PD-1/Anti-PD-L1 Bispecific Antibody LY3434172 | nan |
| Anti-PD-1/CD47 Infusion Protein HX009 | nan |
| Anti-PD-1/CTLA-4 Bispecific Antibody AK104 | nan |
| Anti-PD-1/CTLA-4 Bispecific Antibody MEDI5752 | nan |
| Anti-PD-1/TIM-3 Bispecific Antibody RO7121661 | nan |
| Anti-PD-1/VEGF Bispecific Antibody AK112 | nan |
| Anti-PD-L1 Monoclonal Antibody A167 | nan |
| Anti-PD-L1 Monoclonal Antibody BCD-135 | nan |
| Anti-PD-L1 Monoclonal Antibody BGB-A333 | nan |
| Anti-PD-L1 Monoclonal Antibody CBT-502 | nan |
| Anti-PD-L1 Monoclonal Antibody CK-301 | nan |
| Anti-PD-L1 Monoclonal Antibody CS1001 | nan |
| Anti-PD-L1 Monoclonal Antibody FAZ053 | nan |
| Anti-PD-L1 Monoclonal Antibody GR1405 | nan |
| Anti-PD-L1 Monoclonal Antibody HLX20 | nan |
| Anti-PD-L1 Monoclonal Antibody IMC-001 | nan |
| Anti-PD-L1 Monoclonal Antibody LY3300054 | nan |
| Anti-PD-L1 Monoclonal Antibody MDX-1105 | nan |
| Anti-PD-L1 Monoclonal Antibody MSB2311 | nan |
| Anti-PD-L1 Monoclonal Antibody RC98 | nan |
| Anti-PD-L1 Monoclonal Antibody SHR-1316 | nan |
| Anti-PD-L1 Monoclonal Antibody TG-1501 | nan |
| Anti-PD-L1 Monoclonal Antibody ZKAB001 | nan |
| Anti-PD-L1/4-1BB Bispecific Antibody INBRX-105 | nan |
| Anti-PD-L1/Anti-4-1BB Bispecific Monoclonal Antibody GEN1046 | nan |
| Anti-PD-L1/CD137 Bispecific Antibody MCLA-145 | nan |
| Anti-PD-L1/IL-15 Fusion Protein KD033 | nan |
| Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244 | nan |
| Anti-PD1 Monoclonal Antibody AGEN2034 | nan |
| Anti-PD1/CTLA4 Bispecific Antibody XmAb20717 | nan |
| Anti-PGF Monoclonal Antibody RO5323441 | nan |
| Anti-PKN3 siRNA Atu027 | nan |
| Anti-PLGF Monoclonal Antibody TB-403 | nan |
| Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4 | nan |
| Anti-PRAME Immunotherapeutic GSK2302032A | nan |
| Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C | nan |
| Anti-PRL-3 Monoclonal Antibody PRL3-zumab | nan |
| Anti-prolactin Receptor Antibody LFA102 | nan |
| Anti-PSCA Monoclonal Antibody AGS-1C4D4 | nan |
| Anti-PSMA Monoclonal Antibody MDX1201-A488 | nan |
| Anti-PSMA Monoclonal Antibody MLN591-DM1 Immunoconjugate MLN2704 | nan |
| Anti-PSMA Monoclonal Antibody-MMAE Conjugate | nan |
| Anti-PSMA/CD28 Bispecific Antibody REGN5678 | nan |
| Anti-PSMA/CD3 Bispecific Antibody CCW702 | nan |
| Anti-PSMA/CD3 Bispecific Antibody JNJ-63898081 | nan |
| Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414 | nan |
| Anti-PSMA/PBD ADC MEDI3726 | nan |
| Anti-PTK7/Auristatin-0101 Antibody-drug Conjugate PF-06647020 | nan |
| Anti-PVRIG Monoclonal Antibody COM701 | nan |
| Anti-RANKL Monoclonal Antibody GB-223 | nan |
| Anti-RANKL Monoclonal Antibody JMT103 | nan |
| Anti-Ribonucleoprotein Antibody ATRC-101 | nan |
| Anti-ROR1 ADC VLS-101 | nan |
| Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002 | nan |
| Anti-S15 Monoclonal Antibody NC318 | nan |
| Anti-sCLU Monoclonal Antibody AB-16B5 | nan |
| Anti-SIRPa Monoclonal Antibody CC-95251 | nan |
| Anti-SLITRK6 Monoclonal Antibody-MMAE Conjugate AGS15E | nan |
| Anti-TAG-72 Monoclonal Antibody scFV CC-49/218 | nan |
| Anti-TF Monoclonal Antibody ALT-836 | nan |
| Anti-TGF-beta Monoclonal Antibody NIS793 | nan |
| Anti-TGF-beta Monoclonal Antibody SAR-439459 | nan |
| Anti-TGF-beta RII Monoclonal Antibody IMC-TR1 | nan |
| Anti-TIGIT Monoclonal Antibody AB154 | nan |
| Anti-TIGIT Monoclonal Antibody BGB-A1217 | nan |
| Anti-TIGIT Monoclonal Antibody BMS-986207 | nan |
| Anti-TIGIT Monoclonal Antibody COM902 | nan |
| Anti-TIGIT Monoclonal Antibody OMP-313M32 | nan |
| Anti-TIGIT Monoclonal Antibody SGN-TGT | nan |
| Anti-TIM-3 Antibody BMS-986258 | nan |
| Anti-TIM-3 Monoclonal Antibody BGB-A425 | nan |
| Anti-TIM-3 Monoclonal Antibody INCAGN02390 | nan |
| Anti-TIM-3 Monoclonal Antibody MBG453 | nan |
| Anti-TIM-3 Monoclonal Antibody Sym023 | nan |
| Anti-TIM-3 Monoclonal Antibody TSR-022 | nan |
| Anti-TIM3 Monoclonal Antibody LY3321367 | nan |
| Anti-TIM3 Monoclonal Antibody SHR-1702 | nan |
| Anti-Tissue Factor Monoclonal Antibody MORAb-066 | nan |
| Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711 | nan |
| Anti-TROP2 Antibody-drug Conjugate BAT8003 | nan |
| Anti-TROP2 Antibody-drug Conjugate SKB264 | nan |
| Anti-TROP2/DXd Antibody-drug Conjugate DS-1062a | nan |
| Anti-TWEAK Monoclonal Antibody RG7212 | nan |
| Anti-VEGF Anticalin PRS-050-PEG40 | nan |
| Anti-VEGF Monoclonal Antibody hPV19 | nan |
| Anti-VEGF/ANG2 Nanobody BI 836880 | nan |
| Anti-VEGF/TGF-beta 1 Fusion Protein HB-002T | nan |
| Anti-VEGFC Monoclonal Antibody VGX-100 | nan |
| Anti-VEGFR2 Monoclonal Antibody HLX06 | nan |
| Anti-VEGFR2 Monoclonal Antibody MSB0254 | nan |
| Anti-VEGFR3 Monoclonal Antibody IMC-3C5 | nan |
| Anti-VISTA Monoclonal Antibody JNJ 61610588 | nan |
| Antiangiogenic Drug Combination TL-118 | nan |
| Antibody-drug Conjugate ABBV-011 | nan |
| Antibody-drug Conjugate ABBV-085 | nan |
| Antibody-drug Conjugate ABBV-155 | nan |
| Antibody-drug Conjugate ABBV-176 | nan |
| Antibody-drug Conjugate ABBV-838 | nan |
| Antibody-drug Conjugate ADC XMT-1536 | nan |
| Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014 | nan |
| Antibody-Drug Conjugate DFRF4539A | nan |
| Antibody-drug Conjugate MEDI7247 | nan |
| Antibody-drug Conjugate PF-06647263 | nan |
| Antibody-drug Conjugate PF-06664178 | nan |
| Antibody-drug Conjugate SC-002 | nan |
| Antibody-drug Conjugate SC-003 | nan |
| Antibody-drug Conjugate SC-004 | nan |
| Antibody-drug Conjugate SC-005 | nan |
| Antibody-drug Conjugate SC-006 | nan |
| Antibody-drug Conjugate SC-007 | nan |
| Antibody-like CD95 Receptor/Fc-fusion Protein CAN-008 | nan |
| Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV | nan |
| Antimetabolite FF-10502 | nan |
| Antineoplastic Agent Combination SM-88 | nan |
| Antineoplastic Vaccine | nan |
| Antineoplastic Vaccine GV-1301 | nan |
| Antineoplaston A10 | nan |
| Antineoplaston AS2-1 | nan |
| Antisense Oligonucleotide GTI-2040 | nan |
| Antisense Oligonucleotide QR-313 | nan |
| Antitumor B Key Active Component-alpha | nan |
| Antrodia cinnamomea Supplement | nan |
| Antroquinonol Capsule | nan |
| Apalutamide | nan |
| Apatorsen | nan |
| Apaziquone | nan |
| APC8015F | nan |
| APE1/Ref-1 Redox Inhibitor APX3330 | nan |
| Aphidicoline Glycinate | nan |
| Apilimod Dimesylate Capsule | nan |
| Apitolisib | nan |
| Apolizumab | nan |
| Apomab | nan |
| Apomine | nan |
| Apoptosis Inducer BZL101 | nan |
| Apoptosis Inducer GCS-100 | nan |
| Apoptosis Inducer MPC-2130 | nan |
| Apricoxib | nan |
| Aprinocarsen | nan |
| Aprutumab | nan |
| Aprutumab Ixadotin | nan |
| AR Antagonist BMS-641988 | nan |
| Arabinoxylan Compound MGN3 | nan |
| Aranose | nan |
| ARC Fusion Protein SL-279252 | nan |
| Archexin | nan |
| Arcitumomab | nan |
| Arfolitixorin | nan |
| Arginase Inhibitor INCB001158 | nan |
| Arginine Butyrate | nan |
| Arnebia Indigo Jade Pearl Topical Cream | nan |
| Arsenic Trioxide | nan |
| Arsenic Trioxide Capsule Formulation ORH 2014 | nan |
| Artemether Sublingual Spray | nan |
| Artemisinin Dimer | nan |
| Artesunate | nan |
| Arugula Seed Powder | nan |
| Aryl Hydrocarbon Receptor Antagonist BAY2416964 | nan |
| Aryl Hydrocarbon Receptor Inhibitor IK-175 | nan |
| Asaley | nan |
| Asciminib | nan |
| Ascrinvacumab | nan |
| Ashwagandha Root Powder Extract | nan |
| ASP4132 | nan |
| Aspacytarabine | nan |
| Asparaginase | nan |
| Asparaginase Erwinia chrysanthemi | nan |
| Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10 | nan |
| Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10 | nan |
| Astuprotimut-R | nan |
| Asulacrine | nan |
| Asulacrine Isethionate | nan |
| Asunercept | nan |
| At 211 Monoclonal Antibody 81C6 | nan |
| Atamestane | nan |
| Atezolizumab | nan |
| Atiprimod | nan |
| Atiprimod Dihydrochloride | nan |
| Atiprimod Dimaleate | nan |
| ATM Inhibitor M 3541 | nan |
| ATM Kinase Inhibitor AZD0156 | nan |
| ATM Kinase Inhibitor AZD1390 | nan |
| Atorvastatin Calcium | nan |
| Atorvastatin Sodium | nan |
| ATR Inhibitor RP-3500 | nan |
| ATR Kinase Inhibitor BAY1895344 | nan |
| ATR Kinase Inhibitor M1774 | nan |
| ATR Kinase Inhibitor M6620 | nan |
| ATR Kinase Inhibitor VX-803 | nan |
| Atrasentan Hydrochloride | nan |
| Attenuated Listeria monocytogenes CRS-100 | nan |
| Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001 | nan |
| Attenuated Measles Virus Encoding SCD Transgene TMV-018 | nan |
| Atuveciclib | nan |
| Audencel | nan |
| Auranofin | nan |
| Aurora A Kinase Inhibitor LY3295668 | nan |
| Aurora A Kinase Inhibitor LY3295668 Erbumine | nan |
| Aurora A Kinase Inhibitor MK5108 | nan |
| Aurora A Kinase Inhibitor TAS-119 | nan |
| Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076 | nan |
| Aurora B Serine/Threonine Kinase Inhibitor TAK-901 | nan |
| Aurora B/C Kinase Inhibitor GSK1070916A | nan |
| Aurora kinase A/B inhibitor TT-00420 | nan |
| Aurora Kinase Inhibitor AMG 900 | nan |
| Aurora Kinase Inhibitor BI 811283 | nan |
| Aurora Kinase Inhibitor MLN8054 | nan |
| Aurora Kinase Inhibitor PF-03814735 | nan |
| Aurora Kinase Inhibitor SNS-314 | nan |
| Aurora Kinase Inhibitor TTP607 | nan |
| Aurora Kinase/VEGFR2 Inhibitor CYC116 | nan |
| Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707 | nan |
| Autologous AFP Specific T Cell Receptor Transduced T Cells C-TCR055 | nan |
| Autologous Anti-BCMA CAR T-cells PHE885 | nan |
| Autologous Anti-BCMA CAR-transduced T-cells KITE-585 | nan |
| Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11 | nan |
| Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101 | nan |
| Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T-lymphocytes JCARH125 | nan |
| Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217 | nan |
| Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells C-CAR088 | nan |
| Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells CT053 | nan |
| Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143 | nan |
| Autologous Anti-CD123 CAR-T Cells | nan |
| Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx | nan |
| Autologous Anti-CD19 CAR T-cells IM19 | nan |
| Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19 | nan |
| Autologous Anti-CD19 CAR-4-1BB-CD3zeta-expressing T-cells CNCT19 | nan |
| Autologous Anti-CD19 CAR-CD28 T-cells ET019002 | nan |
| Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells PZ01 | nan |
| Autologous Anti-CD19 CAR-expressing T-lymphocytes CLIC-1901 | nan |
| Autologous Anti-CD19 Chimeric Antigen Receptor T-cells AUTO1 | nan |
| Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19 | nan |
| Autologous Anti-CD19 T-cell Receptor T cells ET190L1 | nan |
| Autologous Anti-CD19 TAC-T cells TAC01-CD19 | nan |
| Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cells | nan |
| Autologous Anti-CD19/CD22 CAR T-cells AUTO3 | nan |
| Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014 | nan |
| Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells | nan |
| Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1 | nan |
| Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s | nan |
| Autologous Anti-EGFR CAR-transduced CXCR 5-modified T-lymphocytes | nan |
| Autologous Anti-FLT3 CAR T Cells AMG 553 | nan |
| Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202 | nan |
| Autologous Anti-HLA-A*0201/AFP CAR T-cells ET1402L1 | nan |
| Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100 | nan |
| Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes | nan |
| Autologous Anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T Lymphocytes GSK3377794 | nan |
| Autologous Anti-PD-1 Antibody-activated Tumor-infiltrating Lymphocytes | nan |
| Autologous Anti-PSMA CAR-T Cells P-PSMA-101 | nan |
| Autologous AXL-targeted CAR T-cells CCT301-38 | nan |
| Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B | nan |
| Autologous BCMA-targeted CAR T Cells CC-98633 | nan |
| Autologous BCMA-targeted CAR T Cells LCAR-B4822M | nan |
| Autologous Bi-epitope BCMA-targeted CAR T-cells JNJ-68284528 | nan |
| Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F | nan |
| Autologous Bispecific CD19/CD22-targeted CAR-T Cells GC022 | nan |
| Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001 | nan |
| Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3005 | nan |
| Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3006 | nan |
| Autologous CD123-4SCAR-expressing T-cells 4SCAR123 | nan |
| Autologous CD19 CAR-expressing CD4+/CD8+ T-cells MB-CART19.1 | nan |
| Autologous CD19-targeted CAR T Cells CC-97540 | nan |
| Autologous CD19-targeted CAR T Cells JWCAR029 | nan |
| Autologous CD19-targeted CAR-T Cells GC007F | nan |
| Autologous CD19/PD-1 Bispecific CAR-T Cells | nan |
| Autologous CD20-4SCAR-expressing T-cells 4SCAR20 | nan |
| Autologous CD22-4SCAR-expressing T-cells 4SCAR22 | nan |
| Autologous CD38-4SCAR-expressing T-cells 4SCAR38 | nan |
| Autologous Clonal Neoantigen T Cells ATL001 | nan |
| Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19 | nan |
| Autologous Deep IL-15 Primed T-cells TRQ15-01 | nan |
| Autologous Dendritic Cell Vaccine ACT2001 | nan |
| Autologous Dendritic Cell-based Immunotherapeutic AV0113 | nan |
| Autologous FRa-4SCAR-expressing T-cells 4SCAR-FRa | nan |
| Autologous Genetically-modified MAGE-A4 C1032 CD8alpha T Cells | nan |
| Autologous Genetically-modified MAGE-A4 C1032 T Cells | nan |
| Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858 | nan |
| Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439 | nan |
| Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T-lymphocytes YT-E001 | nan |
| Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718 | nan |
| Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR | nan |
| Autologous Mesenchymal Stem Cells Apceth_101 | nan |
| Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11 | nan |
| Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC | nan |
| Autologous Multi-lineage Potential Cells | nan |
| Autologous Nectin-4/FAP-targeted CAR-T Cells | nan |
| Autologous NKG2D CAR T-cells CYAD-02 | nan |
| Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01 | nan |
| Autologous Pancreatic Adenocarcinoma Lysate and mRNA-loaded Dendritic Cell Vaccine | nan |
| Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001 | nan |
| Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101 | nan |
| Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601 | nan |
| Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201 | nan |
| Autologous ROR2-targeted CAR T-cells CCT301-59 | nan |
| Autologous TAAs-loaded Autologous Dendritic Cells AV-GBM-1 | nan |
| Autologous TCR-engineered T-cells IMA201 | nan |
| Autologous TCR-engineered T-cells IMA202 | nan |
| Autologous TCR-engineered T-cells IMA203 | nan |
| Autologous TCRm-expressing T-cells ET140203 | nan |
| Autologous Tetravalent Dendritic Cell Vaccine MIDRIX4-LUNG | nan |
| Autologous Tumor Infiltrating Lymphocytes LN-144 | nan |
| Autologous Tumor Infiltrating Lymphocytes LN-145 | nan |
| Autologous Tumor Infiltrating Lymphocytes LN-145-S1 | nan |
| Autologous Tumor Infiltrating Lymphocytes MDA-TIL | nan |
| Autologous Universal CAR-expressing T-lymphocytes UniCAR02-T | nan |
| Avadomide | nan |
| Avadomide Hydrochloride | nan |
| Avapritinib | nan |
| Avdoralimab | nan |
| Avelumab | nan |
| Aviscumine | nan |
| Avitinib Maleate | nan |
| Axalimogene Filolisbac | nan |
| Axatilimab | nan |
| Axicabtagene Ciloleucel | nan |
| Axitinib | nan |
| AXL Inhibitor DS-1205c | nan |
| AXL Inhibitor SLC-391 | nan |
| AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M | nan |
| AXL/ FLT3/VEGFR2 Inhibitor KC1036 | nan |
| Axl/Mer Inhibitor INCB081776 | nan |
| Axl/Mer Inhibitor PF-07265807 | nan |
| Azacitidine | nan |
| Azapicyl | nan |
| Azaribine | nan |
| Azaserine | nan |
| Azathioprine | nan |
| Azimexon | nan |
| Azintuxizumab Vedotin | nan |
| Aziridinylbenzoquinone RH1 | nan |
| Azotomycin | nan |
| Azurin:50-77 Cell Penetrating Peptide p28 | nan |
| B-Raf/VEGFR-2 Inhibitor RAF265 | nan |
| Babaodan Capsule | nan |
| Bacillus Calmette-Guerin Substrain Connaught Live Antigen | nan |
| Bactobolin | nan |
| Bafetinib | nan |
| Balixafortide | nan |
| Balstilimab | nan |
| Baltaleucel-T | nan |
| Banoxantrone | nan |
| Barasertib | nan |
| Bardoxolone | nan |
| Bardoxolone Methyl | nan |
| Baricitinib | nan |
| Batabulin | nan |
| Batabulin Sodium | nan |
| Batimastat | nan |
| Bavituximab | nan |
| Bazedoxifene | nan |
| Bazlitoran | nan |
| BC-819 Plasmid/Polyethylenimine Complex | nan |
| BCG Solution | nan |
| BCG Tokyo-172 Strain Solution | nan |
| BCG Vaccine | nan |
| Bcl-2 Inhibitor APG 2575 | nan |
| Bcl-2 Inhibitor BCL201 | nan |
| Bcl-2 Inhibitor BGB-11417 | nan |
| Bcl-2 Inhibitor LP-108 | nan |
| Bcl-2 Inhibitor S65487 | nan |
| Bcl-Xs Adenovirus Vaccine | nan |
| BCMA x CD3 T-cell Engaging Antibody CC-93269 | nan |
| BCMA-CD19 Compound CAR T Cells | nan |
| BCMA/CD3e Tri-specific T-cell Activating Construct HPN217 | nan |
| Bcr-Abl Kinase Inhibitor K0706 | nan |
| Bcr-Abl Kinase Inhibitor PF-114 | nan |
| BCR-ABL/KIT/AKT/ERK Inhibitor HQP1351 | nan |
| Beauvericin | nan |
| Becatecarin | nan |
| Belagenpumatucel-L | nan |
| Belantamab Mafodotin | nan |
| Belapectin | nan |
| Belimumab | nan |
| Belinostat | nan |
| Belotecan Hydrochloride | nan |
| Belvarafenib | nan |
| Belzutifan | nan |
| Bemarituzumab | nan |
| Bemcentinib | nan |
| Bempegaldesleukin | nan |
| Benaxibine | nan |
| Bendamustine | nan |
| Bendamustine Hydrochloride | nan |
| Bendamustine-containing Nanoparticle-based Formulation RXDX-107 | nan |
| Benzaldehyde Dimethane Sulfonate | nan |
| Benzoylphenylurea | nan |
| Berberine Chloride | nan |
| Bermekimab | nan |
| Bersanlimab | nan |
| Berubicin Hydrochloride | nan |
| Berzosertib | nan |
| BET Bromodomain Inhibitor ZEN-3694 | nan |
| BET Inhibitor ABBV-744 | nan |
| BET Inhibitor BAY1238097 | nan |
| BET inhibitor BI 894999 | nan |
| BET Inhibitor BMS-986158 | nan |
| BET Inhibitor CC-90010 | nan |
| BET Inhibitor CPI-0610 | nan |
| BET Inhibitor FT-1101 | nan |
| BET Inhibitor GS-5829 | nan |
| BET Inhibitor GSK2820151 | nan |
| BET Inhibitor INCB054329 | nan |
| BET Inhibitor INCB057643 | nan |
| BET Inhibitor RO6870810 | nan |
| BET-bromodomain Inhibitor ODM-207 | nan |
| Beta Alethine | nan |
| Beta-Carotene | nan |
| Beta-elemene | nan |
| Beta-Glucan | nan |
| Beta-Glucan MM-10-001 | nan |
| Beta-lapachone Prodrug ARQ 761 | nan |
| Beta-Thioguanine Deoxyriboside | nan |
| Betaglucin Gel | nan |
| Betulinic Acid | nan |
| Bevacizumab | nan |
| Bexarotene | nan |
| Bexmarilimab | nan |
| BF-200 Gel Formulation | nan |
| BH3 Mimetic ABT-737 | nan |
| Bi-functional Alkylating Agent VAL-083 | nan |
| Bicalutamide | nan |
| Bimiralisib | nan |
| Binetrakin | nan |
| Binimetinib | nan |
| Bintrafusp Alfa | nan |
| Birabresib | nan |
| Birinapant | nan |
| Bis(choline)tetrathiomolybdate | nan |
| Bisantrene | nan |
| Bisantrene Hydrochloride | nan |
| Bisnafide | nan |
| Bisnafide Dimesylate | nan |
| Bispecific Antibody 2B1 | nan |
| Bispecific Antibody AGEN1223 | nan |
| Bispecific Antibody AMG 509 | nan |
| Bispecific Antibody GS-1423 | nan |
| Bispecific Antibody MDX-H210 | nan |
| Bispecific Antibody MDX447 | nan |
| Bisthianostat | nan |
| BiTE Antibody AMG 910 | nan |
| Bivalent BRD4 Inhibitor AZD5153 | nan |
| Bizalimogene Ralaplasmid | nan |
| Bizelesin | nan |
| BL22 Immunotoxin | nan |
| Black Cohosh | nan |
| Black Raspberry Nectar | nan |
| Bleomycin | nan |
| Bleomycin A2 | nan |
| Bleomycin B2 | nan |
| Bleomycin Sulfate | nan |
| Blinatumomab | nan |
| Blueberry Powder Supplement | nan |
| BMI1 Inhibitor PTC596 | nan |
| BMS-184476 | nan |
| BMS-188797 | nan |
| BMS-214662 | nan |
| BMS-275183 | nan |
| Boanmycin Hydrochloride | nan |
| Bomedemstat | nan |
| Boronophenylalanine-Fructose Complex | nan |
| Bortezomib | nan |
| Bosutinib | nan |
| Bosutinib Monohydrate | nan |
| Botanical Agent BEL-X-HG | nan |
| Botanical Agent LEAC-102 | nan |
| Bovine Cartilage | nan |
| Bozitinib | nan |
| BP-Cx1-Platinum Complex BP-C1 | nan |
| BR96-Doxorubicin Immunoconjugate | nan |
| Brachyury-expressing Yeast Vaccine GI-6301 | nan |
| BRAF Inhibitor | nan |
| BRAF Inhibitor ARQ 736 | nan |
| BRAF Inhibitor BGB-3245 | nan |
| BRAF Inhibitor PLX8394 | nan |
| BRAF(V600E) Kinase Inhibitor ABM-1310 | nan |
| BRAF(V600E) Kinase Inhibitor RO5212054 | nan |
| BRAF/EGFR Inhibitor BGB-283 | nan |
| BRAFV600/PI3K Inhibitor ASN003 | nan |
| BRD4 Inhibitor PLX2853 | nan |
| BRD4 Inhibitor PLX51107 | nan |
| Breflate | nan |
| Brentuximab | nan |
| Brentuximab Vedotin | nan |
| Brequinar | nan |
| Brequinar Sodium | nan |
| Briciclib Sodium | nan |
| Brigatinib | nan |
| Brilanestrant | nan |
| Brimonidine Tartrate Nanoemulsion OCU-300 | nan |
| Brivanib | nan |
| Brivanib Alaninate | nan |
| Brivudine | nan |
| Brivudine Phosphoramidate | nan |
| Broad-Spectrum Human Papillomavirus Vaccine V505 | nan |
| Broccoli Sprout/Broccoli Seed Extract Supplement | nan |
| Bromacrylide | nan |
| Bromebric Acid | nan |
| Bromocriptine Mesylate | nan |
| Brontictuzumab | nan |
| Brostacillin Hydrochloride | nan |
| Brostallicin | nan |
| Broxuridine | nan |
| Bruceanol A | nan |
| Bruceanol B | nan |
| Bruceanol C | nan |
| Bruceanol D | nan |
| Bruceanol E | nan |
| Bruceanol F | nan |
| Bruceanol G | nan |
| Bruceanol H | nan |
| Bruceantin | nan |
| Bryostatin 1 | nan |
| BTK Inhibitor ARQ 531 | nan |
| BTK Inhibitor CT-1530 | nan |
| BTK Inhibitor DTRMWXHS-12 | nan |
| BTK Inhibitor HZ-A-018 | nan |
| BTK Inhibitor ICP-022 | nan |
| BTK Inhibitor LOXO-305 | nan |
| BTK Inhibitor M7583 | nan |
| BTK inhibitor TG-1701 | nan |
| Budigalimab | nan |
| Budotitane | nan |
| Bufalin | nan |
| Buparlisib | nan |
| Burixafor | nan |
| Burixafor Hydrobromide | nan |
| Burosumab | nan |
| Buserelin | nan |
| Bushen Culuan Decoction | nan |
| Bushen-Jianpi Decoction | nan |
| Busulfan | nan |
| Buthionine Sulfoximine | nan |
| BXQ-350 Nanovesicle Formulation | nan |
| c-Kit Inhibitor PLX9486 | nan |
| c-Met Inhibitor ABN401 | nan |
| c-Met Inhibitor AL2846 | nan |
| c-Met Inhibitor AMG 208 | nan |
| c-Met Inhibitor AMG 337 | nan |
| c-Met Inhibitor GST-HG161 | nan |
| c-Met Inhibitor HS-10241 | nan |
| c-Met Inhibitor JNJ-38877605 | nan |
| c-Met Inhibitor MK2461 | nan |
| c-Met Inhibitor MK8033 | nan |
| c-Met Inhibitor MSC2156119J | nan |
| C-myb Antisense Oligonucleotide G4460 | nan |
| c-raf Antisense Oligonucleotide ISIS 5132 | nan |
| C-VISA BikDD:Liposome | nan |
| C/EBP Beta Antagonist ST101 | nan |
| CAB-ROR2-ADC BA3021 | nan |
| Cabazitaxel | nan |
| Cabiralizumab | nan |
| Cabozantinib | nan |
| Cabozantinib S-malate | nan |
| Cactinomycin | nan |
| Caffeic Acid Phenethyl Ester | nan |
| CAIX Inhibitor DTP348 | nan |
| CAIX Inhibitor SLC-0111 | nan |
| Calaspargase Pegol-mknl | nan |
| Calcitriol | nan |
| Calcium Release-activated Channel Inhibitor CM4620 | nan |
| Calcium Release-activated Channels Inhibitor RP4010 | nan |
| Calcium Saccharate | nan |
| Calculus bovis/Moschus/Olibanum/Myrrha Capsule | nan |
| Calicheamicin Gamma 1I | nan |
| Camidanlumab Tesirine | nan |
| Camptothecin | nan |
| Camptothecin Analogue TLC388 | nan |
| Camptothecin Glycoconjugate BAY 38-3441 | nan |
| Camptothecin Sodium | nan |
| Camptothecin-20(S)-O-Propionate Hydrate | nan |
| Camrelizumab | nan |
| Camsirubicin | nan |
| Cancell | nan |
| Cancer Peptide Vaccine S-588410 | nan |
| Canerpaturev | nan |
| Canertinib Dihydrochloride | nan |
| Canfosfamide | nan |
| Canfosfamide Hydrochloride | nan |
| Cannabidiol | nan |
| Cantrixil | nan |
| Cantuzumab Ravtansine | nan |
| Capecitabine | nan |
| Capecitabine Rapidly Disintegrating Tablet | nan |
| Capivasertib | nan |
| Capmatinib | nan |
| Captopril | nan |
| CAR T-Cells AMG 119 | nan |
| Caracemide | nan |
| Carbendazim | nan |
| Carbetimer | nan |
| Carbogen | nan |
| Carbon C 14-pamiparib | nan |
| Carboplatin | nan |
| Carboquone | nan |
| Carboxyamidotriazole | nan |
| Carboxyamidotriazole Orotate | nan |
| Carboxyphenyl Retinamide | nan |
| Carfilzomib | nan |
| Caricotamide/Tretazicar | nan |
| Carlumab | nan |
| Carmofur | nan |
| Carmustine | nan |
| Carmustine Implant | nan |
| Carmustine in Ethanol | nan |
| Carmustine Sustained-Release Implant Wafer | nan |
| Carotuximab | nan |
| Carubicin | nan |
| Carubicin Hydrochloride | nan |
| Carzelesin | nan |
| Carzinophilin | nan |
| Cathelicidin LL-37 | nan |
| Cationic Liposome-Encapsulated Paclitaxel | nan |
| Cationic Peptide Cream Cypep-1 | nan |
| Catumaxomab | nan |
| CBP/beta-catenin Antagonist PRI-724 | nan |
| CBP/beta-catenin Modulator E7386 | nan |
| CCR2 Antagonist CCX872-B | nan |
| CCR2 Antagonist PF-04136309 | nan |
| CCR2/CCR5 Antagonist BMS-813160 | nan |
| CCR4 Inhibitor FLX475 | nan |
| CD11b Agonist GB1275 | nan |
| CD123-CD33 Compound CAR T Cells | nan |
| CD123-specific Targeting Module TM123 | nan |
| CD20-CD19 Compound CAR T Cells | nan |
| CD28/ICOS Antagonist ALPN-101 | nan |
| CD4-specific Telomerase Peptide Vaccine UCPVax | nan |
| CD40 Agonist Monoclonal Antibody CP-870;893 | nan |
| CD40 Agonistic Monoclonal Antibody APX005M | nan |
| CD44 Targeted Agent SPL-108 | nan |
| CD44v6-specific CAR T-cells | nan |
| CD47 Antagonist ALX148 | nan |
| CD73 Inhibitor AB680 | nan |
| CD73 Inhibitor LY3475070 | nan |
| CD80-Fc Fusion Protein ALPN-202 | nan |
| CD80-Fc Fusion Protein FPT155 | nan |
| CDC7 Inhibitor TAK-931 | nan |
| CDC7 Kinase Inhibitor BMS-863233 | nan |
| CDC7 Kinase Inhibitor LY3143921 Hydrate | nan |
| CDC7 Kinase Inhibitor NMS-1116354 | nan |
| CDK Inhibitor AT7519 | nan |
| CDK Inhibitor R547 | nan |
| CDK Inhibitor SNS-032 | nan |
| CDK/JAK2/FLT3 Inhibitor TG02 Citrate | nan |
| CDK1 Inhibitor BEY1107 | nan |
| CDK1/2/4 Inhibitor AG-024322 | nan |
| CDK2 Inhibitor PF-07104091 | nan |
| CDK2/4/6/FLT3 Inhibitor FN-1501 | nan |
| CDK2/5/9 Inhibitor CYC065 | nan |
| CDK4 Inhibitor P1446A-05 | nan |
| CDK4/6 Inhibitor | nan |
| CDK4/6 Inhibitor BPI-16350 | nan |
| CDK4/6 Inhibitor CS3002 | nan |
| CDK4/6 Inhibitor FCN-437 | nan |
| CDK4/6 Inhibitor G1T38 | nan |
| CDK4/6 Inhibitor HS-10342 | nan |
| CDK4/6 Inhibitor SHR6390 | nan |
| CDK4/6 Inhibitor TQB3616 | nan |
| CDK7 Inhibitor CT7001 | nan |
| CDK7 Inhibitor SY-1365 | nan |
| CDK7 Inhibitor SY-5609 | nan |
| CDK8/19 Inhibitor SEL 120 | nan |
| CDK9 Inhibitor AZD4573 | nan |
| CEA-MUC-1-TRICOM Vaccine CV301 | nan |
| CEA-targeting Agent RG6123 | nan |
| CEBPA-targeting saRNA MTL-CEBPA Liposome | nan |
| Cedazuridine | nan |
| Cedazuridine/Azacitidine Combination Agent ASTX030 | nan |
| Cedazuridine/Decitabine Combination Agent ASTX727 | nan |
| Cedefingol | nan |
| Cediranib | nan |
| Cediranib Maleate | nan |
| Celecoxib | nan |
| Cell Cycle Checkpoint/DNA Repair Antagonist IC83 | nan |
| Cemadotin | nan |
| Cemadotin Hydrochloride | nan |
| Cemiplimab | nan |
| Cenersen | nan |
| Cenisertib | nan |
| CENP-E Inhibitor GSK-923295 | nan |
| Ceralasertib | nan |
| Ceramide Nanoliposome | nan |
| Cerdulatinib | nan |
| Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480 | nan |
| Cereblon E3 Ubiquitin Ligase Modulating Agent CC-99282 | nan |
| Cereblon Modulator CC-90009 | nan |
| Cergutuzumab Amunaleukin | nan |
| Ceritinib | nan |
| Cesalin | nan |
| cEt KRAS Antisense Oligonucleotide AZD4785 | nan |
| Cetrelimab | nan |
| Cetuximab | nan |
| Cetuximab Sarotalocan | nan |
| Cetuximab-IR700 Conjugate RM-1929 | nan |
| Cetuximab-loaded Ethylcellulose Polymeric Nanoparticles Decorated with Octreotide (SY) | nan |
| Cevipabulin | nan |
| Cevipabulin Fumarate | nan |
| Cevipabulin Succinate | nan |
| Cevostamab | nan |
| cFMS Tyrosine Kinase Inhibitor ARRY-382 | nan |
| Chaparrin | nan |
| Chaparrinone | nan |
| Checkpoint Kinase Inhibitor AZD7762 | nan |
| Checkpoint Kinase Inhibitor XL844 | nan |
| Chemotherapy | nan |
| Chiauranib | nan |
| Chimeric Monoclonal Antibody 81C6 | nan |
| ChiNing Decoction | nan |
| Chk1 Inhibitor CCT245737 | nan |
| Chk1 Inhibitor GDC-0425 | nan |
| Chk1 Inhibitor GDC-0575 | nan |
| CHK1 Inhibitor MK-8776 | nan |
| CHK1 Inhibitor PF-477736 | nan |
| Chlorambucil | nan |
| Chlorodihydropyrimidine | nan |
| Chloroquine | nan |
| Chloroquinoxaline Sulfonamide | nan |
| Chlorotoxin | nan |
| Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes | nan |
| Chlorozotocin | nan |
| Choline Kinase Alpha Inhibitor TCD-717 | nan |
| CHP-NY-ESO-1 Peptide Vaccine IMF-001 | nan |
| Chromomycin A3 | nan |
| Chrysanthemum morifolium/Ganoderma lucidum/Glycyrrhiza glabra/Isatis indigotica/Panax pseudoginseng/Rabdosia rubescens/Scutellaria baicalensis/Serona repens Supplement | nan |
| Cibisatamab | nan |
| Ciclopirox Prodrug CPX-POM | nan |
| Cidan Herbal Capsule | nan |
| Ciforadenant | nan |
| Cilengitide | nan |
| Ciltacabtagene Autoleucel | nan |
| Cimetidine | nan |
| Cinacalcet Hydrochloride | nan |
| Cinobufagin | nan |
| Cinobufotalin | nan |
| Cinrebafusp Alfa | nan |
| Cintirorgon | nan |
| Cintredekin Besudotox | nan |
| Cirmtuzumab | nan |
| cis-Urocanic Acid | nan |
| Cisplatin | nan |
| Cisplatin Liposomal | nan |
| Cisplatin-E Therapeutic Implant | nan |
| Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6 | nan |
| Citarinostat | nan |
| Citatuzumab Bogatox | nan |
| Cixutumumab | nan |
| CK1alpha/CDK7/CDK9 Inhibitor BTX-A51 | nan |
| CK2-targeting Synthetic Peptide CIGB-300 | nan |
| CL 246738 | nan |
| Cladribine | nan |
| Clanfenur | nan |
| Clarithromycin | nan |
| Class 1/4 Histone Deacetylase Inhibitor OKI-179 | nan |
| Clinical Trial | nan |
| Clinical Trial Agent | nan |
| Clioquinol | nan |
| Clivatuzumab | nan |
| Clodronate Disodium | nan |
| Clodronic Acid | nan |
| Clofarabine | nan |
| Clomesone | nan |
| Clomiphene | nan |
| Clomiphene Citrate | nan |
| Clostridium Novyi-NT Spores | nan |
| Cobimetinib | nan |
| Cobolimab | nan |
| Cobomarsen | nan |
| Codrituzumab | nan |
| Coenzyme Q10 | nan |
| Cofetuzumab Pelidotin | nan |
| Colchicine-Site Binding Agent ABT-751 | nan |
| Cold Contaminant-free Iobenguane I-131 | nan |
| Colloidal Gold-Bound Tumor Necrosis Factor | nan |
| Colorectal Cancer Peptide Vaccine PolyPEPI1018 | nan |
| Colorectal Tumor-Associated Peptides Vaccine IMA910 | nan |
| Coltuximab Ravtansine | nan |
| Combretastatin | nan |
| Combretastatin A-1 | nan |
| Combretastatin A1 Diphosphate | nan |
| Commensal Bacterial Strain Formulation VE800 | nan |
| Compound Kushen Injection | nan |
| Conatumumab | nan |
| Conbercept | nan |
| Concentrated Lingzhi Mushroom Extract | nan |
| Conditionally Active Biologic Anti-AXL Antibody-drug Conjugate BA3011 | nan |
| Copanlisib | nan |
| Copanlisib Hydrochloride | nan |
| Copper Cu 64-ATSM | nan |
| Copper Cu 67 Tyr3-octreotate | nan |
| Copper Gluconate | nan |
| Cord Blood Derived CAR T-Cells | nan |
| Cord Blood-derived Expanded Natural Killer Cells PNK-007 | nan |
| Cordycepin | nan |
| Cordycepin Triphosphate | nan |
| Coriolus Versicolor Extract | nan |
| Corticorelin Acetate | nan |
| Cortisone Acetate | nan |
| Cosibelimab | nan |
| Cositecan | nan |
| Coxsackievirus A21 | nan |
| Coxsackievirus V937 | nan |
| CpG Oligodeoxynucleotide GNKG168 | nan |
| Crenolanib | nan |
| Crenolanib Besylate | nan |
| Crizotinib | nan |
| Crolibulin | nan |
| Cryptophycin | nan |
| Cryptophycin 52 | nan |
| Crystalline Genistein Formulation AXP107-11 | nan |
| CSF-1R Inhibitor BLZ945 | nan |
| CSF1R Inhibitor ABSK021 | nan |
| CSF1R Inhibitor DCC-3014 | nan |
| CSF1R Inhibitor PLX73086 | nan |
| CT2584 HMS | nan |
| CTLA-4-directed Probody BMS-986249 | nan |
| Curcumin | nan |
| Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110 | nan |
| Cusatuzumab | nan |
| Custirsen Sodium | nan |
| CXC Chemokine Receptor 2 Antagonist AZD5069 | nan |
| CXCR1/2 Inhibitor SX-682 | nan |
| CXCR2 Antagonist QBM076 | nan |
| CXCR4 Antagonist BL-8040 | nan |
| CXCR4 Antagonist USL311 | nan |
| CXCR4 Inhibitor Q-122 | nan |
| CXCR4 Peptide Antagonist LY2510924 | nan |
| CXCR4/E-selectin Antagonist GMI-1359 | nan |
| Cyclin-dependent Kinase 8/19 Inhibitor BCD 115 | nan |
| Cyclin-dependent Kinase Inhibitor PF-06873600 | nan |
| Cyclodextrin-Based Polymer-Camptothecin CRLX101 | nan |
| Cyclodisone | nan |
| Cycloleucine | nan |
| Cyclopentenyl Cytosine | nan |
| Cyclophosphamide | nan |
| Cyclophosphamide Anhydrous | nan |
| Cyclosporine | nan |
| CYL-02 Plasmid DNA | nan |
| CYP11A1 inhibitor ODM-208 | nan |
| CYP11A1 Inhibitor ODM-209 | nan |
| CYP17 Inhibitor CFG920 | nan |
| CYP17 Lyase Inhibitor ASN001 | nan |
| CYP17/Androgen Receptor Inhibitor ODM 204 | nan |
| CYP17/CYP11B2 Inhibitor LAE001 | nan |
| Cyproterone | nan |
| Cyproterone Acetate | nan |
| Cytarabine | nan |
| Cytarabine Monophosphate Prodrug MB07133 | nan |
| Cytarabine-asparagine Prodrug BST-236 | nan |
| Cytidine Analog RX-3117 | nan |
| Cytochlor | nan |
| Cytokine-based Biologic Agent IRX-2 | nan |
| D-methionine Formulation MRX-1024 | nan |
| DAB389 Epidermal Growth Factor | nan |
| Dabrafenib | nan |
| Dabrafenib Mesylate | nan |
| Dacarbazine | nan |
| Dacetuzumab | nan |
| DACH Polymer Platinate AP5346 | nan |
| DACH-Platin Micelle NC-4016 | nan |
| Daclizumab | nan |
| Dacomitinib | nan |
| Dacplatinum | nan |
| Dactinomycin | nan |
| Dactolisib | nan |
| Dactolisib Tosylate | nan |
| Dalantercept | nan |
| Dalotuzumab | nan |
| Daniquidone | nan |
| Danusertib | nan |
| Danvatirsen | nan |
| Daporinad | nan |
| Daratumumab | nan |
| Daratumumab and Hyaluronidase-fihj | nan |
| Daratumumab/rHuPH20 | nan |
| Darinaparsin | nan |
| Darleukin | nan |
| Darolutamide | nan |
| Daromun | nan |
| Dasatinib | nan |
| Daunorubicin | nan |
| Daunorubicin Citrate | nan |
| Daunorubicin Hydrochloride | nan |
| DEC-205/NY-ESO-1 Fusion Protein CDX-1401 | nan |
| Decitabine | nan |
| Decitabine and Cedazuridine | nan |
| Defactinib | nan |
| Defactinib Hydrochloride | nan |
| Deferoxamine | nan |
| Deferoxamine Mesylate | nan |
| Degarelix | nan |
| Degarelix Acetate | nan |
| Delanzomib | nan |
| Delolimogene Mupadenorepvec | nan |
| Demcizumab | nan |
| Demecolcine | nan |
| Demplatin Pegraglumer | nan |
| Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466 | nan |
| Dendritic Cell Vaccine | nan |
| Dendritic Cell-Autologous Lung Tumor Vaccine | nan |
| Dendritic Cell-targeting Lentiviral Vector ID-LV305 | nan |
| Denenicokin | nan |
| Dengue Virus Adjuvant PV-001-DV | nan |
| Denibulin | nan |
| Denibulin Hydrochloride | nan |
| Denileukin Diftitox | nan |
| Denintuzumab Mafodotin | nan |
| Denosumab | nan |
| Deoxycytidine Analogue TAS-109 | nan |
| Deoxycytidine Analogue TAS-109 Hydrochloride | nan |
| Depatuxizumab | nan |
| Depatuxizumab Mafodotin | nan |
| Derazantinib | nan |
| Deslorelin | nan |
| Deslorelin Acetate | nan |
| Detirelix | nan |
| Detorubicin | nan |
| Deuteporfin | nan |
| Deuterated Enzalutamide | nan |
| Devimistat | nan |
| Dexamethason | nan |
| Dexamethasone | nan |
| Dexamethasone Phosphate | nan |
| Dexamethasone Sodium Phosphate | nan |
| Dexanabinol | nan |
| Dexrazoxane | nan |
| Dexrazoxane Hydrochloride | nan |
| Dezaguanine | nan |
| Dezaguanine Mesylate | nan |
| Dezapelisib | nan |
| DHA-Paclitaxel | nan |
| DHEA Mustard | nan |
| DI-Leu16-IL2 Immunocytokine | nan |
| Dianhydrogalactitol | nan |
| Diarylsulfonylurea Compound ILX-295501 | nan |
| Diazepinomicin | nan |
| Diaziquone | nan |
| Diazooxonorleucine | nan |
| Dibrospidium Chloride | nan |
| Dichloroallyl Lawsone | nan |
| Dicycloplatin | nan |
| Didox | nan |
| Dienogest | nan |
| Diethylnorspermine | nan |
| Digitoxin | nan |
| Digoxin | nan |
| Dihydro-5-Azacytidine | nan |
| Dihydrolenperone | nan |
| Dihydroorotate Dehydrogenase Inhibitor AG-636 | nan |
| Dihydroorotate Dehydrogenase Inhibitor BAY2402234 | nan |
| Diindolylmethane | nan |
| Dilpacimab | nan |
| Dimethylmyleran | nan |
| Dinaciclib | nan |
| Dinutuximab | nan |
| Dioscorea nipponica Makino Extract DNE3 | nan |
| Diphencyprone | nan |
| Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein E7777 | nan |
| Ditiocarb | nan |
| DKK1-Neutralizing Monoclonal Antibody DKN-01 | nan |
| DM-CHOC-PEN | nan |
| DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015 | nan |
| DNA Interference Oligonucleotide PNT2258 | nan |
| DNA Minor Groove Binding Agent SG2000 | nan |
| DNA Plasmid Encoding Interleukin-12 INO-9012 | nan |
| DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151 | nan |
| DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457 | nan |
| DNA Vaccine VB10.16 | nan |
| DNA-dependent Protein Kinase Inhibitor VX-984 | nan |
| DNA-PK inhibitor AZD7648 | nan |
| DNA-PK/PI3K-delta Inhibitor BR101801 | nan |
| DNA-PK/TOR Kinase Inhibitor CC-115 | nan |
| DNMT1 Inhibitor NTX-301 | nan |
| DNMT1 Mixed-Backbone Antisense Oligonucleotide MG 98 | nan |
| Docetaxel | nan |
| Docetaxel Anhydrous | nan |
| Docetaxel Emulsion ANX-514 | nan |
| Docetaxel Formulation CKD-810 | nan |
| Docetaxel Lipid Microspheres | nan |
| Docetaxel Nanoparticle CPC634 | nan |
| Docetaxel Polymeric Micelles | nan |
| Docetaxel-loaded Nanopharmaceutical CRLX301 | nan |
| Docetaxel-PNP | nan |
| Docetaxel/Ritonavir | nan |
| Dociparstat sodium | nan |
| Dolastatin 10 | nan |
| Dolastatin 15 | nan |
| Domatinostat | nan |
| Donafenib | nan |
| Dopamine-Somatostatin Chimeric Molecule BIM-23A760 | nan |
| Dostarlimab | nan |
| Double-armed TMZ-CD40L/4-1BBL Oncolytic Ad5/35 Adenovirus LOAd703 | nan |
| Dovitinib | nan |
| Dovitinib Lactate | nan |
| Doxazosin | nan |
| Doxercalciferol | nan |
| Doxifluridine | nan |
| Doxorubicin | nan |
| Doxorubicin Hydrochloride | nan |
| Doxorubicin Prodrug L-377;202 | nan |
| Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370 | nan |
| Doxorubicin-Eluting Beads | nan |
| Doxorubicin-HPMA Conjugate | nan |
| Doxorubicin-loaded EGFR-targeting Nanocells | nan |
| Doxorubicin-Magnetic Targeted Carrier Complex | nan |
| DPT/BCG/Measles/Serratia/Pneumococcus Vaccine | nan |
| DPT/Typhoid/Staphylococcus aureus/Paratyphoid A/Paratyphoid B Vaccine | nan |
| DPX-E7 HPV Vaccine | nan |
| DR5 HexaBody Agonist GEN1029 | nan |
| DR5-targeting Tetrameric Nanobody Agonist TAS266 | nan |
| Dromostanolone Propionate | nan |
| Drozitumab | nan |
| DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555 | nan |
| Dual IGF-1R/InsR Inhibitor BMS-754807 | nan |
| Dual Variable Domain Immunoglobulin ABT-165 | nan |
| Dual-affinity B7-H3/CD3-targeted Protein MGD009 | nan |
| Dubermatinib | nan |
| Duborimycin | nan |
| Dulanermin | nan |
| Duligotuzumab | nan |
| Dupilumab | nan |
| Durvalumab | nan |
| Dusigitumab | nan |
| dUTPase/DPD Inhibitor TAS-114 | nan |
| Duvelisib | nan |
| Duvortuxizumab | nan |
| Dynemicin | nan |
| Dynemicin A | nan |
| E2F1 Pathway Activator ARQ 171 | nan |
| EBNA-1 inhibitor VK-2019 | nan |
| Echinomycin | nan |
| Ecromeximab | nan |
| Edatrexate | nan |
| Edelfosine | nan |
| Edicotinib | nan |
| Edodekin alfa | nan |
| Edotecarin | nan |
| Edrecolomab | nan |
| EED Inhibitor MAK683 | nan |
| Efatutazone | nan |
| Efatutazone Dihydrochloride | nan |
| Efizonerimod | nan |
| Eflornithine | nan |
| Eflornithine Hydrochloride | nan |
| Eftilagimod Alpha | nan |
| Eftozanermin Alfa | nan |
| Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205 | nan |
| Eg5 Kinesin-Related Motor Protein Inhibitor ARQ 621 | nan |
| EGb761 | nan |
| EGFR Antagonist Hemay022 | nan |
| EGFR Antisense DNA BB-401 | nan |
| EGFR Inhibitor AZD3759 | nan |
| EGFR Inhibitor BIBX 1382 | nan |
| EGFR Inhibitor DBPR112 | nan |
| EGFR Inhibitor PD-168393 | nan |
| EGFR Inhibitor TY-9591 | nan |
| EGFR Mutant-selective Inhibitor TQB3804 | nan |
| EGFR Mutant-specific Inhibitor BPI-7711 | nan |
| EGFR Mutant-specific Inhibitor CK-101 | nan |
| EGFR Mutant-specific Inhibitor D-0316 | nan |
| EGFR Mutant-specific Inhibitor ZN-e4 | nan |
| EGFR T790M Antagonist BPI-15086 | nan |
| EGFR T790M Inhibitor HS-10296 | nan |
| EGFR/EGFRvIII Inhibitor WSD0922-FU | nan |
| EGFR/FLT3/Abl Inhibitor SKLB1028 | nan |
| EGFR/HER1/HER2 Inhibitor PKI166 | nan |
| EGFR/HER2 Inhibitor AP32788 | nan |
| EGFR/HER2 Inhibitor AV-412 | nan |
| EGFR/HER2 Inhibitor DZD9008 | nan |
| EGFR/HER2 Kinase Inhibitor TAK-285 | nan |
| EGFR/TGFb Fusion Monoclonal Antibody BCA101 | nan |
| EGFR/VEGFR/RET Inhibitor HA121-28 | nan |
| Eicosapentaenoic Acid | nan |
| eIF4E Antisense Oligonucleotide ISIS 183750 | nan |
| Elacestrant | nan |
| Elacytarabine | nan |
| Elagolix | nan |
| Elbasvir/Grazoprevir | nan |
| Elesclomol | nan |
| Elesclomol Sodium | nan |
| Elgemtumab | nan |
| Elinafide | nan |
| Elisidepsin | nan |
| Elliptinium | nan |
| Elliptinium Acetate | nan |
| Elmustine | nan |
| Elotuzumab | nan |
| Elpamotide | nan |
| Elsamitrucin | nan |
| Eltanexor | nan |
| Emactuzumab | nan |
| Emapalumab | nan |
| Emepepimut-S | nan |
| Emibetuzumab | nan |
| Emitefur | nan |
| Emofolin Sodium | nan |
| Empesertib | nan |
| Enadenotucirev | nan |
| Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A | nan |
| Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641 | nan |
| Enasidenib | nan |
| Enasidenib Mesylate | nan |
| Enavatuzumab | nan |
| Encapsulated Rapamycin | nan |
| Encelimab | nan |
| Enclomiphene | nan |
| Enclomiphene Citrate | nan |
| Encorafenib | nan |
| Endothelin B Receptor Blocker ENB 003 | nan |
| Endothelin Receptor Type A Antagonist YM598 | nan |
| Enfortumab Vedotin | nan |
| Engineered Human Umbilical Vein Endothelial Cells AB-205 | nan |
| Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240 | nan |
| Engineered Toxin Body Targeting CD38 TAK-169 | nan |
| Engineered Toxin Body Targeting HER2 MT-5111 | nan |
| Eniluracil/5-FU Combination Tablet | nan |
| Enloplatin | nan |
| Enoblituzumab | nan |
| Enobosarm | nan |
| Enoticumab | nan |
| Enpromate | nan |
| Ensartinib | nan |
| Ensituximab | nan |
| Enteric-Coated TRPM8 Agonist D-3263 Hydrochloride | nan |
| Enterococcus gallinarum Strain MRx0518 | nan |
| Entinostat | nan |
| Entolimod | nan |
| Entospletinib | nan |
| Entrectinib | nan |
| Envafolimab | nan |
| Enzalutamide | nan |
| Enzastaurin | nan |
| Enzastaurin Hydrochloride | nan |
| EP2/EP4 Antagonist TPST-1495 | nan |
| EP4 Antagonist INV-1120 | nan |
| EP4 Antagonist ONO-4578 | nan |
| Epacadostat | nan |
| Epcoritamab | nan |
| EphA2-targeting Bicycle Toxin Conjugate BT5528 | nan |
| Epipodophyllotoxin Analog GL331 | nan |
| Epipropidine | nan |
| Epirubicin | nan |
| Epirubicin Hydrochloride | nan |
| Epitinib Succinate | nan |
| Epitiostanol | nan |
| Epothilone Analog UTD1 | nan |
| Epothilone KOS-1584 | nan |
| Epratuzumab | nan |
| Epratuzumab-cys-tesirine | nan |
| ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471 | nan |
| ERa36 Modulator Icaritin | nan |
| Erastin Analogue PRLX 93936 | nan |
| Erbulozole | nan |
| Erdafitinib | nan |
| Eribulin | nan |
| Eribulin Mesylate | nan |
| ERK 1/2 Inhibitor ASTX029 | nan |
| ERK Inhibitor CC-90003 | nan |
| ERK Inhibitor GDC-0994 | nan |
| ERK Inhibitor LTT462 | nan |
| ERK Inhibitor MK-8353 | nan |
| ERK1/2 Inhibitor ASN007 | nan |
| ERK1/2 Inhibitor HH2710 | nan |
| ERK1/2 Inhibitor JSI-1187 | nan |
| ERK1/2 Inhibitor KO-947 | nan |
| ERK1/2 Inhibitor LY3214996 | nan |
| Erlotinib | nan |
| Erlotinib Hydrochloride | nan |
| Ertumaxomab | nan |
| Erythrocyte-encapsulated L-asparaginase Suspension | nan |
| Esorubicin | nan |
| Esorubicin Hydrochloride | nan |
| Esperamicin A1 | nan |
| Essiac | nan |
| Esterified Estrogens | nan |
| Estradiol Valerate | nan |
| Estramustine | nan |
| Estramustine Phosphate Sodium | nan |
| Estrogen Receptor Agonist GTx-758 | nan |
| Estrogens; Conjugated | nan |
| Etalocib | nan |
| Etanercept | nan |
| Etanidazole | nan |
| Etaracizumab | nan |
| Etarotene | nan |
| Ethaselen | nan |
| Ethinyl Estradiol | nan |
| Ethyleneimine | nan |
| Ethylnitrosourea | nan |
| Etidronate-Cytarabine Conjugate MBC-11 | nan |
| Etigilimab | nan |
| Etirinotecan Pegol | nan |
| Etoglucid | nan |
| Etoposide | nan |
| Etoposide Phosphate | nan |
| Etoposide Toniribate | nan |
| Etoprine | nan |
| Etoricoxib | nan |
| Ets-family Transcription Factor Inhibitor TK216 | nan |
| Everolimus | nan |
| Everolimus Tablets for Oral Suspension | nan |
| Evofosfamide | nan |
| Ex Vivo-expanded Autologous T Cells IMA101 | nan |
| Exatecan Mesylate | nan |
| Exatecan Mesylate Anhydrous | nan |
| Exemestane | nan |
| Exicorilant | nan |
| Exisulind | nan |
| Extended Release Flucytosine | nan |
| Extended Release Metformin Hydrochloride | nan |
| Extended-release Onapristone | nan |
| Ezabenlimab | nan |
| EZH1/2 Inhibitor DS-3201 | nan |
| EZH1/2 Inhibitor HH2853 | nan |
| EZH2 inhibitor CPI-0209 | nan |
| EZH2 Inhibitor CPI-1205 | nan |
| EZH2 Inhibitor PF-06821497 | nan |
| EZH2 Inhibitor SHR2554 | nan |
| F16-IL2 Fusion Protein | nan |
| FACT Complex-targeting Curaxin CBL0137 | nan |
| Factor VII-targeting Immunoconjugate Protein ICON-1 | nan |
| Factor VIIa Inhibitor PCI-27483 | nan |
| Fadraciclib | nan |
| Fadrozole Hydrochloride | nan |
| FAK Inhibitor GSK2256098 | nan |
| FAK Inhibitor PF-00562271 | nan |
| FAK Inhibitor VS-4718 | nan |
| FAK/ALK/ROS1 Inhibitor APG-2449 | nan |
| Falimarev | nan |
| Famitinib | nan |
| FAP/4-1BB-targeting DARPin MP0310 | nan |
| FAP/4-1BB-targeting Fusion Protein RO7122290 | nan |
| Farletuzumab | nan |
| Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778;123 | nan |
| Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells | nan |
| Fas Receptor Agonist APO010 | nan |
| Fascin Inhibitor NP-G2-044 | nan |
| FASN Inhibitor TVB-2640 | nan |
| Favezelimab | nan |
| Fazarabine | nan |
| Fc-engineered Anti-CD40 Agonist Antibody 2141-V11 | nan |
| Febuxostat | nan |
| Fedratinib | nan |
| Fedratinib Hydrochloride | nan |
| Feladilimab | nan |
| Felzartamab | nan |
| Fenebrutinib | nan |
| Fenretinide | nan |
| Fenretinide Lipid Matrix | nan |
| Fenretinide Phospholipid Suspension ST-001 | nan |
| FGF Receptor Antagonist HGS1036 | nan |
| FGF/FGFR Pathway Inhibitor E7090 | nan |
| FGFR Inhibitor ASP5878 | nan |
| FGFR Inhibitor AZD4547 | nan |
| FGFR Inhibitor CPL304110 | nan |
| FGFR Inhibitor Debio 1347 | nan |
| FGFR Inhibitor TAS-120 | nan |
| FGFR/CSF-1R Inhibitor 3D185 | nan |
| FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999 | nan |
| FGFR1/2/3 Inhibitor HMPL-453 | nan |
| FGFR2 Inhibitor RLY-4008 | nan |
| FGFR4 Antagonist INCB062079 | nan |
| FGFR4 Inhibitor BLU 9931 | nan |
| FGFR4 Inhibitor FGF401 | nan |
| FGFR4 Inhibitor H3B-6527 | nan |
| FGFR4 Inhibitor ICP-105 | nan |
| Fianlimab | nan |
| Fibromun | nan |
| Ficlatuzumab | nan |
| Figitumumab | nan |
| Filanesib | nan |
| Filgotinib | nan |
| Filgrastim | nan |
| Fimaporfin A | nan |
| Fimepinostat | nan |
| Firtecan Pegol | nan |
| Fisogatinib | nan |
| Flanvotumab | nan |
| Flotetuzumab | nan |
| Floxuridine | nan |
| FLT3 Inhibitor FF-10101 Succinate | nan |
| FLT3 Inhibitor HM43239 | nan |
| FLT3 Inhibitor SKI-G-801 | nan |
| Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01 | nan |
| FLT3 Tyrosine Kinase Inhibitor TTT-3002 | nan |
| FLT3/ABL/Aurora Kinase Inhibitor KW-2449 | nan |
| FLT3/CDK4/6 Inhibitor FLX925 | nan |
| FLT3/FGFR Dual Kinase Inhibitor MAX-40279 | nan |
| FLT3/KIT Kinase Inhibitor AKN-028 | nan |
| FLT3/KIT/CSF1R Inhibitor NMS-03592088 | nan |
| Flt3/MerTK Inhibitor MRX-2843 | nan |
| Fludarabine | nan |
| Fludarabine Phosphate | nan |
| Flumatinib | nan |
| Flumatinib Mesylate | nan |
| Fluorine F 18 Ara-G | nan |
| Fluorodopan | nan |
| Fluorouracil | nan |
| Fluorouracil Implant | nan |
| Fluorouracil-E Therapeutic Implant | nan |
| Fluoxymesterone | nan |
| Flutamide | nan |
| Fluvastatin | nan |
| Fluvastatin Sodium | nan |
| Fluzoparib | nan |
| FMS Inhibitor JNJ-40346527 | nan |
| Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate | nan |
| Folate Receptor Targeted Epothilone BMS753493 | nan |
| Folate Receptor-Targeted Tubulysin Conjugate EC1456 | nan |
| Folate Receptor-Targeted Vinca Alkaloid EC0489 | nan |
| Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225 | nan |
| Folate-FITC | nan |
| Folic Acid | nan |
| Folitixorin | nan |
| Foretinib | nan |
| Foritinib Succinate | nan |
| Formestane | nan |
| Forodesine Hydrochloride | nan |
| Fosaprepitant | nan |
| Fosbretabulin | nan |
| Fosbretabulin Disodium | nan |
| Fosbretabulin Tromethamine | nan |
| Fosgemcitabine Palabenamide | nan |
| Fosifloxuridine Nafalbenamide | nan |
| Foslinanib | nan |
| Foslinanib Disodium | nan |
| Fosquidone | nan |
| Fostriecin | nan |
| Fotemustine | nan |
| Fotretamine | nan |
| FPV Vaccine CV301 | nan |
| FPV-Brachyury-TRICOM Vaccine | nan |
| Fresolimumab | nan |
| Fruquintinib | nan |
| Fulvestrant | nan |
| Fumagillin-Derived Polymer Conjugate XMT-1107 | nan |
| Fursultiamine | nan |
| Futibatinib | nan |
| Futuximab | nan |
| Futuximab/Modotuximab Mixture | nan |
| G Protein-coupled Estrogen Receptor Agonist LNS8801 | nan |
| G-Quadruplex Stabilizer BMVC | nan |
| Galamustine | nan |
| Galarubicin | nan |
| Galectin Inhibitor GR-MD-02 | nan |
| Galectin-1 Inhibitor OTX008 | nan |
| Galeterone | nan |
| Galiximab | nan |
| Gallium-based Bone Resorption Inhibitor AP-002 | nan |
| Galocitabine | nan |
| Galunisertib | nan |
| Gamboge Resin Extract TSB-9-W1 | nan |
| Gamma-delta Tocotrienol | nan |
| Gamma-Secretase Inhibitor LY3039478 | nan |
| Gamma-Secretase Inhibitor RO4929097 | nan |
| Gandotinib | nan |
| Ganetespib | nan |
| Ganglioside GD2 | nan |
| Ganglioside GM2 | nan |
| Ganitumab | nan |
| Ganoderma lucidum Spores Powder Capsule | nan |
| Garlic | nan |
| Gastrin Immunotoxin | nan |
| Gastrin/cholecystokinin Type B Receptor Inhibitor Z-360 | nan |
| Gataparsen Sodium | nan |
| Gatipotuzumab | nan |
| GBM Antigens and Alloantigens Immunotherapeutic Vaccine | nan |
| Gedatolisib | nan |
| Gefitinib | nan |
| Geldanamycin | nan |
| Gelonin | nan |
| Gemcitabine | nan |
| Gemcitabine Elaidate | nan |
| Gemcitabine Hydrochloride | nan |
| Gemcitabine Hydrochloride Emulsion | nan |
| Gemcitabine Prodrug LY2334737 | nan |
| Gemcitabine-Phosphoramidate Hydrochloride NUC-1031 | nan |
| Gemcitabine-Releasing Intravesical System | nan |
| Gemtuzumab Ozogamicin | nan |
| Genetically Modified Interleukin-12 Transgene-encoding Bifidobacterium longum | nan |
| Genistein | nan |
| Gentuximab | nan |
| Geranylgeranyltransferase I Inhibitor | nan |
| GI-4000 Vaccine | nan |
| Giloralimab | nan |
| Gilteritinib | nan |
| Gilteritinib Fumarate | nan |
| Gimatecan | nan |
| Gimeracil | nan |
| Ginsenoside Rg3 Capsule | nan |
| Giredestrant | nan |
| Girentuximab | nan |
| Girodazole | nan |
| GITR Agonist MEDI1873 | nan |
| Givinostat | nan |
| Glasdegib | nan |
| Glasdegib Maleate | nan |
| Glaucarubolone | nan |
| Glecaprevir/Pibrentasvir | nan |
| Glembatumumab Vedotin | nan |
| Glesatinib | nan |
| Glioblastoma Cancer Vaccine ERC1671 | nan |
| Glioblastoma Multiforme Multipeptide Vaccine IMA950 | nan |
| Glioma Lysate Vaccine GBM6-AD | nan |
| Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701 | nan |
| Globo H-DT Vaccine OBI-833 | nan |
| Glofitamab | nan |
| Glucarpidase | nan |
| Glucocorticoid Receptor Antagonist ORIC-101 | nan |
| Glufosfamide | nan |
| Glumetinib | nan |
| Glutaminase Inhibitor CB-839 | nan |
| Glutaminase Inhibitor CB-839 Hydrochloride | nan |
| Glutaminase Inhibitor IPN60090 | nan |
| Glutamine Antagonist DRP-104 | nan |
| Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101 | nan |
| Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01 | nan |
| Glycooptimized Trastuzumab-GEX | nan |
| GM-CSF-encoding Oncolytic Adenovirus CGTG-102 | nan |
| Gold Sodium Thiomalate | nan |
| Golnerminogene Pradenovec | nan |
| Golotimod | nan |
| Golvatinib | nan |
| Gonadotropin-releasing Hormone Analog | nan |
| Goserelin | nan |
| Goserelin Acetate | nan |
| Goserelin Acetate Extended-release Microspheres LY01005 | nan |
| Gossypol | nan |
| Gossypol Acetic Acid | nan |
| Grapiprant | nan |
| Green Tea Extract-based Antioxidant Supplement | nan |
| GS/pan-Notch Inhibitor AL101 | nan |
| GS/pan-Notch Inhibitor BMS-986115 | nan |
| GSK-3 Inhibitor 9-ING-41 | nan |
| GSK-3 Inhibitor LY2090314 | nan |
| Guadecitabine | nan |
| Guanabenz Acetate | nan |
| Guselkumab | nan |
| Gusperimus Trihydrochloride | nan |
| Gutolactone | nan |
| H-ras Antisense Oligodeoxynucleotide ISIS 2503 | nan |
| H1299 Tumor Cell Lysate Vaccine | nan |
| HAAH Lambda phage Vaccine SNS-301 | nan |
| Hafnium Oxide-containing Nanoparticles NBTXR3 | nan |
| Halichondrin Analogue E7130 | nan |
| Halichondrin B | nan |
| Halofuginone | nan |
| Halofuginone Hydrobromide | nan |
| HCV DNA Vaccine INO-8000 | nan |
| HDAC Class I/IIb Inhibitor HG146 | nan |
| HDAC Inhibitor AR-42 | nan |
| HDAC inhibitor CG200745 | nan |
| HDAC Inhibitor CHR-2845 | nan |
| HDAC Inhibitor CKD-581 | nan |
| HDAC Inhibitor CXD101 | nan |
| HDAC Inhibitor MPT0E028 | nan |
| HDAC Inhibitor OBP-801 | nan |
| HDAC/EGFR/HER2 Inhibitor CUDC-101 | nan |
| HDAC6 Inhibitor KA2507 | nan |
| HDAC8 Inhibitor NBM-BMX | nan |
| HDM2 Inhibitor HDM201 | nan |
| HDM2 Inhibitor MK-8242 | nan |
| Hedgehog Inhibitor IPI-609 | nan |
| Hematoporphyrin Derivative | nan |
| Hemiasterlin Analog E7974 | nan |
| Henatinib Maleate | nan |
| Heparan Sulfate Glycosaminoglycan Mimetic M402 | nan |
| Heparin Derivative SST0001 | nan |
| HER-2-positive B-cell Peptide Antigen P467-DT-CRM197/Montanide Vaccine IMU-131 | nan |
| HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901 | nan |
| HER2 Inhibitor CP-724;714 | nan |
| HER2 Inhibitor DZD1516 | nan |
| HER2 Inhibitor TAS0728 | nan |
| HER2 Tri-specific Natural Killer Cell Engager DF1001 | nan |
| HER2-directed TLR8 Agonist SBT6050 | nan |
| HER2-targeted DARPin MP0274 | nan |
| HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302 | nan |
| HER2-targeting Antibody Fc Fragment FS102 | nan |
| Herba Scutellaria Barbata | nan |
| Herbimycin | nan |
| Heterodimeric Interleukin-15 | nan |
| Hexamethylene Bisacetamide | nan |
| Hexaminolevulinate | nan |
| Hexylresorcinol | nan |
| HIF-1alpha Inhibitor PX-478 | nan |
| HIF-2alpha Inhibitor PT2385 | nan |
| HIF-2alpha Inhibitor PT2977 | nan |
| HIF2a RNAi ARO-HIF2 | nan |
| Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126 | nan |
| Histrelin Acetate | nan |
| HLA-A*0201 Restricted TERT(572Y)/TERT(572) Peptides Vaccine Vx-001 | nan |
| HLA-A*2402-Restricted Multipeptide Vaccine S-488410 | nan |
| HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201 | nan |
| HM2/MMAE Antibody-Drug Conjugate ALT-P7 | nan |
| Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine | nan |
| Holmium Ho 166 Poly(L-Lactic Acid) Microspheres | nan |
| Hormone Therapy | nan |
| HPPH | nan |
| HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202 | nan |
| HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c | nan |
| HPV DNA Plasmids Therapeutic Vaccine VGX-3100 | nan |
| HPV E6/E7 DNA Vaccine GX-188E | nan |
| HPV E6/E7-encoding Arenavirus Vaccine HB-201 | nan |
| HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C | nan |
| HPV-16 E6 Peptides Vaccine/Candida albicans Extract | nan |
| HPV-6-targeting Immunotherapeutic Vaccine INO-3106 | nan |
| HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101 | nan |
| HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN | nan |
| HPV6/11-targeted DNA Plasmid Vaccine INO-3107 | nan |
| Hsp90 Antagonist KW-2478 | nan |
| Hsp90 Inhibitor AB-010 | nan |
| Hsp90 Inhibitor BIIB021 | nan |
| Hsp90 Inhibitor BIIB028 | nan |
| Hsp90 Inhibitor Debio 0932 | nan |
| Hsp90 Inhibitor DS-2248 | nan |
| Hsp90 Inhibitor HSP990 | nan |
| Hsp90 Inhibitor MPC-3100 | nan |
| Hsp90 Inhibitor PU-H71 | nan |
| Hsp90 Inhibitor SNX-5422 Mesylate | nan |
| Hsp90 Inhibitor SNX-5542 Mesylate | nan |
| Hsp90 Inhibitor TQB3474 | nan |
| Hsp90 Inhibitor XL888 | nan |
| Hsp90-targeted Photosensitizer HS-201 | nan |
| HSP90-targeted SN-38 Conjugate PEN-866 | nan |
| HSP90alpha/beta Inhibitor TAS-116 | nan |
| hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301 | nan |
| hTERT Vaccine V934/V935 | nan |
| hTERT-encoding DNA Vaccine INVAC-1 | nan |
| Hu14.18-IL2 Fusion Protein EMD 273063 | nan |
| HuaChanSu | nan |
| Huaier Extract Granule | nan |
| Huang Lian | nan |
| huBC1-huIL12 Fusion Protein AS1409 | nan |
| Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736 | nan |
| Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104 | nan |
| Human MOAB LICO 28a32 | nan |
| Human Monoclonal Antibody 216 | nan |
| Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307 | nan |
| Human Papillomavirus 16 E7 Peptide/Padre 965.10 | nan |
| Hyaluronidase-zzxf/Pertuzumab/Trastuzumab | nan |
| Hycanthone | nan |
| Hydralazine Hydrochloride | nan |
| Hydrocortisone Sodium Succinate | nan |
| Hydroxychloroquine | nan |
| Hydroxyprogesterone Caproate | nan |
| Hydroxytyrosol | nan |
| Hydroxyurea | nan |
| Hypericin | nan |
| Hypoxia-activated Prodrug TH-4000 | nan |
| I 131 Antiferritin Immunoglobulin | nan |
| I 131 Monoclonal Antibody A33 | nan |
| I 131 Monoclonal Antibody CC49 | nan |
| I 131 Monoclonal Antibody F19 | nan |
| I 131 Monoclonal Antibody Lym-1 | nan |
| Iadademstat | nan |
| Ianalumab | nan |
| IAP Inhibitor APG-1387 | nan |
| IAP Inhibitor AT-406 | nan |
| IAP Inhibitor HGS1029 | nan |
| Ibandronate Sodium | nan |
| Iberdomide | nan |
| Iboctadekin | nan |
| Ibritumomab Tiuxetan | nan |
| Ibrutinib | nan |
| Icotinib Hydrochloride | nan |
| Icrucumab | nan |
| ICT-121 Dendritic Cell Vaccine | nan |
| Idarubicin | nan |
| Idarubicin Hydrochloride | nan |
| Idarubicin-Eluting Beads | nan |
| Idasanutlin | nan |
| Idecabtagene Vicleucel | nan |
| Idelalisib | nan |
| Idetrexed | nan |
| IDH1 Mutant Inhibitor LY3410738 | nan |
| IDH1(R132) Inhibitor IDH305 | nan |
| IDH1R132H-Specific Peptide Vaccine PEPIDH1M | nan |
| Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020 | nan |
| IDO Peptide Vaccine IO102 | nan |
| IDO-1 Inhibitor LY3381916 | nan |
| IDO/TDO Inhibitor HTI-1090 | nan |
| IDO/TDO Inhibitor LY-01013 | nan |
| IDO1 Inhibitor KHK2455 | nan |
| IDO1 Inhibitor MK-7162 | nan |
| IDO1 Inhibitor PF-06840003 | nan |
| IDO1/TDO2 Inhibitor DN1406131 | nan |
| IDO1/TDO2 Inhibitor M4112 | nan |
| Idronoxil | nan |
| Idronoxil Suppository NOX66 | nan |
| Ieramilimab | nan |
| Ifabotuzumab | nan |
| Ifetroban | nan |
| Ifosfamide | nan |
| IGF-1R Inhibitor | nan |
| IGF-1R Inhibitor PL225B | nan |
| IGF-1R/IR Inhibitor KW-2450 | nan |
| IGF-methotrexate Conjugate | nan |
| IL-10 Immunomodulator MK-1966 | nan |
| IL-12-expressing HSV-1 NSC 733972 | nan |
| IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051 | nan |
| IL-12sc; IL-15sushi; IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000 | nan |
| IL-2 Recombinant Fusion Protein ALT-801 | nan |
| IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1 | nan |
| IL4-Pseudomonas Exotoxin Fusion Protein MDNA55 | nan |
| Ilginatinib | nan |
| Ilixadencel | nan |
| Iloprost | nan |
| Ilorasertib | nan |
| Imalumab | nan |
| Imaradenant | nan |
| Imatinib | nan |
| Imatinib Mesylate | nan |
| Imetelstat | nan |
| Imetelstat Sodium | nan |
| Imexon | nan |
| Imgatuzumab | nan |
| Imidazole Mustard | nan |
| Imidazole-Pyrazole | nan |
| Imifoplatin | nan |
| Imipramine Blue | nan |
| Imiquimod | nan |
| Immediate-release Onapristone | nan |
| Immediate-release Tablet Afuresertib | nan |
| Immune Checkpoint Inhibitor ASP8374 | nan |
| Immunoconjugate RO5479599 | nan |
| Immunocytokine NHS-IL12 | nan |
| Immunocytokine NHS-IL2-LT | nan |
| Immunomodulator LAM-003 | nan |
| Immunomodulator OHR/AVR118 | nan |
| Immunomodulatory Agent CC-11006 | nan |
| Immunomodulatory Oligonucleotide HYB2055 | nan |
| Immunotherapeutic Combination Product CMB305 | nan |
| Immunotherapeutic GSK1572932A | nan |
| Immunotherapy Regimen MKC-1106-MT | nan |
| Immunotoxin CMD-193 | nan |
| IMT-1012 Immunotherapeutic Vaccine | nan |
| Inactivated Oncolytic Virus Particle GEN0101 | nan |
| Inalimarev | nan |
| Incyclinide | nan |
| Indatuximab Ravtansine | nan |
| Indibulin | nan |
| Indicine-N-Oxide | nan |
| Indisulam | nan |
| Individualized MVA-based Vaccine TG4050 | nan |
| Indocyanine Green-labeled Polymeric Micelles ONM-100 | nan |
| Indole-3-Carbinol | nan |
| Indomethacin | nan |
| Indoximod | nan |
| Indoximod Prodrug NLG802 | nan |
| Indusatumab Vedotin | nan |
| Inebilizumab | nan |
| Inecalcitol | nan |
| Infigratinib | nan |
| Infigratinib Mesylate | nan |
| Infliximab | nan |
| Ingenol Mebutate | nan |
| Ingenol Mebutate Gel | nan |
| Iniparib | nan |
| iNKT Cell Agonist ABX196 | nan |
| Innate Immunostimulator rBBX-01 | nan |
| INO-1001 | nan |
| Inodiftagene Vixteplasmid | nan |
| iNOS Dimerization Inhibitor ASP9853 | nan |
| Inosine 5'-monophosphate Dehydrogenase Inhibitor FF-10501-01 | nan |
| Inosine Monophosphate Dehydrogenase Inhibitor AVN944 | nan |
| Inositol | nan |
| Inotuzumab Ozogamicin | nan |
| Inproquone | nan |
| Integrin alpha-2 Inhibitor E7820 | nan |
| Integrin Receptor Antagonist GLPG0187 | nan |
| Interferon | nan |
| Interferon Alfa-2B | nan |
| Interferon Alfa-N1 | nan |
| Interferon Alfa-N3 | nan |
| Interferon Alfacon-1 | nan |
| Interferon Beta-1A | nan |
| Interferon Gamma-1b | nan |
| Interferon-gamma-expressing Adenovirus Vaccine ASN-002 | nan |
| Interleukin Therapy | nan |
| Interleukin-12-Fc Fusion Protein DF6002 | nan |
| Interleukin-15 Agonist Fusion Protein SHR1501 | nan |
| Interleukin-15 Fusion Protein BJ-001 | nan |
| Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306 | nan |
| Interleukin-15/Interleukin-15 Receptor Alpha Sushi+ Domain Fusion Protein SO-C101 | nan |
| Interleukin-2 Liposome | nan |
| Intermediate-affinity Interleukin-2 Receptor Agonist ALKS 4230 | nan |
| Intetumumab | nan |
| Intiquinatine | nan |
| Intoplicine | nan |
| Inulin | nan |
| Iobenguane I-131 | nan |
| Iodine I 124 Monoclonal Antibody A33 | nan |
| Iodine I 124 Monoclonal Antibody M5A | nan |
| Iodine I 125-Anti-EGFR-425 Monoclonal Antibody | nan |
| Iodine I 131 Anti-Fibronectin Antibody Fragment L19-SIP | nan |
| Iodine I 131 Apamistamab | nan |
| Iodine I 131 Derlotuximab Biotin | nan |
| Iodine I 131 Ethiodized Oil | nan |
| Iodine I 131 IPA | nan |
| Iodine I 131 MIP-1095 | nan |
| Iodine I 131 Monoclonal Antibody 81C6 | nan |
| Iodine I 131 Monoclonal Antibody BC8 | nan |
| Iodine I 131 Monoclonal Antibody CC49-deltaCH2 | nan |
| Iodine I 131 Monoclonal Antibody F16SIP | nan |
| Iodine I 131 Monoclonal Antibody G-250 | nan |
| Iodine I 131 Monoclonal Antibody muJ591 | nan |
| Iodine I 131 Omburtamab | nan |
| Iodine I 131 Rituximab | nan |
| Iodine I 131 Tenatumomab | nan |
| Iodine I 131 TM-601 | nan |
| Iodine I 131 Tositumomab | nan |
| Iodine I-131 | nan |
| Ioflubenzamide I-131 | nan |
| Ionomycin | nan |
| Ipafricept | nan |
| Ipatasertib | nan |
| Ipilimumab | nan |
| Ipomeanol | nan |
| Iproplatin | nan |
| iPSC-derived CD16-expressing Natural Killer Cells FT516 | nan |
| iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596 | nan |
| iPSC-derived Natural Killer Cells FT500 | nan |
| IRAK4 Inhibitor CA-4948 | nan |
| Iratumumab | nan |
| Iridium Ir 192 | nan |
| Irinotecan | nan |
| Irinotecan Hydrochloride | nan |
| Irinotecan Sucrosofate | nan |
| Irinotecan-Eluting Beads | nan |
| Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet | nan |
| Irofulven | nan |
| Iroplact | nan |
| Irosustat | nan |
| Irradiated Allogeneic Human Lung Cancer Cells Expressing OX40L-Ig Vaccine HS-130 | nan |
| Isatuximab | nan |
| Iso-fludelone | nan |
| Isobrucein B | nan |
| Isocoumarin NM-3 | nan |
| Isotretinoin | nan |
| Ispinesib | nan |
| Ispinesib Mesylate | nan |
| ISS 1018 CpG Oligodeoxynucleotide | nan |
| Istiratumab | nan |
| Itacitinib | nan |
| Itacitinib Adipate | nan |
| ITK Inhibitor CPI-818 | nan |
| Itraconazole | nan |
| Itraconazole Dispersion In Polymer Matrix | nan |
| Ivaltinostat | nan |
| Ivosidenib | nan |
| Ivuxolimab | nan |
| Ixabepilone | nan |
| Ixazomib | nan |
| Ixazomib Citrate | nan |
| JAK Inhibitor | nan |
| JAK Inhibitor INCB047986 | nan |
| JAK1 Inhibitor AZD4205 | nan |
| JAK1 Inhibitor INCB052793 | nan |
| JAK2 Inhibitor AZD1480 | nan |
| JAK2 Inhibitor BMS-911543 | nan |
| JAK2 Inhibitor XL019 | nan |
| JAK2/Src Inhibitor NS-018 | nan |
| Jin Fu Kang | nan |
| JNK Inhibitor CC-401 | nan |
| Kanglaite | nan |
| Kanitinib | nan |
| Ketoconazole | nan |
| Ketotrexate | nan |
| KRAS G12C Inhibitor GDC-6036 | nan |
| KRAS G12C Inhibitor LY3499446 | nan |
| KRAS G12C Inhibitor MRTX849 | nan |
| KRAS Mutant-targeting AMG 510 | nan |
| KRAS-MAPK Signaling Pathway Inhibitor JAB-3312 | nan |
| KRASG12C Inhibitor JNJ-74699157 | nan |
| KRN5500 | nan |
| KSP Inhibitor AZD4877 | nan |
| KSP Inhibitor SB-743921 | nan |
| Kunecatechins Ointment | nan |
| L-Gossypol | nan |
| L-methylfolate | nan |
| Labetuzumab Govitecan | nan |
| Lactoferrin-derived Lytic Peptide LTX-315 | nan |
| Lacutamab | nan |
| Ladiratuzumab Vedotin | nan |
| Ladirubicin | nan |
| Laetrile | nan |
| LAIR-2 Fusion Protein NC410 | nan |
| Landogrozumab | nan |
| Laniquidar | nan |
| Lanreotide Acetate | nan |
| Lapachone | nan |
| Lapatinib | nan |
| Lapatinib Ditosylate | nan |
| Laprituximab Emtansine | nan |
| Lapuleucel-T | nan |
| Laromustine | nan |
| Larotaxel | nan |
| Larotinib Mesylate | nan |
| Larotrectinib | nan |
| Larotrectinib Sulfate | nan |
| Lavendustin A | nan |
| Lazertinib | nan |
| Lead Pb 212 TCMC-trastuzumab | nan |
| Lefitolimod | nan |
| Leflunomide | nan |
| Lenalidomide | nan |
| Lenalidomide Analog KPG-121 | nan |
| Lentinan | nan |
| Lenvatinib | nan |
| Lenvatinib Mesylate | nan |
| Lenzilumab | nan |
| Lerociclib | nan |
| Lestaurtinib | nan |
| Letetresgene Autoleucel | nan |
| Letolizumab | nan |
| Letrozole | nan |
| Leucovorin | nan |
| Leucovorin Calcium | nan |
| Leuprolide | nan |
| Leuprolide Acetate | nan |
| Leuprolide Mesylate Injectable Suspension | nan |
| Leurubicin | nan |
| Levetiracetam | nan |
| Levoleucovorin Calcium | nan |
| Levothyroxine | nan |
| Levothyroxine Sodium | nan |
| Lexatumumab | nan |
| Lexibulin | nan |
| Liarozole | nan |
| Liarozole Fumarate | nan |
| Liarozole Hydrochloride | nan |
| Licartin | nan |
| Licorice | nan |
| Lifastuzumab Vedotin | nan |
| Lifileucel | nan |
| Lifirafenib | nan |
| Light-activated AU-011 | nan |
| Light-Emitting Oncolytic Vaccinia Virus GL-ONC1 | nan |
| Lilotomab | nan |
| Limonene; (+)- | nan |
| Limonene; (+/-)- | nan |
| Linifanib | nan |
| Linoleyl Carbonate-Paclitaxel | nan |
| Linperlisib | nan |
| Linrodostat | nan |
| Linsitinib | nan |
| Lintuzumab | nan |
| Liothyronine I-131 | nan |
| Liothyronine Sodium | nan |
| Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1 | nan |
| Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191 | nan |
| Lipid Nanoparticle Encapsulated OX40L mRNA-2416 | nan |
| Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006 | nan |
| Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752 | nan |
| Liposomal Bcl-2 Antisense Oligonucleotide BP1002 | nan |
| Liposomal c-raf Antisense Oligonucleotide | nan |
| Liposomal Curcumin | nan |
| Liposomal Cytarabine | nan |
| Liposomal Daunorubicin Citrate | nan |
| Liposomal Docetaxel | nan |
| Liposomal Eribulin Mesylate | nan |
| Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101 | nan |
| Liposomal Irinotecan | nan |
| Liposomal Mitoxantrone Hydrochloride | nan |
| Liposomal MUC1/PET-lipid A Vaccine ONT-10 | nan |
| Liposomal NDDP | nan |
| Liposomal Rhenium Re 186 | nan |
| Liposomal SN-38 | nan |
| Liposomal Topotecan FF-10850 | nan |
| Liposomal Vinorelbine | nan |
| Liposomal Vinorelbine Tartrate | nan |
| Liposome | nan |
| Liposome-encapsulated Daunorubicin-Cytarabine | nan |
| Liposome-Encapsulated Doxorubicin Citrate | nan |
| Liposome-encapsulated miR-34 Mimic MRX34 | nan |
| Liposome-encapsulated OSI-7904 | nan |
| Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94 | nan |
| Liposome-encapsulated TAAs mRNA Vaccine W_ova1 | nan |
| Lirilumab | nan |
| Lisavanbulin | nan |
| Lisocabtagene Maraleucel | nan |
| Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142 | nan |
| Litronesib | nan |
| Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809 | nan |
| Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207 | nan |
| Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623 | nan |
| Liver X Receptor beta Agonist RGX-104 | nan |
| Lm-tLLO-neoantigens Vaccine ADXS-NEO | nan |
| LMB-1 Immunotoxin | nan |
| LMB-2 Immunotoxin | nan |
| LMB-7 Immunotoxin | nan |
| LMB-9 Immunotoxin | nan |
| LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine ADXS31-164 | nan |
| LMP-2:340-349 Peptide Vaccine | nan |
| LMP-2:419-427 Peptide Vaccine | nan |
| LMP2-specific T Cell Receptor-transduced Autologous T-lymphocytes | nan |
| LMP7 Inhibitor M3258 | nan |
| Lobaplatin | nan |
| Lodapolimab | nan |
| Lometrexol | nan |
| Lometrexol Sodium | nan |
| Lomustine | nan |
| Lonafarnib | nan |
| Loncastuximab Tesirine | nan |
| Long Peptide Vaccine 7 | nan |
| Long-acting Release Pasireotide | nan |
| Lontucirev | nan |
| Lorlatinib | nan |
| Lorukafusp alfa | nan |
| Lorvotuzumab Mertansine | nan |
| Losatuxizumab Vedotin | nan |
| Losoxantrone | nan |
| Losoxantrone Hydrochloride | nan |
| Lovastatin | nan |
| LOXL2 Inhibitor PAT-1251 | nan |
| LRP5 Antagonist BI 905681 | nan |
| LRP5/6 Antagonist BI 905677 | nan |
| LSD1 Inhibitor CC-90011 | nan |
| LSD1 Inhibitor GSK2879552 | nan |
| LSD1 Inhibitor IMG-7289 | nan |
| LSD1 Inhibitor RO7051790 | nan |
| LSD1 Inhibitor SYHA1807 | nan |
| Lucanthone | nan |
| Lucatumumab | nan |
| Lucitanib | nan |
| Luminespib | nan |
| Luminespib Mesylate | nan |
| Lumretuzumab | nan |
| Lung-targeted Immunomodulator QBKPN | nan |
| Lupartumab Amadotin | nan |
| Lurbinectedin | nan |
| Lurtotecan | nan |
| Lurtotecan Liposome | nan |
| Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1 | nan |
| Lutetium Lu 177 DOTA-biotin | nan |
| Lutetium Lu 177 DOTA-N3-CTT1403 | nan |
| Lutetium Lu 177 DOTA-Tetulomab | nan |
| Lutetium Lu 177 Dotatate | nan |
| Lutetium Lu 177 Lilotomab-satetraxetan | nan |
| Lutetium Lu 177 Monoclonal Antibody CC49 | nan |
| Lutetium Lu 177 Monoclonal Antibody J591 | nan |
| Lutetium Lu 177 PP-F11N | nan |
| Lutetium Lu 177 Satoreotide Tetraxetan | nan |
| Lutetium Lu 177-DOTA-EB-TATE | nan |
| Lutetium Lu 177-DTPA-omburtamab | nan |
| Lutetium Lu 177-Edotreotide | nan |
| Lutetium Lu 177-NeoB | nan |
| Lutetium Lu 177-PSMA-617 | nan |
| Lutetium Lu-177 Capromab | nan |
| Lutetium Lu-177 Girentuximab | nan |
| Lutetium Lu-177 PSMA-R2 | nan |
| Lutetium Lu-177 Rituximab | nan |
| LV.IL-2/B7.1-Transduced AML Blast Vaccine RFUSIN2-AML1 | nan |
| Lyophilized Black Raspberry Lozenge | nan |
| Lyophilized Black Raspberry Saliva Substitute | nan |
| Lysine-specific Demethylase 1 Inhibitor INCB059872 | nan |
| Lyso-Thermosensitive Liposome Doxorubicin | nan |
| Maackia amurensis Seed Lectin | nan |
| Macimorelin | nan |
| Macitentan | nan |
| Macrocycle-bridged STING Agonist E7766 | nan |
| Maekmoondong-tang | nan |
| Mafosfamide | nan |
| MAGE-10.A2 | nan |
| MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells | nan |
| MAGE-A3 Multipeptide Vaccine GL-0817 | nan |
| MAGE-A3 Peptide Vaccine | nan |
| MAGE-A3-specific Immunotherapeutic GSK 2132231A | nan |
| MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201 | nan |
| Magnesium Valproate | nan |
| Magrolimab | nan |
| MALT1 Inhibitor JNJ-67856633 | nan |
| Manelimab | nan |
| Mannosulfan | nan |
| Mannosylerythritol Lipid | nan |
| Mapatumumab | nan |
| Maraba Oncolytic Virus Expressing Mutant HPV E6/E7 | nan |
| Marcellomycin | nan |
| MARCKS Protein Inhibitor BIO-11006 | nan |
| Margetuximab | nan |
| Marimastat | nan |
| Marizomib | nan |
| Masitinib Mesylate | nan |
| Masoprocol | nan |
| MAT2A Inhibitor AG-270 | nan |
| Matrix Metalloproteinase Inhibitor MMI270 | nan |
| Matuzumab | nan |
| Mavelertinib | nan |
| Mavorixafor | nan |
| Maytansine | nan |
| MCL-1 Inhibitor ABBV-467 | nan |
| MCL-1 Inhibitor AMG 176 | nan |
| MCL-1 inhibitor AMG 397 | nan |
| Mcl-1 Inhibitor AZD5991 | nan |
| Mcl-1 Inhibitor MIK665 | nan |
| MDM2 Antagonist ASTX295 | nan |
| MDM2 Antagonist RO5045337 | nan |
| MDM2 Antagonist RO6839921 | nan |
| MDM2 Inhibitor AMG-232 | nan |
| MDM2 Inhibitor AMGMDS3 | nan |
| MDM2 Inhibitor BI 907828 | nan |
| MDM2 Inhibitor KRT-232 | nan |
| MDM2/MDMX Inhibitor ALRN-6924 | nan |
| MDR Modulator CBT-1 | nan |
| Mechlorethamine | nan |
| Mechlorethamine Hydrochloride | nan |
| Mechlorethamine Hydrochloride Gel | nan |
| Medorubicin | nan |
| Medroxyprogesterone | nan |
| Medroxyprogesterone Acetate | nan |
| Megestrol Acetate | nan |
| MEK 1/2 Inhibitor AS703988/MSC2015103B | nan |
| MEK 1/2 Inhibitor FCN-159 | nan |
| MEK Inhibitor AZD8330 | nan |
| MEK Inhibitor CI-1040 | nan |
| MEK inhibitor CS3006 | nan |
| MEK Inhibitor GDC-0623 | nan |
| MEK Inhibitor HL-085 | nan |
| MEK Inhibitor PD0325901 | nan |
| MEK Inhibitor RO4987655 | nan |
| MEK Inhibitor SHR 7390 | nan |
| MEK Inhibitor TAK-733 | nan |
| MEK Inhibitor WX-554 | nan |
| MEK-1/MEKK-1 Inhibitor E6201 | nan |
| MEK/Aurora Kinase Inhibitor BI 847325 | nan |
| Melanoma Monoclonal Antibody hIgG2A | nan |
| Melanoma TRP2 CTL Epitope Vaccine SCIB1 | nan |
| Melapuldencel-T | nan |
| MELK Inhibitor OTS167 | nan |
| Melphalan | nan |
| Melphalan Flufenamide | nan |
| Melphalan Hydrochloride | nan |
| Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex | nan |
| Membrane-Disrupting Peptide EP-100 | nan |
| Menatetrenone | nan |
| Menin-MLL Interaction Inhibitor SNDX-5613 | nan |
| Menogaril | nan |
| Merbarone | nan |
| Mercaptopurine | nan |
| Mercaptopurine Anhydrous | nan |
| Mercaptopurine Oral Suspension | nan |
| Merestinib | nan |
| Mesna | nan |
| Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536 | nan |
| MET Kinase Inhibitor OMO-1 | nan |
| MET Tyrosine Kinase Inhibitor BMS-777607 | nan |
| MET Tyrosine Kinase Inhibitor EMD 1204831 | nan |
| MET Tyrosine Kinase Inhibitor PF-04217903 | nan |
| MET Tyrosine Kinase Inhibitor SAR125844 | nan |
| MET Tyrosine Kinase Inhibitor SGX523 | nan |
| MET x MET Bispecific Antibody REGN5093 | nan |
| Metamelfalan | nan |
| MetAP2 Inhibitor APL-1202 | nan |
| MetAP2 Inhibitor SDX-7320 | nan |
| Metarrestin | nan |
| Metatinib Tromethamine | nan |
| Metformin | nan |
| Metformin Hydrochloride | nan |
| Methanol Extraction Residue of BCG | nan |
| Methazolamide | nan |
| Methionine Aminopeptidase 2 Inhibitor M8891 | nan |
| Methionine Aminopeptidase 2 Inhibitor PPI-2458 | nan |
| Methotrexate | nan |
| Methotrexate Sodium | nan |
| Methotrexate-E Therapeutic Implant | nan |
| Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles | nan |
| Methoxsalen | nan |
| Methoxyamine | nan |
| Methoxyamine Hydrochloride | nan |
| Methyl-5-Aminolevulinate Hydrochloride Cream | nan |
| Methylcantharidimide | nan |
| Methylmercaptopurine Riboside | nan |
| Methylprednisolone | nan |
| Methylprednisolone Acetate | nan |
| Methylprednisolone Sodium Succinate | nan |
| Methylselenocysteine | nan |
| Methyltestosterone | nan |
| Metoprine | nan |
| Mevociclib | nan |
| Mezagitamab | nan |
| Mibefradil | nan |
| Mibefradil Dihydrochloride | nan |
| Micellar Nanoparticle-encapsulated Epirubicin | nan |
| Micro Needle Array-Doxorubicin | nan |
| Microbiome GEN-001 | nan |
| Microbiome-derived Peptide Vaccine EO2401 | nan |
| Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300 | nan |
| Microtubule Inhibitor SCB01A | nan |
| Midostaurin | nan |
| Mifamurtide | nan |
| Mifepristone | nan |
| Milademetan Tosylate | nan |
| Milataxel | nan |
| Milatuzumab | nan |
| Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110 | nan |
| Milciclib Maleate | nan |
| Milk Thistle | nan |
| Miltefosine | nan |
| Minretumomab | nan |
| Mipsagargin | nan |
| Miptenalimab | nan |
| Mirabegron | nan |
| Miransertib | nan |
| Mirdametinib | nan |
| Mirvetuximab Soravtansine | nan |
| Mirzotamab Clezutoclax | nan |
| Misonidazole | nan |
| Mistletoe Extract | nan |
| Mitazalimab | nan |
| Mitindomide | nan |
| Mitobronitol | nan |
| Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101 | nan |
| Mitoclomine | nan |
| Mitoflaxone | nan |
| Mitoguazone | nan |
| Mitoguazone Dihydrochloride | nan |
| Mitolactol | nan |
| Mitomycin | nan |
| Mitomycin A | nan |
| Mitomycin B | nan |
| Mitomycin C Analog KW-2149 | nan |
| Mitosis Inhibitor T 1101 Tosylate | nan |
| Mitotane | nan |
| Mitotenamine | nan |
| Mitoxantrone | nan |
| Mitoxantrone Hydrochloride | nan |
| Mitozolomide | nan |
| Mivavotinib | nan |
| Mivebresib | nan |
| Mivobulin | nan |
| Mivobulin Isethionate | nan |
| Mixed Bacteria Vaccine | nan |
| MK0731 | nan |
| MKC-1 | nan |
| MKNK1 Inhibitor BAY 1143269 | nan |
| MMP Inhibitor S-3304 | nan |
| MNK1/2 Inhibitor ETC-1907206 | nan |
| Mobocertinib | nan |
| Mocetinostat | nan |
| Modakafusp Alfa | nan |
| Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208 | nan |
| Modified Vitamin D Binding Protein Macrophage Activator EF-022 | nan |
| Modotuximab | nan |
| MOF Compound RiMO-301 | nan |
| Mofarotene | nan |
| Mogamulizumab | nan |
| Molibresib | nan |
| Molibresib Besylate | nan |
| Momelotinib | nan |
| Monalizumab | nan |
| Monocarboxylate Transporter 1 Inhibitor AZD3965 | nan |
| Monoclonal Antibody 105AD7 Anti-idiotype Vaccine | nan |
| Monoclonal Antibody 11D10 | nan |
| Monoclonal Antibody 11D10 Anti-Idiotype Vaccine | nan |
| Monoclonal Antibody 14G2A | nan |
| Monoclonal Antibody 1F5 | nan |
| Monoclonal Antibody 3622W94 | nan |
| Monoclonal Antibody 3F8 | nan |
| Monoclonal Antibody 3H1 Anti-Idiotype Vaccine | nan |
| Monoclonal Antibody 4B5 Anti-Idiotype Vaccine | nan |
| Monoclonal Antibody 7C11 | nan |
| Monoclonal Antibody 81C6 | nan |
| Monoclonal Antibody A1G4 Anti-Idiotype Vaccine | nan |
| Monoclonal Antibody A27.15 | nan |
| Monoclonal Antibody A33 | nan |
| Monoclonal Antibody AbGn-7 | nan |
| Monoclonal Antibody AK002 | nan |
| Monoclonal Antibody ASP1948 | nan |
| Monoclonal Antibody CAL | nan |
| Monoclonal Antibody CC49-delta CH2 | nan |
| Monoclonal Antibody CEP-37250/KHK2804 | nan |
| Monoclonal Antibody D6.12 | nan |
| Monoclonal Antibody E2.3 | nan |
| Monoclonal Antibody F19 | nan |
| Monoclonal Antibody GD2 Anti-Idiotype Vaccine | nan |
| Monoclonal Antibody HeFi-1 | nan |
| Monoclonal Antibody Hu3S193 | nan |
| Monoclonal Antibody HuAFP31 | nan |
| Monoclonal Antibody HuHMFG1 | nan |
| Monoclonal Antibody huJ591 | nan |
| Monoclonal Antibody HuPAM4 | nan |
| Monoclonal Antibody IMMU-14 | nan |
| Monoclonal Antibody L6 | nan |
| Monoclonal Antibody Lym-1 | nan |
| Monoclonal Antibody m170 | nan |
| Monoclonal Antibody Me1-14 F(ab')2 | nan |
| Monoclonal Antibody muJ591 | nan |
| Monoclonal Antibody MX35 F(ab')2 | nan |
| Monoclonal Antibody NEO-201 | nan |
| Monoclonal Antibody R24 | nan |
| Monoclonal Antibody RAV12 | nan |
| Monoclonal Antibody SGN-14 | nan |
| Monoclonal Antibody TRK-950 | nan |
| Monoclonal Microbial EDP1503 | nan |
| Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100 | nan |
| Monomethyl Auristatin E | nan |
| Morinda Citrifolia Fruit Extract | nan |
| Morpholinodoxorubicin | nan |
| Mosedipimod | nan |
| Mosunetuzumab | nan |
| Motesanib | nan |
| Motesanib Diphosphate | nan |
| Motexafin Gadolinium | nan |
| Motexafin Lutetium | nan |
| Motixafortide | nan |
| Motolimod | nan |
| MOv-gamma Chimeric Receptor Gene | nan |
| Moxetumomab Pasudotox | nan |
| Mps1 Inhibitor BAY 1217389 | nan |
| Mps1 Inhibitor BOS172722 | nan |
| mRNA-based Personalized Cancer Vaccine mRNA-4157 | nan |
| mRNA-based Personalized Cancer Vaccine NCI-4650 | nan |
| mRNA-based TriMix Melanoma Vaccine ECI-006 | nan |
| mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902 | nan |
| mRNA-derived KRAS-targeted Vaccine V941 | nan |
| mRNA-derived Lung Cancer Vaccine BI 1361849 | nan |
| mRNA-Derived Prostate Cancer Vaccine CV9103 | nan |
| mRNA-derived Prostate Cancer Vaccine CV9104 | nan |
| MTF-1 Inhibitor APTO-253 HCl | nan |
| mTOR Inhibitor GDC-0349 | nan |
| mTOR Kinase Inhibitor AZD8055 | nan |
| mTOR Kinase Inhibitor CC-223 | nan |
| mTOR Kinase Inhibitor OSI-027 | nan |
| mTOR Kinase Inhibitor PP242 | nan |
| mTOR1/2 Kinase Inhibitor ME-344 | nan |
| mTORC 1/2 Inhibitor LXI-15029 | nan |
| mTORC1/2 Kinase Inhibitor BI 860585 | nan |
| mTORC1/mTORC2/DHFR Inhibitor ABTL0812 | nan |
| MUC-1/WT1 Peptide-primed Autologous Dendritic Cells | nan |
| MUC1-targeted Peptide GO-203-2C | nan |
| Mucoadhesive Paclitaxel Formulation | nan |
| Multi-AGC Kinase Inhibitor AT13148 | nan |
| Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200 | nan |
| Multi-epitope HER2 Peptide Vaccine H2NVAC | nan |
| Multi-epitope HER2 Peptide Vaccine TPIV100 | nan |
| Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107 | nan |
| Multi-kinase Inhibitor TPX-0022 | nan |
| Multi-kinase Inhibitor XL092 | nan |
| Multi-mode Kinase Inhibitor EOC317 | nan |
| Multi-neo-epitope Vaccine OSE 2101 | nan |
| Multifunctional/Multitargeted Anticancer Agent OMN54 | nan |
| Multikinase Inhibitor 4SC-203 | nan |
| Multikinase Inhibitor AEE788 | nan |
| Multikinase Inhibitor AT9283 | nan |
| Multikinase Inhibitor SAR103168 | nan |
| Multipeptide Vaccine S-588210 | nan |
| Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327 | nan |
| Muparfostat | nan |
| Mureletecan | nan |
| Murizatoclax | nan |
| Muscadine Grape Extract | nan |
| Mutant IDH1 Inhibitor DS-1001 | nan |
| Mutant p53 Activator COTI-2 | nan |
| Mutant-selective EGFR Inhibitor PF-06459988 | nan |
| MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP | nan |
| MVA-BN Smallpox Vaccine | nan |
| MVA-FCU1 TG4023 | nan |
| MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1 | nan |
| MYC-targeting siRNA DCR-MYC | nan |
| Mycobacterium tuberculosis Arabinomannan Z-100 | nan |
| Mycobacterium w | nan |
| Mycophenolic Acid | nan |
| N-(5-tert-butyl-3-isoxazolyl)-N-(4-(4-pyridinyl)oxyphenyl) Urea | nan |
| N-dihydrogalactochitosan | nan |
| N-Methylformamide | nan |
| N;N-Dibenzyl Daunomycin | nan |
| NA17-A Antigen | nan |
| NA17.A2 Peptide Vaccine | nan |
| Nab-paclitaxel | nan |
| Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 | nan |
| Nadofaragene Firadenovec | nan |
| Nagrestipen | nan |
| Namirotene | nan |
| Namodenoson | nan |
| NAMPT Inhibitor OT-82 | nan |
| Nanafrocin | nan |
| Nanatinostat | nan |
| Nanocell-encapsulated miR-16-based microRNA Mimic | nan |
| Nanoparticle Albumin-Bound Docetaxel | nan |
| Nanoparticle Albumin-Bound Rapamycin | nan |
| Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404 | nan |
| Nanoparticle Paclitaxel Ointment SOR007 | nan |
| Nanoparticle-based Paclitaxel Suspension | nan |
| Nanoparticle-encapsulated Doxorubicin Hydrochloride | nan |
| Nanoscale Coordination Polymer Nanoparticles CPI-100 | nan |
| Nanosomal Docetaxel Lipid Suspension | nan |
| Napabucasin | nan |
| Naphthalimide Analogue UNBS5162 | nan |
| Naptumomab Estafenatox | nan |
| Naquotinib | nan |
| Naratuximab Emtansine | nan |
| Narnatumab | nan |
| Natalizumab | nan |
| Natural IFN-alpha OPC-18 | nan |
| Natural Killer Cells ZRx101 | nan |
| Navarixin | nan |
| Navicixizumab | nan |
| Navitoclax | nan |
| Navoximod | nan |
| Navy Bean Powder | nan |
| Naxitamab | nan |
| Nazartinib | nan |
| ncmtRNA Oligonucleotide Andes-1537 | nan |
| Necitumumab | nan |
| Nedaplatin | nan |
| NEDD8 Activating Enzyme E1 Inhibitor TAS4464 | nan |
| Nedisertib | nan |
| Nelarabine | nan |
| Nelipepimut-S | nan |
| Nelipepimut-S Plus GM-CSF Vaccine | nan |
| Nemorubicin | nan |
| Nemorubicin Hydrochloride | nan |
| Neoantigen Vaccine GEN-009 | nan |
| Neoantigen-based Glioblastoma Vaccine | nan |
| Neoantigen-based Melanoma-Poly-ICLC Vaccine | nan |
| Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine | nan |
| Neoantigen-based Therapeutic Cancer Vaccine GRT-C903 | nan |
| Neoantigen-based Therapeutic Cancer Vaccine GRT-R904 | nan |
| Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017 | nan |
| Neratinib | nan |
| Neratinib Maleate | nan |
| Nesvacumab | nan |
| NG-nitro-L-arginine | nan |
| Niacinamide | nan |
| Niclosamide | nan |
| Nicotinamide Riboside | nan |
| Nidanilimab | nan |
| Nifurtimox | nan |
| Nilotinib | nan |
| Nilotinib Hydrochloride Anhydrous | nan |
| Nilotinib Hydrochloride Monohydrate | nan |
| Nilutamide | nan |
| Nimesulide-Hyaluronic Acid Conjugate CA102N | nan |
| Nimodipine | nan |
| Nimotuzumab | nan |
| Nimustine | nan |
| Nimustine Hydrochloride | nan |
| Ningetinib Tosylate | nan |
| Nintedanib | nan |
| Niraparib | nan |
| Niraparib Tosylate Monohydrate | nan |
| Nirogacestat | nan |
| Nitric Oxide-Releasing Acetylsalicylic Acid Derivative | nan |
| Nitrogen Mustard Prodrug PR-104 | nan |
| Nitroglycerin Transdermal Patch | nan |
| Nivolumab | nan |
| NLRP3 Agonist BMS-986299 | nan |
| Nocodazole | nan |
| Nogalamycin | nan |
| Nogapendekin Alfa | nan |
| Nolatrexed Dihydrochloride | nan |
| Non-Small Cell Lung Cancer mRNA-Derived Vaccine CV9201 | nan |
| Norgestrel | nan |
| North American Ginseng Extract AFX-2 | nan |
| Nortopixantrone | nan |
| Noscapine | nan |
| Noscapine Hydrochloride | nan |
| Not Otherwise Specified | nan |
| Notch Signaling Inhibitor PF-06650808 | nan |
| Notch Signaling Pathway Inhibitor MK0752 | nan |
| NTRK/ROS1 Inhibitor DS-6051b | nan |
| Nucleolin Antagonist IPP-204106N | nan |
| Nucleoside Analog DFP-10917 | nan |
| Nucleotide Analog Prodrug NUC-3373 | nan |
| Nucleotide Analogue GS 9219 | nan |
| Numidargistat | nan |
| Nurulimab | nan |
| Nutlin-3a | nan |
| Nutraceutical TBL-12 | nan |
| NY-ESO-1 Plasmid DNA Cancer Vaccine pPJV7611 | nan |
| NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301 | nan |
| NY-ESO-1/GLA-SE Vaccine ID-G305 | nan |
| NY-ESO-B | nan |
| O-Chloroacetylcarbamoylfumagillol | nan |
| O6-Benzylguanine | nan |
| Obatoclax Mesylate | nan |
| Obinutuzumab | nan |
| Oblimersen Sodium | nan |
| Ocaratuzumab | nan |
| Ocrelizumab | nan |
| Octreotide | nan |
| Octreotide Acetate | nan |
| Octreotide Pamoate | nan |
| Odronextamab | nan |
| Ofatumumab | nan |
| Ofranergene Obadenovec | nan |
| Oglufanide Disodium | nan |
| Olaparib | nan |
| Olaptesed Pegol | nan |
| Olaratumab | nan |
| Oleandrin | nan |
| Oleclumab | nan |
| Oligo-fucoidan | nan |
| Oligonucleotide SPC2996 | nan |
| Olinvacimab | nan |
| Olivomycin | nan |
| Olmutinib | nan |
| Oltipraz | nan |
| Olutasidenib | nan |
| Olvimulogene Nanivacirepvec | nan |
| Omacetaxine Mepesuccinate | nan |
| Ombrabulin | nan |
| Omipalisib | nan |
| Onalespib | nan |
| Onalespib Lactate | nan |
| Onartuzumab | nan |
| Onatasertib | nan |
| Oncolytic Adenovirus Ad5-DNX-2401 | nan |
| Oncolytic Adenovirus ORCA-010 | nan |
| Oncolytic Herpes Simplex Virus-1 ONCR-177 | nan |
| Oncolytic HSV-1 C134 | nan |
| Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011 | nan |
| Oncolytic HSV-1 G207 | nan |
| Oncolytic HSV-1 NV1020 | nan |
| Oncolytic HSV-1 rQNestin34.5v.2 | nan |
| Oncolytic HSV-1 rRp450 | nan |
| Oncolytic HSV1716 | nan |
| Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein | nan |
| Oncolytic Newcastle Disease Virus MEDI5395 | nan |
| Oncolytic Newcastle Disease Virus MTH-68H | nan |
| Oncolytic Newcastle Disease Virus Strain PV701 | nan |
| Oncolytic Virus ASP9801 | nan |
| Oncolytic Virus RP1 | nan |
| Ondansetron Hydrochloride | nan |
| Ontorpacept | nan |
| Ontuxizumab | nan |
| Onvansertib | nan |
| Onvatilimab | nan |
| Opaganib | nan |
| OPCs/Green Tea/Spirullina/Curcumin/Antrodia Camphorate/Fermented Soymilk Extract Capsule | nan |
| Opioid Growth Factor | nan |
| Opolimogene Capmilisbac | nan |
| Oportuzumab Monatox | nan |
| Oprozomib | nan |
| Opucolimab | nan |
| Oral Aminolevulinic Acid Hydrochloride | nan |
| Oral Azacitidine | nan |
| Oral Cancer Vaccine V3-OVA | nan |
| Oral Docetaxel | nan |
| Oral Fludarabine Phosphate | nan |
| Oral Hsp90 Inhibitor IPI-493 | nan |
| Oral Ixabepilone | nan |
| Oral Microencapsulated Diindolylmethane | nan |
| Oral Milataxel | nan |
| Oral Myoma Vaccine V3-myoma | nan |
| Oral Pancreatic Cancer Vaccine V3-P | nan |
| Oral Picoplatin | nan |
| Oral Sodium Phenylbutyrate | nan |
| Oral Topotecan Hydrochloride | nan |
| Orantinib | nan |
| Oraxol | nan |
| Oregovomab | nan |
| Orelabrutinib | nan |
| Ormaplatin | nan |
| Ortataxel | nan |
| Orteronel | nan |
| Orvacabtagene Autoleucel | nan |
| Osilodrostat | nan |
| Osimertinib | nan |
| Other | nan |
| Otlertuzumab | nan |
| Ovapuldencel-T | nan |
| Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine DC-006 | nan |
| Ovine Submaxillary Mucin | nan |
| OX40L-expressing Oncolytic Adenovirus DNX-2440 | nan |
| Oxaliplatin | nan |
| Oxaliplatin Eluting Beads | nan |
| Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome | nan |
| Oxcarbazepine | nan |
| Oxeclosporin | nan |
| Oxidative Phosphorylation Inhibitor IACS-010759 | nan |
| Oxidative Phosphorylation Inhibitor IM156 | nan |
| Oxidopamine | nan |
| OxPhos Inhibitor VLX600 | nan |
| Ozarelix | nan |
| P-cadherin Antagonist PF-03732010 | nan |
| P-cadherin Inhibitor PCA062 | nan |
| P-cadherin-targeting Agent PF-06671008 | nan |
| P-p68 Inhibitor RX-5902 | nan |
| P-TEFb Inhibitor BAY1143572 | nan |
| p300/CBP Bromodomain Inhibitor CCS1477 | nan |
| p38 MAPK Inhibitor LY3007113 | nan |
| p53 Peptide Vaccine MPS-128 | nan |
| p53-HDM2 Interaction Inhibitor MI-773 | nan |
| p53-HDM2 Protein-protein Interaction Inhibitor APG-115 | nan |
| p53/HDM2 Interaction Inhibitor CGM097 | nan |
| p70S6K Inhibitor LY2584702 | nan |
| p70S6K/Akt Inhibitor MSC2363318A | nan |
| p97 Inhibitor CB-5083 | nan |
| p97 Inhibitor CB-5339 | nan |
| p97 Inhibitor CB-5339 Tosylate | nan |
| Paclitaxel | nan |
| Paclitaxel Ceribate | nan |
| Paclitaxel Injection Concentrate for Nanodispersion | nan |
| Paclitaxel Liposome | nan |
| Paclitaxel Poliglumex | nan |
| Paclitaxel Polymeric Micelle Formulation NANT-008 | nan |
| Paclitaxel PPE Microspheres | nan |
| Paclitaxel Trevatide | nan |
| Paclitaxel Vitamin E-Based Emulsion | nan |
| Paclitaxel-Loaded Polymeric Micelle | nan |
| Pacmilimab | nan |
| Pacritinib | nan |
| Padeliporfin | nan |
| Padoporfin | nan |
| PAK4 Inhibitor PF-03758309 | nan |
| PAK4/NAMPT Inhibitor KPT-9274 | nan |
| Palbociclib | nan |
| Palbociclib Isethionate | nan |
| Palifosfamide | nan |
| Palifosfamide Tromethamine | nan |
| Palladium Pd-103 | nan |
| Palonosetron Hydrochloride | nan |
| Pamidronate Disodium | nan |
| Pamidronic Acid | nan |
| Pamiparib | nan |
| Pamrevlumab | nan |
| pan FGFR Inhibitor PRN1371 | nan |
| Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514 | nan |
| Pan-AKT Inhibitor ARQ751 | nan |
| Pan-AKT Kinase Inhibitor GSK690693 | nan |
| Pan-FGFR Inhibitor LY2874455 | nan |
| Pan-FLT3/Pan-BTK Multi-kinase Inhibitor CG-806 | nan |
| pan-HER Kinase Inhibitor AC480 | nan |
| Pan-IDH Mutant Inhibitor AG-881 | nan |
| Pan-KRAS Inhibitor BI 1701963 | nan |
| Pan-Mutant-IDH1 Inhibitor Bay-1436032 | nan |
| Pan-mutation-selective EGFR Inhibitor CLN-081 | nan |
| pan-PI3K Inhibitor CLR457 | nan |
| pan-PI3K/mTOR Inhibitor SF1126 | nan |
| Pan-PIM Inhibitor INCB053914 | nan |
| pan-PIM Kinase Inhibitor AZD1208 | nan |
| pan-PIM Kinase Inhibitor NVP-LGB-321 | nan |
| pan-RAF Inhibitor LXH254 | nan |
| Pan-RAF Inhibitor LY3009120 | nan |
| pan-RAF Kinase Inhibitor CCT3833 | nan |
| pan-RAF Kinase Inhibitor TAK-580 | nan |
| Pan-RAR Agonist/AP-1 Inhibitor LGD 1550 | nan |
| Pan-TRK Inhibitor NOV1601 | nan |
| Pan-TRK Inhibitor ONO-7579 | nan |
| Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981 | nan |
| Pancratistatin | nan |
| Panitumumab | nan |
| Panobinostat | nan |
| Panobinostat Nanoparticle Formulation MTX110 | nan |
| Panulisib | nan |
| Paricalcitol | nan |
| PARP 1/2 Inhibitor IMP4297 | nan |
| PARP 1/2 Inhibitor NOV1401 | nan |
| PARP Inhibitor AZD2461 | nan |
| PARP Inhibitor CEP-9722 | nan |
| PARP Inhibitor E7016 | nan |
| PARP Inhibitor NMS-03305293 | nan |
| PARP-1/2 Inhibitor ABT-767 | nan |
| PARP/Tankyrase Inhibitor 2X-121 | nan |
| PARP7 Inhibitor RBN-2397 | nan |
| Parsaclisib | nan |
| Parsaclisib Hydrochloride | nan |
| Parsatuzumab | nan |
| Partially Engineered T-regulatory Cell Donor Graft TRGFT-201 | nan |
| Parvovirus H-1 | nan |
| Pasireotide | nan |
| Pasotuxizumab | nan |
| Patidegib | nan |
| Patidegib Topical Gel | nan |
| Patritumab | nan |
| Patritumab Deruxtecan | nan |
| Patupilone | nan |
| Paxalisib | nan |
| Pazopanib | nan |
| Pazopanib Hydrochloride | nan |
| pbi-shRNA STMN1 Lipoplex | nan |
| PBN Derivative OKN-007 | nan |
| PCNU | nan |
| PD-1 Directed Probody CX-188 | nan |
| PD-1 Inhibitor | nan |
| PD-L1 Inhibitor GS-4224 | nan |
| PD-L1 Inhibitor INCB086550 | nan |
| PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480 | nan |
| PD-L1/PD-L2/VISTA Antagonist CA-170 | nan |
| PDK1 Inhibitor AR-12 | nan |
| pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0 | nan |
| PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1 | nan |
| PEG-interleukin-2 | nan |
| PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1 | nan |
| PEG-Proline-Interferon Alfa-2b | nan |
| Pegargiminase | nan |
| Pegaspargase | nan |
| Pegdinetanib | nan |
| Pegfilgrastim | nan |
| Pegilodecakin | nan |
| Peginterferon Alfa-2a | nan |
| Peginterferon Alfa-2b | nan |
| Pegvisomant | nan |
| Pegvorhyaluronidase Alfa | nan |
| Pegylated Deoxycytidine Analogue DFP-14927 | nan |
| Pegylated Interferon Alfa | nan |
| Pegylated Liposomal Belotecan | nan |
| Pegylated Liposomal Doxorubicin Hydrochloride | nan |
| Pegylated Liposomal Irinotecan | nan |
| Pegylated Liposomal Mitomycin C Lipid-based Prodrug | nan |
| Pegylated Liposomal Mitoxantrone Hydrochloride | nan |
| Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010 | nan |
| Pegylated Paclitaxel | nan |
| Pegylated Recombinant Human Arginase I BCT-100 | nan |
| Pegylated Recombinant Human Hyaluronidase PH20 | nan |
| Pegylated Recombinant Interleukin-2 THOR-707 | nan |
| Pegylated Recombinant L-asparaginase Erwinia chrysanthemi | nan |
| Pegylated SN-38 Conjugate PLX038 | nan |
| Pegzilarginase | nan |
| Pelabresib | nan |
| Pelareorep | nan |
| Peldesine | nan |
| Pelitinib | nan |
| Pelitrexol | nan |
| Pembrolizumab | nan |
| Pemetrexed | nan |
| Pemetrexed Disodium | nan |
| Pemigatinib | nan |
| Pemlimogene Merolisbac | nan |
| Penberol | nan |
| Penclomedine | nan |
| Penicillamine | nan |
| Pentamethylmelamine | nan |
| Pentamustine | nan |
| Pentostatin | nan |
| Pentoxifylline | nan |
| PEOX-based Polymer Encapsulated Paclitaxel FID-007 | nan |
| PEP-3-KLH Conjugate Vaccine | nan |
| Pepinemab | nan |
| Peplomycin | nan |
| Peplomycin Sulfate | nan |
| Peposertib | nan |
| Peptichemio | nan |
| Peptide 946 Melanoma Vaccine | nan |
| Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine | nan |
| Peretinoin | nan |
| Perflenapent Emulsion | nan |
| Perfosfamide | nan |
| Perifosine | nan |
| Perillyl Alcohol | nan |
| Personalized ALL-specific Multi-HLA-binding Peptide Vaccine | nan |
| Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC | nan |
| Personalized Cancer Vaccine RO7198457 | nan |
| Personalized Neoantigen DNA Vaccine GNOS-PV01 | nan |
| Personalized Neoantigen DNA Vaccine GNOS-PVO2 | nan |
| Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01 | nan |
| Personalized Neoepitope Yeast Vaccine YE-NEO-001 | nan |
| Personalized Peptide Cancer Vaccine NEO-PV-01 | nan |
| Pertuzumab | nan |
| Pevonedistat | nan |
| Pexastimogene Devacirepvec | nan |
| Pexidartinib | nan |
| Pexmetinib | nan |
| PGG Beta-Glucan | nan |
| PGLA/PEG Copolymer-Based Paclitaxel | nan |
| PH20 Hyaluronidase-expressing Adenovirus VCN-01 | nan |
| Phaleria macrocarpa Extract DLBS-1425 | nan |
| Pharmacological Ascorbate | nan |
| Phellodendron amurense Bark Extract | nan |
| Phenesterin | nan |
| Phenethyl Isothiocyanate | nan |
| Phenethyl Isothiocyanate-containing Watercress Juice | nan |
| Phenyl Acetate | nan |
| Phenytoin Sodium | nan |
| Phosphaplatin PT-112 | nan |
| Phosphatidylcholine-Bound Silybin | nan |
| Phospholipid Ether-drug Conjugate CLR 131 | nan |
| Phosphoramide Mustard | nan |
| Phosphorodiamidate Morpholino Oligomer AVI-4126 | nan |
| Phosphorus P-32 | nan |
| Photodynamic Compound TLD-1433 | nan |
| Photosensitizer LUZ 11 | nan |
| Phytochlorin Sodium-Polyvinylpyrrolidone Complex | nan |
| PI3K Alpha/Beta Inhibitor BAY1082439 | nan |
| PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate | nan |
| PI3K Inhibitor ACP-319 | nan |
| PI3K Inhibitor BGT226 | nan |
| PI3K Inhibitor GDC-0084 | nan |
| PI3K Inhibitor GDC0077 | nan |
| PI3K Inhibitor GSK1059615 | nan |
| PI3K Inhibitor WX-037 | nan |
| PI3K Inhibitor ZSTK474 | nan |
| PI3K p110beta/delta Inhibitor KA2237 | nan |
| PI3K-alpha Inhibitor MEN1611 | nan |
| PI3K-beta Inhibitor GSK2636771 | nan |
| PI3K-beta Inhibitor SAR260301 | nan |
| PI3K-delta Inhibitor AMG 319 | nan |
| PI3K-delta Inhibitor HMPL 689 | nan |
| PI3K-delta Inhibitor INCB050465 | nan |
| PI3K-delta Inhibitor PWT143 | nan |
| PI3K-delta Inhibitor SHC014748M | nan |
| PI3K-delta Inhibitor YY-20394 | nan |
| PI3K-gamma Inhibitor IPI-549 | nan |
| PI3K/BET Inhibitor LY294002 | nan |
| PI3K/mTOR Kinase Inhibitor DS-7423 | nan |
| PI3K/mTOR Kinase Inhibitor PF-04691502 | nan |
| PI3K/mTOR Kinase Inhibitor VS-5584 | nan |
| PI3K/mTOR Kinase Inhibitor WXFL10030390 | nan |
| PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170 | nan |
| PI3K/mTORC1/mTORC2 Inhibitor DCBCI0901 | nan |
| PI3Ka/mTOR Inhibitor PKI-179 | nan |
| PI3Kalpha Inhibitor AZD8835 | nan |
| PI3Kbeta Inhibitor AZD8186 | nan |
| PI3Kdelta Inhibitor GS-9901 | nan |
| Pibenzimol | nan |
| Pibrozelesin | nan |
| Pibrozelesin Hydrobromide | nan |
| Picibanil | nan |
| Picoplatin | nan |
| Picrasinoside H | nan |
| Picropodophyllin | nan |
| Pictilisib | nan |
| Pictilisib Bismesylate | nan |
| Pidilizumab | nan |
| Pilaralisib | nan |
| PIM Kinase Inhibitor LGH447 | nan |
| PIM Kinase Inhibitor SGI-1776 | nan |
| PIM Kinase Inhibitor TP-3654 | nan |
| PIM/FLT3 Kinase Inhibitor SEL24 | nan |
| Pimasertib | nan |
| Pimitespib | nan |
| Pimurutamab | nan |
| Pinatuzumab Vedotin | nan |
| Pingyangmycin | nan |
| Pinometostat | nan |
| Pioglitazone | nan |
| Pioglitazone Hydrochloride | nan |
| Pipendoxifene | nan |
| Piperazinedione | nan |
| Piperine Extract (Standardized) | nan |
| Pipobroman | nan |
| Piposulfan | nan |
| Pirarubicin | nan |
| Pirarubicin Hydrochloride | nan |
| Pirfenidone | nan |
| Piritrexim | nan |
| Piritrexim Isethionate | nan |
| Pirotinib | nan |
| Piroxantrone | nan |
| Piroxantrone Hydrochloride | nan |
| Pixantrone | nan |
| Pixantrone Dimaleate | nan |
| Pixatimod | nan |
| PKA Regulatory Subunit RIalpha Mixed-Backbone Antisense Oligonucleotide GEM 231 | nan |
| PKC-alpha Antisense Oligodeoxynucleotide ISIS 3521 | nan |
| PKC-beta Inhibitor MS-553 | nan |
| Placebo | nan |
| Pladienolide Derivative E7107 | nan |
| Plamotamab | nan |
| Plasmid DNA Vaccine pING-hHER3FL | nan |
| Platinum | nan |
| Platinum Acetylacetonate-Titanium Dioxide Nanoparticles | nan |
| Platinum Compound | nan |
| Plevitrexed | nan |
| Plicamycin | nan |
| Plinabulin | nan |
| Plitidepsin | nan |
| Plk1 Inhibitor BI 2536 | nan |
| PLK1 Inhibitor CYC140 | nan |
| PLK1 Inhibitor TAK-960 | nan |
| Plocabulin | nan |
| Plozalizumab | nan |
| pNGVL4a-CRT-E6E7L2 DNA Vaccine | nan |
| pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 Fusion Protein TA-CIN Vaccine PVX-2 | nan |
| Pol I Inhibitor CX5461 | nan |
| Polatuzumab Vedotin | nan |
| Polidocanol | nan |
| Poliglusam | nan |
| Polo-like Kinase 1 Inhibitor GSK461364 | nan |
| Polo-like Kinase 1 Inhibitor MK1496 | nan |
| Polo-like Kinase 1 Inhibitor NMS-1286937 | nan |
| Polo-like Kinase 4 Inhibitor CFI-400945 Fumarate | nan |
| Poly-alendronate Dextran-Guanidine Conjugate | nan |
| Poly-gamma Glutamic Acid | nan |
| Polyamine Analog SL11093 | nan |
| Polyamine Analogue PG11047 | nan |
| Polyamine Analogue SBP-101 | nan |
| Polyamine Transport Inhibitor AMXT-1501 Dicaprate | nan |
| Polyandrol | nan |
| Polyethylene Glycol Recombinant Endostatin | nan |
| Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318 | nan |
| Polymer-conjugated IL-15 Receptor Agonist NKTR-255 | nan |
| Polymer-encapsulated Luteolin Nanoparticle | nan |
| Polymeric Camptothecin Prodrug XMT-1001 | nan |
| Polypodium leucotomos Extract | nan |
| Polysaccharide-K | nan |
| Polysialic Acid | nan |
| Polyunsaturated Fatty Acid | nan |
| Polyvalent Melanoma Vaccine | nan |
| Pomalidomide | nan |
| Pomegranate Juice | nan |
| Pomegranate Liquid Extract | nan |
| Ponatinib | nan |
| Ponatinib Hydrochloride | nan |
| Porcupine Inhibitor CGX1321 | nan |
| Porcupine Inhibitor ETC-1922159 | nan |
| Porcupine Inhibitor RXC004 | nan |
| Porcupine Inhibitor WNT974 | nan |
| Porcupine Inhibitor XNW7201 | nan |
| Porfimer Sodium | nan |
| Porfiromycin | nan |
| Poziotinib | nan |
| PPAR Alpha Antagonist TPST-1120 | nan |
| PR1 Leukemia Peptide Vaccine | nan |
| Pracinostat | nan |
| Pralatrexate | nan |
| Pralsetinib | nan |
| Praluzatamab Ravtansine | nan |
| PRAME-targeting T-cell Receptor/Inducible Caspase 9 BPX-701 | nan |
| Pravastatin Sodium | nan |
| Prednimustine | nan |
| Prednisolone | nan |
| Prednisolone Acetate | nan |
| Prednisolone Sodium Phosphate | nan |
| Prednisone | nan |
| Prexasertib | nan |
| Prexigebersen | nan |
| PRIMA-1 Analog APR-246 | nan |
| Prime Cancer Vaccine MVA-BN-CV301 | nan |
| Prinomastat | nan |
| PRMT1 Inhibitor GSK3368715 | nan |
| PRMT5 Inhibitor JNJ-64619178 | nan |
| PRMT5 Inhibitor PRT811 | nan |
| Proapoptotic Sulindac Analog CP-461 | nan |
| Procarbazine | nan |
| Procarbazine Hydrochloride | nan |
| Procaspase Activating Compound-1 VO-100 | nan |
| Progestational IUD | nan |
| Prohibitin-Targeting Peptide 1 | nan |
| Prolgolimab | nan |
| Prostaglandin E2 EP4 Receptor Inhibitor AN0025 | nan |
| Prostaglandin E2 EP4 Receptor Inhibitor E7046 | nan |
| Prostate Cancer Vaccine ONY-P1 | nan |
| Prostate Health Cocktail Dietary Supplement | nan |
| Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024 | nan |
| Protease-activated Anti-PD-L1 Antibody Prodrug CX-072 | nan |
| Protein Arginine Methyltransferase 5 Inhibitor GSK3326595 | nan |
| Protein Arginine Methyltransferase 5 Inhibitor PF-06939999 | nan |
| Protein Arginine Methyltransferase 5 Inhibitor PRT543 | nan |
| Protein Kinase C Inhibitor IDE196 | nan |
| Protein Phosphatase 2A Inhibitor LB-100 | nan |
| Protein Stabilized Liposomal Docetaxel Nanoparticles | nan |
| Protein Tyrosine Kinase 2 Inhibitor IN10018 | nan |
| Proxalutamide | nan |
| PSA/IL-2/GM-CSF Vaccine | nan |
| PSA/PSMA DNA Plasmid INO-5150 | nan |
| Pseudoisocytidine | nan |
| PSMA-targeted Docetaxel Nanoparticles BIND-014 | nan |
| PSMA-targeted Tubulysin B-containing Conjugate EC1169 | nan |
| PSMA/CD3 Tri-specific T-cell Activating Construct HPN424 | nan |
| PTEF-b/CDK9 Inhibitor BAY1251152 | nan |
| Pterostilbene | nan |
| Pumitepa | nan |
| Puquitinib | nan |
| Puquitinib Mesylate | nan |
| Puromycin | nan |
| Puromycin Hydrochloride | nan |
| PV-10 | nan |
| PVA Microporous Hydrospheres/Doxorubicin Hydrochloride | nan |
| Pyrazinamide | nan |
| Pyrazoloacridine | nan |
| Pyridyl Cyanoguanidine CHS 828 | nan |
| Pyrotinib | nan |
| Pyrotinib Dimaleate | nan |
| Pyroxamide | nan |
| Pyruvate Kinase Inhibitor TLN-232 | nan |
| Pyruvate Kinase M2 Isoform Activator TP-1454 | nan |
| Qilisheng Immunoregulatory Oral Solution | nan |
| Quadrivalent Human Papillomavirus (types 6; 11; 16; 18) Recombinant Vaccine | nan |
| Quarfloxin | nan |
| Quinacrine Hydrochloride | nan |
| Quinine | nan |
| Quisinostat | nan |
| Quizartinib | nan |
| R-(-)-Gossypol Acetic Acid | nan |
| Rabusertib | nan |
| Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88 | nan |
| Racotumomab | nan |
| RAD51 Inhibitor CYT-0851 | nan |
| Radgocitabine | nan |
| Radgocitabine Hydrochloride | nan |
| Radioactive Iodine | nan |
| Radiolabeled CC49 | nan |
| Radium Ra 223 Dichloride | nan |
| Radium Ra 224-labeled Calcium Carbonate Microparticles | nan |
| Radix Angelicae Sinensis/Radix Astragali Herbal Supplement | nan |
| Radotinib Hydrochloride | nan |
| Raf Kinase Inhibitor HM95573 | nan |
| RAF Kinase Inhibitor L-779450 | nan |
| RAF Kinase Inhibitor XL281 | nan |
| Ragifilimab | nan |
| Ralaniten Acetate | nan |
| Ralimetinib Mesylate | nan |
| Raloxifene | nan |
| Raloxifene Hydrochloride | nan |
| Raltitrexed | nan |
| Ramucirumab | nan |
| Ranibizumab | nan |
| Ranimustine | nan |
| Ranolazine | nan |
| Ranpirnase | nan |
| RARalpha Agonist IRX5183 | nan |
| Ras Inhibitor | nan |
| Ras Peptide ASP | nan |
| Ras Peptide CYS | nan |
| Ras Peptide VAL | nan |
| Razoxane | nan |
| Realgar-Indigo naturalis Formulation | nan |
| Rebastinib Tosylate | nan |
| Rebeccamycin | nan |
| Rebimastat | nan |
| Receptor Tyrosine Kinase Inhibitor R1530 | nan |
| Recombinant Adenovirus-p53 SCH-58500 | nan |
| Recombinant Anti-WT1 Immunotherapeutic GSK2302024A | nan |
| Recombinant Bacterial Minicells VAX014 | nan |
| Recombinant Bispecific Single-Chain Antibody rM28 | nan |
| Recombinant CD40-Ligand | nan |
| Recombinant Erwinia asparaginase JZP-458 | nan |
| Recombinant Erythropoietin | nan |
| Recombinant Fas Ligand | nan |
| Recombinant Fractalkine | nan |
| Recombinant Granulocyte-Macrophage Colony-Stimulating Factor | nan |
| Recombinant Human 6Ckine | nan |
| Recombinant Human Adenovirus Type 5 H101 | nan |
| Recombinant Human Angiotensin Converting Enzyme 2 APN01 | nan |
| Recombinant Human Apolipoprotein(a) Kringle V MG1102 | nan |
| Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine | nan |
| Recombinant Human Endostatin | nan |
| Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine | nan |
| Recombinant Human Papillomavirus 11-valent Vaccine | nan |
| Recombinant Human Papillomavirus Bivalent Vaccine | nan |
| Recombinant Human Papillomavirus Nonavalent Vaccine | nan |
| Recombinant Human Plasminogen Kringle 5 Domain ABT 828 | nan |
| Recombinant Human TRAIL-Trimer Fusion Protein SCB-313 | nan |
| Recombinant Humanized Anti-HER-2 Bispecific Monoclonal Antibody MBS301 | nan |
| Recombinant Interferon | nan |
| Recombinant Interferon Alfa | nan |
| Recombinant Interferon Alfa-1b | nan |
| Recombinant Interferon Alfa-2a | nan |
| Recombinant Interferon Alfa-2b | nan |
| Recombinant Interferon Alpha 2b-like Protein | nan |
| Recombinant Interferon Beta | nan |
| Recombinant Interferon Gamma | nan |
| Recombinant Interleukin-12 | nan |
| Recombinant Interleukin-13 | nan |
| Recombinant Interleukin-18 | nan |
| Recombinant Interleukin-2 | nan |
| Recombinant Interleukin-6 | nan |
| Recombinant KSA Glycoprotein CO17-1A | nan |
| Recombinant Leukocyte Interleukin | nan |
| Recombinant Leukoregulin | nan |
| Recombinant Luteinizing Hormone | nan |
| Recombinant Macrophage Colony-Stimulating Factor | nan |
| Recombinant MAGE-3.1 Antigen | nan |
| Recombinant MIP1-alpha Variant ECI301 | nan |
| Recombinant Modified Vaccinia Ankara-5T4 Vaccine | nan |
| Recombinant Oncolytic Poliovirus PVS-RIPO | nan |
| Recombinant Platelet Factor 4 | nan |
| Recombinant PRAME Protein Plus AS15 Adjuvant GSK2302025A | nan |
| Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207 | nan |
| Recombinant Super-compound Interferon | nan |
| Recombinant Thyroglobulin | nan |
| Recombinant Thyrotropin Alfa | nan |
| Recombinant Transforming Growth Factor-Beta | nan |
| Recombinant Transforming Growth Factor-Beta-2 | nan |
| Recombinant Tumor Necrosis Factor-Alpha | nan |
| Recombinant Tyrosinase-Related Protein-2 | nan |
| Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter | nan |
| Redaporfin | nan |
| Refametinib | nan |
| Regorafenib | nan |
| Relacorilant | nan |
| Relatlimab | nan |
| Relugolix | nan |
| Remetinostat | nan |
| Renal Cell Carcinoma Peptides Vaccine IMA901 | nan |
| Reparixin | nan |
| Repotrectinib | nan |
| Resiquimod | nan |
| Resiquimod Topical Gel | nan |
| Resistant Starch | nan |
| Resminostat | nan |
| Resveratrol | nan |
| Resveratrol Formulation SRT501 | nan |
| RET Inhibitor DS-5010 | nan |
| RET Mutation/Fusion Inhibitor BLU-667 | nan |
| RET/SRC Inhibitor TPX-0046 | nan |
| Retaspimycin | nan |
| Retaspimycin Hydrochloride | nan |
| Retelliptine | nan |
| Retifanlimab | nan |
| Retinoic Acid Agent Ro 16-9100 | nan |
| Retinoid 9cUAB30 | nan |
| Retinol | nan |
| Retinyl Acetate | nan |
| Retinyl Palmitate | nan |
| Retrovector Encoding Mutant Anti-Cyclin G1 | nan |
| Revdofilimab | nan |
| Rexinoid NRX 194204 | nan |
| Rezivertinib | nan |
| RFT5-dgA Immunotoxin IMTOX25 | nan |
| Rhenium Re 188 BMEDA-labeled Liposomes | nan |
| Rhenium Re-186 Hydroxyethylidene Diphosphonate | nan |
| Rhenium Re-188 Ethiodized Oil | nan |
| Rhenium Re-188 Etidronate | nan |
| Rhizoxin | nan |
| RhoC Peptide Vaccine RV001V | nan |
| Ribociclib | nan |
| Ribociclib/Letrozole | nan |
| Ribonuclease QBI-139 | nan |
| Ribosome-Inactivating Protein CY503 | nan |
| Ribozyme RPI.4610 | nan |
| Rice Bran | nan |
| Ricolinostat | nan |
| Ridaforolimus | nan |
| Rigosertib | nan |
| Rigosertib Sodium | nan |
| Rilimogene Galvacirepvec | nan |
| Rilimogene Galvacirepvec/Rilimogene Glafolivec | nan |
| Rilimogene Glafolivec | nan |
| Rilotumumab | nan |
| Rindopepimut | nan |
| Ripertamab | nan |
| RIPK1 Inhibitor GSK3145095 | nan |
| Ripretinib | nan |
| Risperidone Formulation in Rumenic Acid | nan |
| Ritrosulfan | nan |
| Rituximab | nan |
| Rituximab and Hyaluronidase Human | nan |
| Rituximab Conjugate CON-4619 | nan |
| Riviciclib | nan |
| Rivoceranib | nan |
| Rivoceranib Mesylate | nan |
| RNR Inhibitor COH29 | nan |
| Robatumumab | nan |
| Roblitinib | nan |
| ROBO1-targeted BiCAR-NKT Cells | nan |
| Rocakinogene Sifuplasmid | nan |
| Rocapuldencel-T | nan |
| Rociletinib | nan |
| Rodorubicin | nan |
| Roducitabine | nan |
| Rofecoxib | nan |
| Roflumilast | nan |
| Rogaratinib | nan |
| Rogletimide | nan |
| Rolinsatamab Talirine | nan |
| Romidepsin | nan |
| Roneparstat | nan |
| Roniciclib | nan |
| Ropeginterferon Alfa-2B | nan |
| Ropidoxuridine | nan |
| Ropocamptide | nan |
| Roquinimex | nan |
| RORgamma Agonist LYC-55716 | nan |
| Rosabulin | nan |
| Rose Bengal Solution PV-10 | nan |
| Rosiglitazone Maleate | nan |
| Rosmantuzumab | nan |
| Rosopatamab | nan |
| Rosuvastatin | nan |
| Rovalpituzumab Tesirine | nan |
| RSK1-4 Inhibitor PMD-026 | nan |
| Rubitecan | nan |
| Rucaparib | nan |
| Rucaparib Camsylate | nan |
| Rucaparib Phosphate | nan |
| Ruthenium Ru-106 | nan |
| Ruthenium-based Small Molecule Therapeutic BOLD-100 | nan |
| Ruthenium-based Transferrin Targeting Agent NKP-1339 | nan |
| Ruxolitinib | nan |
| Ruxolitinib Phosphate | nan |
| Ruxotemitide | nan |
| S-Adenosylmethionine | nan |
| S-equol | nan |
| S1P Receptor Agonist KRP203 | nan |
| Sabarubicin | nan |
| Sabatolimab | nan |
| Sacituzumab Govitecan | nan |
| Sacubitril/Valsartan | nan |
| Safingol | nan |
| Sagopilone | nan |
| Salirasib | nan |
| Salmonella VNP20009 | nan |
| Sam68 Modulator CWP232291 | nan |
| Samalizumab | nan |
| Samarium Sm 153-DOTMP | nan |
| Samotolisib | nan |
| Samrotamab Vedotin | nan |
| Samuraciclib | nan |
| Sapacitabine | nan |
| Sapanisertib | nan |
| Sapitinib | nan |
| Saracatinib | nan |
| Saracatinib Difumarate | nan |
| SarCNU | nan |
| Sardomozide | nan |
| Sargramostim | nan |
| Sasanlimab | nan |
| Satraplatin | nan |
| Savolitinib | nan |
| SBIL-2 | nan |
| Scopoletin | nan |
| SDF-1 Receptor Antagonist PTX-9908 | nan |
| Seclidemstat | nan |
| Sedoxantrone Trihydrochloride | nan |
| Selatinib Ditosilate | nan |
| Selective Androgen Receptor Modulator RAD140 | nan |
| Selective Cytokine Inhibitory Drug CC-1088 | nan |
| Selective Estrogen Receptor Degrader AZD9496 | nan |
| Selective Estrogen Receptor Degrader AZD9833 | nan |
| Selective Estrogen Receptor Degrader LSZ102 | nan |
| Selective Estrogen Receptor Degrader LX-039 | nan |
| Selective Estrogen Receptor Degrader LY3484356 | nan |
| Selective Estrogen Receptor Degrader SRN-927 | nan |
| Selective Estrogen Receptor Modulator CC-8490 | nan |
| Selective Estrogen Receptor Modulator TAS-108 | nan |
| Selective Glucocorticoid Receptor Antagonist CORT125281 | nan |
| Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352 | nan |
| Seliciclib | nan |
| Selicrelumab | nan |
| Selinexor | nan |
| Selitrectinib | nan |
| Selonsertib | nan |
| Selpercatinib | nan |
| Selumetinib | nan |
| Selumetinib Sulfate | nan |
| Semaxanib | nan |
| Semuloparin | nan |
| Semustine | nan |
| Seneca Valley Virus-001 | nan |
| Seocalcitol | nan |
| Sepantronium Bromide | nan |
| Serabelisib | nan |
| Serclutamab Talirine | nan |
| SERD D-0502 | nan |
| SERD G1T48 | nan |
| SERD GDC-9545 | nan |
| SERD SAR439859 | nan |
| SERD SHR9549 | nan |
| SERD ZN-c5 | nan |
| Serdemetan | nan |
| Sergiolide | nan |
| Seribantumab | nan |
| Serine/Threonine Kinase Inhibitor CBP501 | nan |
| Serine/Threonine Kinase Inhibitor XL418 | nan |
| Serplulimab | nan |
| Sevacizumab | nan |
| Seviteronel | nan |
| Shared Anti-Idiotype-AB-S006 | nan |
| Shared Anti-Idiotype-AB-S024A | nan |
| Shark Cartilage | nan |
| Shark Cartilage Extract AE-941 | nan |
| Shenqi Fuzheng Injection SQ001 | nan |
| Sho-Saiko-To | nan |
| Short Chain Fatty Acid HQK-1004 | nan |
| SHP-1 Agonist SC-43 | nan |
| SHP2 Inhibitor JAB-3068 | nan |
| SHP2 Inhibitor RLY-1971 | nan |
| SHP2 Inhibitor RMC-4630 | nan |
| SHP2 Inhibitor TNO155 | nan |
| Shu Yu Wan Formula | nan |
| Sialyl Tn Antigen | nan |
| Sialyl Tn-KLH Vaccine | nan |
| Sibrotuzumab | nan |
| siG12D LODER | nan |
| Silatecan AR-67 | nan |
| Silibinin | nan |
| Silicon Phthalocyanine 4 | nan |
| Silmitasertib Sodium | nan |
| Siltuximab | nan |
| Simalikalactone D | nan |
| Simeprevir | nan |
| Simlukafusp Alfa | nan |
| Simmitinib | nan |
| Simotaxel | nan |
| Simtuzumab | nan |
| Simurosertib | nan |
| Sintilimab | nan |
| Siplizumab | nan |
| Sipuleucel-T | nan |
| Siremadlin | nan |
| siRNA-transfected Peripheral Blood Mononuclear Cells APN401 | nan |
| Sirolimus | nan |
| SIRPa-4-1BBL Fusion Protein DSP107 | nan |
| SIRPa-Fc Fusion Protein TTI-621 | nan |
| SIRPa-Fc-CD40L Fusion Protein SL-172154 | nan |
| SIRPa-IgG4-Fc Fusion Protein TTI-622 | nan |
| Sitimagene Ceradenovec | nan |
| Sitravatinib | nan |
| Sivifene | nan |
| Sizofiran | nan |
| SLC6A8 Inhibitor RGX-202 | nan |
| SLCT Inhibitor GNS561 | nan |
| SMAC Mimetic BI 891065 | nan |
| Smac Mimetic GDC-0152 | nan |
| Smac Mimetic GDC-0917 | nan |
| Smac Mimetic LCL161 | nan |
| SMO Protein Inhibitor ZSP1602 | nan |
| Smoothened Antagonist BMS-833923 | nan |
| Smoothened Antagonist LDE225 Topical | nan |
| Smoothened Antagonist LEQ506 | nan |
| Smoothened Antagonist TAK-441 | nan |
| SN-38-Loaded Polymeric Micelles NK012 | nan |
| SNS01-T Nanoparticles | nan |
| Sobuzoxane | nan |
| Sodium Borocaptate | nan |
| Sodium Butyrate | nan |
| Sodium Dichloroacetate | nan |
| Sodium Iodide I-131 | nan |
| Sodium Metaarsenite | nan |
| Sodium Phenylbutyrate | nan |
| Sodium Salicylate | nan |
| Sodium Selenite | nan |
| Sodium Stibogluconate | nan |
| Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108 | nan |
| Sofituzumab Vedotin | nan |
| Solitomab | nan |
| Sonepcizumab | nan |
| Sonidegib | nan |
| Sonolisib | nan |
| Sorafenib | nan |
| Sorafenib Tosylate | nan |
| Sorghum bicolor Supplement | nan |
| Sotigalimab | nan |
| Sotorasib | nan |
| Sotrastaurin | nan |
| Sotrastaurin Acetate | nan |
| Soy Isoflavones | nan |
| Soy Protein Isolate | nan |
| Spanlecortemlocel | nan |
| Sparfosate Sodium | nan |
| Sparfosic Acid | nan |
| Spartalizumab | nan |
| Spebrutinib | nan |
| Spherical Nucleic Acid Nanoparticle NU-0129 | nan |
| Spirogermanium | nan |
| Spiromustine | nan |
| Spiroplatin | nan |
| Splicing Inhibitor H3B-8800 | nan |
| Spongistatin | nan |
| Squalamine Lactate | nan |
| SR-BP1/HSI Inhibitor SR31747A | nan |
| SR-T100 Gel | nan |
| Src Kinase Inhibitor AP 23846 | nan |
| Src Kinase Inhibitor KX2-391 | nan |
| Src Kinase Inhibitor KX2-391 Ointment | nan |
| Src Kinase Inhibitor M475271 | nan |
| Src/Abl Kinase Inhibitor AZD0424 | nan |
| Src/tubulin Inhibitor KX02 | nan |
| SRPK1/ABCG2 Inhibitor SCO-101 | nan |
| ssRNA-based Immunomodulator CV8102 | nan |
| SSTR2-targeting Protein/DM1 Conjugate PEN-221 | nan |
| St. John's Wort | nan |
| Stallimycin | nan |
| Staphylococcal Enterotoxin A | nan |
| Staphylococcal Enterotoxin B | nan |
| STAT Inhibitor OPB-111077 | nan |
| STAT3 Inhibitor DSP-0337 | nan |
| STAT3 Inhibitor OPB-31121 | nan |
| STAT3 Inhibitor OPB-51602 | nan |
| STAT3 Inhibitor TTI-101 | nan |
| STAT3 Inhibitor WP1066 | nan |
| Staurosporine | nan |
| STING Agonist BMS-986301 | nan |
| STING Agonist GSK3745417 | nan |
| STING Agonist IMSA101 | nan |
| STING Agonist MK-1454 | nan |
| STING Agonist SB 11285 | nan |
| STING Agonist TAK-676 | nan |
| STING-activating Cyclic Dinucleotide Agonist MIW815 | nan |
| STING-expressing E. coli SYNB1891 | nan |
| Streptonigrin | nan |
| Streptozocin | nan |
| Strontium Chloride Sr-89 | nan |
| Submicron Particle Paclitaxel Sterile Suspension | nan |
| Sugemalimab | nan |
| Sulfatinib | nan |
| Sulforaphane | nan |
| Sulindac | nan |
| Sulofenur | nan |
| Sumoylation Inhibitor TAK-981 | nan |
| Sunitinib | nan |
| Sunitinib Malate | nan |
| Super Enhancer Inhibitor GZ17-6.02 | nan |
| Superagonist Interleukin-15:Interleukin-15 Receptor alphaSu/Fc Fusion Complex ALT-803 | nan |
| Superoxide Dismutase Mimetic GC4711 | nan |
| Suramin | nan |
| Suramin Sodium | nan |
| Survivin Antigen | nan |
| Survivin Antigen Vaccine DPX-Survivac | nan |
| Survivin mRNA Antagonist EZN-3042 | nan |
| Survivin-expressing CVD908ssb-TXSVN Vaccine | nan |
| Sustained-release Lipid Inhaled Cisplatin | nan |
| Sustained-release Mitomycin C Hydrogel Formulation UGN-101 | nan |
| Sustained-release Mitomycin C Hydrogel Formulation UGN-102 | nan |
| Syk Inhibitor HMPL-523 | nan |
| Synchrotope TA2M Plasmid DNA Vaccine | nan |
| Synchrovax SEM Plasmid DNA Vaccine | nan |
| Synthetic Alkaloid PM00104 | nan |
| Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2 | nan |
| Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1 | nan |
| Synthetic hTERT DNA Vaccine INO-1400 | nan |
| Synthetic hTERT DNA Vaccine INO-1401 | nan |
| Synthetic Hypericin | nan |
| Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201 | nan |
| Synthetic Long E6/E7 Peptides Vaccine HPV-01 | nan |
| Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b | nan |
| Synthetic Plumbagin PCUR-101 | nan |
| T900607 | nan |
| Tabalumab | nan |
| Tabelecleucel | nan |
| Tacedinaline | nan |
| Tafasitamab | nan |
| Tagraxofusp-erzs | nan |
| Talabostat | nan |
| Talabostat Mesylate | nan |
| Talacotuzumab | nan |
| Talactoferrin Alfa | nan |
| Taladegib | nan |
| Talampanel | nan |
| Talaporfin Sodium | nan |
| Talazoparib | nan |
| Taletrectinib | nan |
| Talimogene Laherparepvec | nan |
| Tallimustine | nan |
| Talmapimod | nan |
| Talotrexin | nan |
| Talotrexin Ammonium | nan |
| Taltobulin | nan |
| TAM/c-Met Inhibitor RXDX-106 | nan |
| Tamibarotene | nan |
| Taminadenant | nan |
| Tamoxifen | nan |
| Tamoxifen Citrate | nan |
| Tamrintamab Pamozirine | nan |
| Tandutinib | nan |
| Tanespimycin | nan |
| Tanibirumab | nan |
| Tankyrase Inhibitor STP1002 | nan |
| Tanomastat | nan |
| Tapotoclax | nan |
| Tarenflurbil | nan |
| Tarextumab | nan |
| Tariquidar | nan |
| Tasadenoturev | nan |
| Taselisib | nan |
| Tasidotin | nan |
| Tasisulam | nan |
| Tasisulam Sodium | nan |
| Tasquinimod | nan |
| Taurolidine | nan |
| Tauromustine | nan |
| Taurultam | nan |
| Taurultam Analogue GP-2250 | nan |
| Tavokinogene Telseplasmid | nan |
| Tavolimab | nan |
| Taxane Analogue TPI 287 | nan |
| Taxane Compound | nan |
| Taxol Analogue SID 530 | nan |
| Tazarotene | nan |
| Tazemetostat | nan |
| Tebentafusp | nan |
| Teclistamab | nan |
| Tecogalan Sodium | nan |
| Tefinostat | nan |
| Tegafur | nan |
| Tegafur-gimeracil-oteracil Potassium | nan |
| Tegafur-Gimeracil-Oteracil Potassium-Leucovorin Calcium Oral Formulation | nan |
| Tegafur-Uracil | nan |
| Tegavivint | nan |
| Teglarinad | nan |
| Teglarinad Chloride | nan |
| Telaglenastat | nan |
| Telaglenastat Hydrochloride | nan |
| Telapristone | nan |
| Telapristone Acetate | nan |
| Telatinib Mesylate | nan |
| Telisotuzumab | nan |
| Telisotuzumab Vedotin | nan |
| Telomerase Inhibitor FJ5002 | nan |
| Telomerase-specific Type 5 Adenovirus OBP-301 | nan |
| Teloxantrone | nan |
| Teloxantrone Hydrochloride | nan |
| Telratolimod | nan |
| Temarotene | nan |
| Temoporfin | nan |
| Temozolomide | nan |
| Temsirolimus | nan |
| Tenalisib | nan |
| Tenifatecan | nan |
| Teniposide | nan |
| Tepoditamab | nan |
| Tepotinib | nan |
| Teprotumumab | nan |
| Terameprocol | nan |
| Terfluranol | nan |
| Tergenpumatucel-L | nan |
| Teroxirone | nan |
| Tertomotide | nan |
| Tesetaxel | nan |
| Tesevatinib | nan |
| Tesidolumab | nan |
| Testolactone | nan |
| Testosterone Enanthate | nan |
| Tetanus Toxoid Vaccine | nan |
| Tetradecanoylphorbol Acetate | nan |
| Tetrahydrouridine | nan |
| Tetraphenyl Chlorin Disulfonate | nan |
| Tetrathiomolybdate | nan |
| Tezacitabine | nan |
| Tezacitabine Anhydrous | nan |
| TGF-beta Receptor 1 Inhibitor PF-06952229 | nan |
| TGF-beta Receptor 1 Kinase Inhibitor SH3051 | nan |
| TGF-beta Receptor 1 Kinase Inhibitor YL-13027 | nan |
| TGFa-PE38 Immunotoxin | nan |
| TGFbeta Inhibitor LY3200882 | nan |
| TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein AVID200 | nan |
| Thalicarpine | nan |
| Thalidomide | nan |
| Theliatinib | nan |
| Theramide | nan |
| Therapeutic Angiotensin-(1-7) | nan |
| Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907 | nan |
| Therapeutic Cancer Vaccine ATP128 | nan |
| Therapeutic Estradiol | nan |
| Therapeutic Hydrocortisone | nan |
| Therapeutic Liver Cancer Peptide Vaccine IMA970A | nan |
| Thiarabine | nan |
| Thiodiglycol | nan |
| Thioguanine | nan |
| Thioguanine Anhydrous | nan |
| Thioinosine | nan |
| Thioredoxin-1 Inhibitor PX-12 | nan |
| Thiotepa | nan |
| Thioureidobutyronitrile | nan |
| THL-P | nan |
| Thorium Th 227 Anetumab | nan |
| Thorium Th 227 Anetumab Corixetan | nan |
| Thorium Th 227 Anti-HER2 Monoclonal Antibody BAY2701439 | nan |
| Thorium Th 227 Anti-PSMA Monoclonal Antibody BAY 2315497 | nan |
| Threonine Tyrosine Kinase Inhibitor CFI-402257 | nan |
| Thymidylate Synthase Inhibitor CX1106 | nan |
| Thymidylate Synthase Inhibitor DFP-11207 | nan |
| Thymopentin | nan |
| Thyroid Extract | nan |
| Tiazofurin | nan |
| Tidutamab | nan |
| Tigapotide | nan |
| Tigatuzumab | nan |
| TIGIT Inhibitor M6223 | nan |
| TIGIT-targeting Agent MK-7684 | nan |
| Tilarginine | nan |
| Tilogotamab | nan |
| Tilsotolimod Sodium | nan |
| Timonacic | nan |
| Tin Ethyl Etiopurpurin | nan |
| Tinostamustine | nan |
| Tinzaparin Sodium | nan |
| Tiomolibdate Choline | nan |
| Tiomolibdate Diammonium | nan |
| Tipapkinogene Sovacivec | nan |
| Tipifarnib | nan |
| Tipiracil | nan |
| Tipiracil Hydrochloride | nan |
| Tirabrutinib | nan |
| Tiragolumab | nan |
| Tirapazamine | nan |
| Tirbanibulin | nan |
| Tisagenlecleucel | nan |
| Tislelizumab | nan |
| Tisotumab Vedotin | nan |
| Tivantinib | nan |
| Tivozanib | nan |
| TLC ELL-12 | nan |
| TLR Agonist BDB001 | nan |
| TLR Agonist BSG-001 | nan |
| TLR Agonist CADI-05 | nan |
| TLR-Directed Cationic Lipid-DNA Complex JVRS-100 | nan |
| TLR7 Agonist 852A | nan |
| TLR7 agonist BNT411 | nan |
| TLR7 Agonist LHC165 | nan |
| TLR7/8/9 Antagonist IMO-8400 | nan |
| TLR8 Agonist DN1508052 | nan |
| TLR9 Agonist AST-008 | nan |
| TM4SF1-CAR/EpCAM-CAR-expressing Autologous T Cells | nan |
| Tocilizumab | nan |
| Tocladesine | nan |
| Tocotrienol | nan |
| Tocotrienol-rich Fraction | nan |
| Tolebrutinib | nan |
| Toll-like Receptor 7 Agonist DSP-0509 | nan |
| Tolnidamine | nan |
| Tomaralimab | nan |
| Tomato-Soy Juice | nan |
| Tomivosertib | nan |
| Topical Betulinic Acid | nan |
| Topical Celecoxib | nan |
| Topical Fluorouracil | nan |
| Topical Gemcitabine Hydrochloride | nan |
| Topical Potassium Dobesilate | nan |
| Topical Trichloroacetic Acid | nan |
| Topixantrone | nan |
| Topoisomerase I Inhibitor Genz-644282 | nan |
| Topoisomerase I Inhibitor LMP400 | nan |
| Topoisomerase I Inhibitor LMP776 | nan |
| Topoisomerase I/II Inhibitor NEV-801 | nan |
| Topoisomerase-1 Inhibitor LMP744 | nan |
| Topoisomerase-II Inhibitor Racemic XK469 | nan |
| Topoisomerase-II-beta Inhibitor Racemic XK469 | nan |
| Topotecan | nan |
| Topotecan Hydrochloride | nan |
| Topotecan Hydrochloride Liposomes | nan |
| Topotecan Sustained-release Episcleral Plaque | nan |
| Topsalysin | nan |
| TORC1/2 Kinase Inhibitor DS-3078a | nan |
| Toremifene | nan |
| Toremifene Citrate | nan |
| Toripalimab | nan |
| Tosedostat | nan |
| Tositumomab | nan |
| Total Androgen Blockade | nan |
| Tovetumab | nan |
| Tozasertib Lactate | nan |
| TP40 Immunotoxin | nan |
| Trabectedin | nan |
| Trabedersen | nan |
| TRAIL Receptor Agonist ABBV-621 | nan |
| Trametinib | nan |
| Trametinib Dimethyl Sulfoxide | nan |
| Trans Sodium Crocetinate | nan |
| Transdermal 17beta-Estradiol Gel BHR-200 | nan |
| Transdermal 4-Hydroxytestosterone | nan |
| Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01 | nan |
| Transferrin Receptor-Targeted Liposomal p53 cDNA | nan |
| Transferrin-CRM107 | nan |
| Tranylcypromine Sulfate | nan |
| Trapoxin | nan |
| Trastuzumab | nan |
| Trastuzumab Conjugate BI-CON-02 | nan |
| Trastuzumab Deruxtecan | nan |
| Trastuzumab Duocarmazine | nan |
| Trastuzumab Emtansine | nan |
| Trastuzumab Monomethyl Auristatin F | nan |
| Trastuzumab-TLR 7/8 Agonist BDC-1001 | nan |
| Trastuzumab/Hyaluronidase-oysk | nan |
| Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502 | nan |
| Trebananib | nan |
| Tremelimumab | nan |
| Treosulfan | nan |
| Tretazicar | nan |
| Tretinoin | nan |
| Tretinoin Liposome | nan |
| Triamcinolone Acetonide | nan |
| Triamcinolone Hexacetonide | nan |
| Triapine | nan |
| Triazene Derivative CB10-277 | nan |
| Triazene Derivative TriN2755 | nan |
| Triazinate | nan |
| Triaziquone | nan |
| Tributyrin | nan |
| Triciribine Phosphate | nan |
| Trientine Hydrochloride | nan |
| Triethylenemelamine | nan |
| Trifluridine | nan |
| Trifluridine and Tipiracil Hydrochloride | nan |
| Trigriluzole | nan |
| Trilaciclib | nan |
| Trimelamol | nan |
| Trimeric GITRL-Fc OMP-336B11 | nan |
| Trimethylcolchicinic Acid | nan |
| Trimetrexate | nan |
| Trimetrexate Glucuronate | nan |
| Trioxifene | nan |
| Triplatin Tetranitrate | nan |
| Triptolide Analog | nan |
| Triptorelin | nan |
| Triptorelin Pamoate | nan |
| Tris-acryl Gelatin Microspheres | nan |
| Tritylcysteine | nan |
| TRK Inhibitor AZD6918 | nan |
| TRK Inhibitor TQB3558 | nan |
| TrkA Inhibitor VMD-928 | nan |
| Trodusquemine | nan |
| Trofosfamide | nan |
| Troglitazone | nan |
| Tropomyosin Receptor Kinase Inhibitor AZD7451 | nan |
| Troriluzole | nan |
| Troxacitabine | nan |
| Troxacitabine Nucleotide Prodrug MIV-818 | nan |
| TRPM8 Agonist D-3263 | nan |
| TRPV6 Calcium Channel Inhibitor SOR-C13 | nan |
| TSP-1 Mimetic ABT-510 | nan |
| TSP-1 Mimetic Fusion Protein CVX-045 | nan |
| Tubercidin | nan |
| Tubulin Binding Agent TTI-237 | nan |
| Tubulin Inhibitor ALB 109564 Dihydrochloride | nan |
| Tubulin Inhibitor ALB-109564 | nan |
| Tubulin Polymerization Inhibitor AEZS 112 | nan |
| Tubulin Polymerization Inhibitor CKD-516 | nan |
| Tubulin Polymerization Inhibitor VERU-111 | nan |
| Tubulin-Binding Agent SSR97225 | nan |
| Tucatinib | nan |
| Tucidinostat | nan |
| Tucotuzumab Celmoleukin | nan |
| Tyroserleutide | nan |
| Tyrosinase Peptide | nan |
| Tyrosinase-KLH | nan |
| Tyrosinase:146-156 Peptide | nan |
| Tyrosine Kinase Inhibitor | nan |
| Tyrosine Kinase Inhibitor OSI-930 | nan |
| Tyrosine Kinase Inhibitor SU5402 | nan |
| Tyrosine Kinase Inhibitor TL-895 | nan |
| Tyrosine Kinase Inhibitor XL228 | nan |
| UAE Inhibitor TAK-243 | nan |
| Ubenimex | nan |
| Ubidecarenone Nanodispersion BPM31510n | nan |
| Ublituximab | nan |
| Ulinastatin | nan |
| Ulixertinib | nan |
| Ulocuplumab | nan |
| Umbralisib | nan |
| Uncaria tomentosa Extract | nan |
| Upamostat | nan |
| Upifitamab | nan |
| Uproleselan | nan |
| Uprosertib | nan |
| Urabrelimab | nan |
| Uracil Ointment | nan |
| Urelumab | nan |
| Uroacitides | nan |
| Urokinase-Derived Peptide A6 | nan |
| Ursolic Acid | nan |
| USP14/UCHL5 Inhibitor VLX1570 | nan |
| Utomilumab | nan |
| Uzansertib | nan |
| V930 Vaccine | nan |
| Vaccine-Sensitized Draining Lymph Node Cells | nan |
| Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules | nan |
| Vactosertib | nan |
| Vadacabtagene Leraleucel | nan |
| Vadastuximab Talirine | nan |
| Vadimezan | nan |
| Valecobulin | nan |
| Valemetostat | nan |
| Valproic Acid | nan |
| Valrubicin | nan |
| Valspodar | nan |
| Vandetanib | nan |
| Vandetanib-eluting Radiopaque Bead BTG-002814 | nan |
| Vandortuzumab Vedotin | nan |
| Vantictumab | nan |
| Vanucizumab | nan |
| Vapreotide | nan |
| Varlilumab | nan |
| Varlitinib | nan |
| Varlitinib Tosylate | nan |
| Vascular Disrupting Agent BNC105 | nan |
| Vascular Disrupting Agent BNC105P | nan |
| Vascular Disrupting Agent ZD6126 | nan |
| Vatalanib | nan |
| Vatalanib Succinate | nan |
| Vecabrutinib | nan |
| Vector-peptide Conjugated Paclitaxel | nan |
| Vedolizumab | nan |
| VEGF Inhibitor PTC299 | nan |
| VEGF/HGF-targeting DARPin MP0250 | nan |
| VEGFR Inhibitor KRN951 | nan |
| VEGFR-2 DNA Vaccine VXM01 | nan |
| VEGFR/FGFR Inhibitor ODM-203 | nan |
| VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593 | nan |
| VEGFR2 Tyrosine Kinase Inhibitor PF-00337210 | nan |
| VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813 | nan |
| Veliparib | nan |
| Veltuzumab | nan |
| Vemurafenib | nan |
| Venetoclax | nan |
| Verapamil | nan |
| Verpasep Caltespen | nan |
| Verubulin | nan |
| Verubulin Hydrochloride | nan |
| Vesencumab | nan |
| Vesigenurtucel-L | nan |
| VGEF Mixed-Backbone Antisense Oligonucleotide GEM 220 | nan |
| VGEFR/c-kit/PDGFR Tyrosine Kinase Inhibitor XL820 | nan |
| Viagenpumatucel-L | nan |
| Vibecotamab | nan |
| Vibostolimab | nan |
| Vilaprisan | nan |
| Vinblastine | nan |
| Vinblastine Sulfate | nan |
| Vincristine | nan |
| Vincristine Liposomal | nan |
| Vincristine Sulfate | nan |
| Vincristine Sulfate Liposome | nan |
| Vindesine | nan |
| Vinepidine | nan |
| Vinflunine | nan |
| Vinflunine Ditartrate | nan |
| Vinfosiltine | nan |
| Vinorelbine | nan |
| Vinorelbine Tartrate | nan |
| Vinorelbine Tartrate Emulsion | nan |
| Vinorelbine Tartrate Oral | nan |
| Vintafolide | nan |
| Vinzolidine | nan |
| Vinzolidine Sulfate | nan |
| Virulizin | nan |
| Vismodegib | nan |
| Vistusertib | nan |
| Vitamin D3 Analogue ILX23-7553 | nan |
| Vitamin E Compound | nan |
| Vitespen | nan |
| VLP-encapsulated TLR9 Agonist CMP-001 | nan |
| Vocimagene Amiretrorepvec | nan |
| Vofatamab | nan |
| Volasertib | nan |
| Volociximab | nan |
| Vonlerolizumab | nan |
| Vopratelimab | nan |
| Vorasidenib | nan |
| Vorinostat | nan |
| Vorolanib | nan |
| Vorsetzumab Mafodotin | nan |
| Vosaroxin | nan |
| Vosilasarm | nan |
| Voxtalisib | nan |
| Vulinacimab | nan |
| Warfarin Sodium | nan |
| Wee1 Inhibitor ZN-c3 | nan |
| Wee1 Kinase Inhibitor Debio 0123 | nan |
| White Carrot | nan |
| Wnt Signaling Inhibitor SM04755 | nan |
| Wnt Signaling Pathway Inhibitor SM08502 | nan |
| Wnt-5a Mimic Hexapeptide Foxy-5 | nan |
| Wobe-Mugos E | nan |
| WT1 Peptide Vaccine OCV-501 | nan |
| WT1 Peptide Vaccine WT2725 | nan |
| WT1 Protein-derived Peptide Vaccine DSP-7888 | nan |
| WT1-A10/AS01B Immunotherapeutic GSK2130579A | nan |
| WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401 | nan |
| Xanthohumol | nan |
| XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410 | nan |
| Xeloda | nan |
| Xentuzumab | nan |
| Xevinapant | nan |
| Xiaoai Jiedu Decoction | nan |
| XIAP Antisense Oligonucleotide AEG35156 | nan |
| XIAP/cIAP1 Antagonist ASTX660 | nan |
| Xiliertinib | nan |
| Xisomab 3G3 | nan |
| XPO1 Inhibitor SL-801 | nan |
| Y 90 Monoclonal Antibody CC49 | nan |
| Y 90 Monoclonal Antibody HMFG1 | nan |
| Y 90 Monoclonal Antibody Lym-1 | nan |
| Y 90 Monoclonal Antibody m170 | nan |
| Y 90 Monoclonal Antibody M195 | nan |
| Yang Yin Fu Zheng | nan |
| Yangzheng Xiaoji Extract | nan |
| Yiqi-yangyin-jiedu Herbal Decoction | nan |
| Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12 | nan |
| Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 | nan |
| Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 | nan |
| Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101 | nan |
| Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66 | nan |
| Yttrium Y 90 Basiliximab | nan |
| Yttrium Y 90 Colloid | nan |
| Yttrium Y 90 Daclizumab | nan |
| Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A | nan |
| Yttrium Y 90 Glass Microspheres | nan |
| Yttrium Y 90 Monoclonal Antibody B3 | nan |
| Yttrium Y 90 Monoclonal Antibody BrE-3 | nan |
| Yttrium Y 90 Monoclonal Antibody Hu3S193 | nan |
| Yttrium Y 90 Monoclonal Antibody MN-14 | nan |
| Yttrium Y 90 Resin Microspheres | nan |
| Yttrium Y 90 Tabituximab Barzuxetan | nan |
| Yttrium Y 90-DOTA-Biotin | nan |
| Yttrium Y 90-DOTA-di-HSG Peptide IMP-288 | nan |
| Yttrium Y 90-Edotreotide | nan |
| Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101 | nan |
| Yttrium Y-90 Clivatuzumab Tetraxetan | nan |
| Yttrium Y-90 Epratuzumab Tetraxetan | nan |
| Yttrium Y-90 Ibritumomab Tiuxetan | nan |
| Yttrium Y-90 Tacatuzumab Tetraxetan | nan |
| Yttrium-90 Polycarbonate Brachytherapy Plaque | nan |
| Z-Endoxifen Hydrochloride | nan |
| Zalcitabine | nan |
| Zalifrelimab | nan |
| Zalutumumab | nan |
| Zandelisib | nan |
| Zanidatamab | nan |
| Zanolimumab | nan |
| Zanubrutinib | nan |
| Zebularine | nan |
| Zelavespib | nan |
| Zibotentan | nan |
| Zinc Finger Nuclease ZFN-603 | nan |
| Zinc Finger Nuclease ZFN-758 | nan |
| Zinostatin | nan |
| Zinostatin Stimalamer | nan |
| Zirconium Zr 89 Panitumumab | nan |
| Ziv-Aflibercept | nan |
| Zolbetuximab | nan |
| Zoledronic Acid | nan |
| Zoptarelin Doxorubicin | nan |
| Zorifertinib | nan |
| Zorubicin | nan |
| Zorubicin Hydrochloride | nan |
| Zotatifin | nan |
| Zotiraciclib Citrate | nan |
| Zuclomiphene Citrate | nan |
| Unknown | nan |
| Not Reported | nan |